Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Vaccines

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 829 articles:
HTML format



Single Articles


    January 2024
  1. CZARNEK G, Kossowska M
    Strong correlational but no causal evidence on the link between the perception of scientific consensus and support for vaccination.
    PLoS One. 2024;19:e0296066.
    PubMed     Abstract available


  2. FLUSBERG SJ, Mackey A, Semino E
    Seatbelts and raincoats, or banks and castles: Investigating the impact of vaccine metaphors.
    PLoS One. 2024;19:e0294739.
    PubMed     Abstract available


  3. MATSUMURA A, Garg R, Hussain M, Matsumura ME, et al
    Political orientation of online media sources and reporting of Covid-19 vaccine myocarditis.
    PLoS One. 2024;19:e0296295.
    PubMed     Abstract available


  4. ALALAWI M, Alsalloum MA, Garwan YM, Abuzeid M, et al
    COVID-19 vaccine hesitancy among healthcare workers in Arab Countries: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0296432.
    PubMed     Abstract available


  5. RABIENIA M, Mortazavidehkordi N, Roudbari Z, Daneshi R, et al
    Designing of a new multi-epitope vaccine against Leishmania major using Leish-F1 epitopes: An In-silico study.
    PLoS One. 2024;19:e0295495.
    PubMed     Abstract available


  6. SAFARI D, Daningrat WOD, Milucky JL, Khoeri MM, et al
    Nasopharyngeal carriage of Streptococcus pneumoniae among children <5 years of age in Indonesia prior to pneumococcal conjugate vaccine introduction.
    PLoS One. 2024;19:e0297041.
    PubMed     Abstract available



  7. Expression of Concern: Split inactivated COBRA vaccine elicits protective antibodies against H1N1 and H3N2 influenza viruses.
    PLoS One. 2024;19:e0297253.
    PubMed    


  8. HAMILTON LC
    Trumpism, climate and COVID: Social bases of the new science rejection.
    PLoS One. 2024;19:e0293059.
    PubMed     Abstract available


  9. ETERAFI M, Fouladi N, Golizadeh M, Shaker H, et al
    Reported side-effects following Oxford/AstraZeneca COVID-19 vaccine in the north-west province, Iran: A cross-sectional study.
    PLoS One. 2024;19:e0296669.
    PubMed     Abstract available


  10. AL-KAIF LAIK, Al-Ameri H, Alfatlawi WRO, Mahdi AE, et al
    Detection of CTLA-4 level and humeral immune response after the second dose of COVID-19 vaccine in certain Iraqi provinces participants.
    PLoS One. 2024;19:e0296521.
    PubMed     Abstract available


  11. SETIAWAN D, Nurulita NA, Khoirunnisa SM, Postma MJ, et al
    The clinical effectiveness of one-dose vaccination with an HPV vaccine: A meta-analysis of 902,368 vaccinated women.
    PLoS One. 2024;19:e0290808.
    PubMed     Abstract available


  12. AIMAN S, Farooq QUA, Han Z, Aslam M, et al
    Core-genome-mediated promising alternative drug and multi-epitope vaccine targets prioritization against infectious Clostridium difficile.
    PLoS One. 2024;19:e0293731.
    PubMed     Abstract available


  13. SAAKA SA, Mohammed K, K A Pienaah C, Luginaah I, et al
    Child malaria vaccine uptake in Ghana: Factors influencing parents' willingness to allow vaccination of their children under five (5) years.
    PLoS One. 2024;19:e0296934.
    PubMed     Abstract available


  14. MORCIANO C, Spila Alegiani S, Menniti Ippolito F, Belleudi V, et al
    Post-marketing active surveillance of Guillain Barre Syndrome following COVID-19 vaccination in persons aged >/=12 years in Italy: A multi-database self-controlled case series study.
    PLoS One. 2024;19:e0290879.
    PubMed     Abstract available


  15. HOBBS A, Aldosery A, Kostkova P
    Low credibility URL sharing on Twitter during reporting linking rare blood clots with the Oxford/AstraZeneca COVID-19 vaccine.
    PLoS One. 2024;19:e0296444.
    PubMed     Abstract available


  16. VENKATESAN MM, Barnoy S, Frenck R, McNeal M, et al
    B memory cell responses to LPS, IVP and IpaB antigen after oral vaccination with Shigella sonnei vaccine candidates WRSs2 and WRSs3.
    PLoS One. 2024;19:e0290987.
    PubMed     Abstract available


  17. GUILLAUME D, Waheed DE, Schleiff M, Muralidharan KK, et al
    Global perspectives of determinants influencing HPV vaccine introduction and scale-up in low- and middle-income countries.
    PLoS One. 2024;19:e0291990.
    PubMed     Abstract available


  18. SOW A, Diallo C, Cherifi H
    Interplay between vaccines and treatment for dengue control: An epidemic model.
    PLoS One. 2024;19:e0295025.
    PubMed     Abstract available


  19. TREGNAGO D, Avancini A, Belluomini L, Trestini I, et al
    Cross-sectional survey evaluating the psychological impact of the COVID-19 vaccination campaign in patients with cancer: The VACCINATE study.
    PLoS One. 2024;19:e0290792.
    PubMed     Abstract available


  20. LIU CC, Ling J, Zahry NR, Liu C, et al
    Using the Theory of Planned Behavior to determine COVID-19 vaccination intentions and behavior among international and domestic college students in the United States.
    PLoS One. 2024;19:e0293130.
    PubMed     Abstract available


  21. GEHRING S, Kowalzik F, Okasha O, Engelmann T, et al
    A prospective cohort study of SARS-CoV-2 infection-induced seroconversion and disease incidence in German healthcare workers before and during the rollout of COVID-19 vaccines.
    PLoS One. 2024;19:e0294025.
    PubMed     Abstract available


  22. ASADI-POOYA AA, Nemati M, Shahisavandi M, Nemati H, et al
    How does COVID-19 vaccination affect long-COVID symptoms?
    PLoS One. 2024;19:e0296680.
    PubMed     Abstract available


  23. AGIMAS MC, Asmamaw M, Mekonen N, Mamo F, et al
    Spatial pattern and associated factors of timely vaccination in Ethiopia using EDHS-2016 data: A multilevel and spatial analysis.
    PLoS One. 2024;19:e0296123.
    PubMed     Abstract available


  24. LAUE T, Junge N, Leiskau C, Mutschler F, et al
    Diminished measles immunity after paediatric liver transplantation-A retrospective, single-centre, cross-sectional analysis.
    PLoS One. 2024;19:e0296653.
    PubMed     Abstract available


  25. SARMIENTO-MEDINA MI, de Amaya MP, Villamizar-Gomez L, Gonzalez-Coba AC, et al
    High-risk HPV prevalence and vaccination coverage among Indigenous women in the Colombian Amazon: Implications for cervical cancer prevention. Cross-sectional study.
    PLoS One. 2024;19:e0297579.
    PubMed     Abstract available


  26. UDOAKANG AJ, Nganyewo NN, Djomkam Zune AL, Olwal CO, et al
    Knowledge, attitude and perception towards COVID-19 among representative educated sub-Saharan Africans: A cross-sectional study during the exponential phase of the pandemic.
    PLoS One. 2024;19:e0281342.
    PubMed     Abstract available


  27. TAKEBAYASHI M, Namba M, Kaneda Y, Koyama T, et al
    How can we promote vaccination of the mass population?-Lessons from the COVID-19 vaccination defaults.
    PLoS One. 2024;19:e0298983.
    PubMed     Abstract available


  28. PELLETIER C, Gagnon D, Dube E
    "It's not that I don't trust vaccines, I just don't think I need them": Perspectives on COVID-19 vaccination.
    PLoS One. 2024;19:e0293643.
    PubMed     Abstract available


  29. MANZEMU DG, Opara JPA, Kasai ET, Mumbere M, et al
    Rotavirus and adenovirus infections in children with acute gastroenteritis after introducing the Rotasiil(R) vaccine in Kisangani, Democratic Republic of the Congo.
    PLoS One. 2024;19:e0297219.
    PubMed     Abstract available


  30. VEPACHEDU S, Nurzenska A, Lohiniva AL, Hudi AH, et al
    Understanding COVID-19 vaccination behaviors and intentions in Ghana: A Behavioral Insights (BI) study.
    PLoS One. 2024;19:e0292532.
    PubMed     Abstract available


    January 2023
  31. TESFA GA, Yehualashet DE, Getnet A, Bimer KB, et al
    Spatial distribution of complete basic childhood vaccination and associated factors among children aged 12-23 months in Ethiopia. A spatial and multilevel analysis.
    PLoS One. 2023;18:e0279399.
    PubMed     Abstract available


  32. ANZALONE AJ, Sun J, Vinson AJ, Beasley WH, et al
    Community risks for SARS-CoV-2 infection among fully vaccinated US adults by rurality: A retrospective cohort study from the National COVID Cohort Collaborative.
    PLoS One. 2023;18:e0279968.
    PubMed     Abstract available


  33. TESHALE AB, Amare T
    Exploring spatial variations and the individual and contextual factors of uptake of measles-containing second dose vaccine among children aged 24 to 35 months in Ethiopia.
    PLoS One. 2023;18:e0280083.
    PubMed     Abstract available


  34. KIM Y, Kim J, Li Y
    Did Massachusetts COVID-19 vaccine lottery increase vaccine uptake?
    PLoS One. 2023;18:e0279283.
    PubMed     Abstract available


  35. REIS AT, Camacho KG, Junqueira-Marinho MF, Gomes Junior SCDS, et al
    Trustworthiness of information sources on vaccines for COVID-19 prevention among Brazilians.
    PLoS One. 2023;18:e0279393.
    PubMed     Abstract available


  36. COVAS DT, de Jesus Lopes de Abreu A, Zampirolli Dias C, Vansan Ferreira R, et al
    Adverse events of COVID-19 vaccines in pregnant and postpartum women in Brazil: A cross-sectional study.
    PLoS One. 2023;18:e0280284.
    PubMed     Abstract available


  37. SHIRAHMADI S, Hazavehei SMM, Abbasi H, Otogara M, et al
    Effectiveness of online practical education on vaccination training in the students of bachelor programs during the Covid-19 pandemic.
    PLoS One. 2023;18:e0280312.
    PubMed     Abstract available


  38. BUNTING SR, Morris S, Chael J, Feinstein BA, et al
    Knowledge of human papillomavirus vaccination: A multi-institution, cross-sectional study of allopathic and osteopathic medical students.
    PLoS One. 2023;18:e0280287.
    PubMed     Abstract available


  39. ARITA T, Suzuki Y, Shimasaki N, Kobayashi H, et al
    Identification of the properties of H5 influenza vaccine viruses with high hemagglutinin yields.
    PLoS One. 2023;18:e0280811.
    PubMed     Abstract available


  40. SCHNEIDER KA, Tsoungui Obama HCJ, Adil Mahmoud Yousif N
    A flexible age-dependent, spatially-stratified predictive model for the spread of COVID-19, accounting for multiple viral variants and vaccines.
    PLoS One. 2023;18:e0277505.
    PubMed     Abstract available


  41. CHO FN, Ngah YE, Tassang AN, Fru CN, et al
    Face mask ownership/utilisation and COVID-19 vaccine hesitancy amongst patients recovering from COVID-19 in Cameroon: A cross-sectional study.
    PLoS One. 2023;18:e0280269.
    PubMed     Abstract available


  42. NARTEY Y, Amo-Antwi K, Hill PC, Dassah ET, et al
    Human papillomavirus genotype distribution among women with and without cervical cancer: Implication for vaccination and screening in Ghana.
    PLoS One. 2023;18:e0280437.
    PubMed     Abstract available


  43. IZEOGU C, Gill E, Van Allen K, Williams N, et al
    Attitudes, perceptions, and preferences towards SARS CoV-2 testing and vaccination among African American and Hispanic public housing residents, New York City: 2020-2021.
    PLoS One. 2023;18:e0280460.
    PubMed     Abstract available


  44. VILLAVICENCIO A, Kelsey G, Nogueira NF, Zukerberg J, et al
    Knowledge, attitudes, and practices towards HPV vaccination among reproductive age women in a HIV hotspot in the US.
    PLoS One. 2023;18:e0275141.
    PubMed     Abstract available


  45. CADDY C, Cheong M, Lim MSC, Power R, et al
    "Tell us what's going on": Exploring the information needs of pregnant and post-partum women in Australia during the pandemic with 'Tweets', 'Threads', and women's views.
    PLoS One. 2023;18:e0279990.
    PubMed     Abstract available


  46. DE FOUW M, Stroeken Y, Niwagaba B, Musheshe M, et al
    Involving men in cervical cancer prevention; a qualitative enquiry into male perspectives on screening and HPV vaccination in Mid-Western Uganda.
    PLoS One. 2023;18:e0280052.
    PubMed     Abstract available


  47. KONTOS Z
    Reducing Vaccinia virus transmission indoors within 60 seconds: Applying SAFEAIR-X aerosol with Iodine-V as a disinfectant.
    PLoS One. 2023;18:e0279027.
    PubMed     Abstract available


  48. MERKELBACH I, Magnee T, Sana S, Kollmann J, et al
    Using the health belief model to explain COVID-19 vaccination hesitancy in Dutch urban citizens under thirty.
    PLoS One. 2023;18:e0279453.
    PubMed     Abstract available


  49. TAKAHASHI M, Saito K, Ai T, Nojiri S, et al
    Performance evaluation of the Ortho VITROS SARS-CoV-2 Spike-Specific Quantitative IgG test by comparison with the surrogate virus neutralizing antibody test and clinical assessment.
    PLoS One. 2023;18:e0279779.
    PubMed     Abstract available


  50. EMIRE MS, Shiferaw BZ
    Attitudes towards receiving COVID-19 vaccine and its associated factors among Southwest Ethiopian adults, 2021.
    PLoS One. 2023;18:e0280633.
    PubMed     Abstract available


  51. ONIFADE AA, Fowotade A, Rahamon SK, Edem VF, et al
    Seroprevalence of anti-SARS-CoV-2 specific antibodies in vaccinated and vaccine naive adult Nigerians.
    PLoS One. 2023;18:e0280276.
    PubMed     Abstract available


  52. ASADIAN M, Hassanzadeh SM, Safarchi A, Douraghi M, et al
    The effect of in vitro consecutive passages and culture medium on the genetic variations in BCG Pasteur 1173P2 vaccine.
    PLoS One. 2023;18:e0280294.
    PubMed     Abstract available


  53. DIAS HF, Mochizuki Y, Kuhtreiber WM, Takahashi H, et al
    Bacille Calmette Guerin (BCG) and prevention of types 1 and 2 diabetes: Results of two observational studies.
    PLoS One. 2023;18:e0276423.
    PubMed     Abstract available


  54. PRAPHASIRI P, Prasert K, Shrestha M, Ditsungnoen D, et al
    Does prior vaccination affect the immune response to seasonal influenza vaccination among older adults? Findings from a prospective cohort study in a Northeastern Province of Thailand.
    PLoS One. 2023;18:e0279962.
    PubMed     Abstract available


  55. KINYILI M, Munyakazi JB, Mukhtar AYA
    Modeling the impact of combined use of COVID Alert SA app and vaccination to curb COVID-19 infections in South Africa.
    PLoS One. 2023;18:e0264863.
    PubMed     Abstract available


  56. LANGAT B, Muge EK, Night D, Okoth F, et al
    Sero-prevalence of hepatitis B virus and compliance with hepatitis B vaccination schedules among outpatient clinic attendees in Nairobi.
    PLoS One. 2023;18:e0281256.
    PubMed     Abstract available


  57. ABAD N, Messinger SD, Huang Q, Hendrich MA, et al
    A qualitative study of behavioral and social drivers of COVID-19 vaccine confidence and uptake among unvaccinated Americans in the US April-May 2021.
    PLoS One. 2023;18:e0281497.
    PubMed     Abstract available


  58. LOHINIVA AL, Nurzhynska A, Mueed A, Ali A, et al
    Strengthening polio vaccine demand in Ghana: Understanding the factors influencing uptake of the vaccine and the effectiveness of different message frames.
    PLoS One. 2023;18:e0279809.
    PubMed     Abstract available


  59. PUSPITASARI M, Sattwika PD, Rahari DS, Wijaya W, et al
    Outcomes of vaccinations against respiratory diseases in patients with end-stage renal disease undergoing hemodialysis: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0281160.
    PubMed     Abstract available


  60. GAROFALO E, Biamonte F, Palmieri C, Battaglia AM, et al
    Severe and mild-moderate SARS-CoV-2 vaccinated patients show different frequencies of IFNgamma-releasing cells: An exploratory study.
    PLoS One. 2023;18:e0281444.
    PubMed     Abstract available


  61. KLOSE AM, Kosoy G, Miller BL
    Arrayed Imaging Reflectometry monitoring of anti-viral antibody production throughout vaccination and breakthrough Covid-19.
    PLoS One. 2023;18:e0277846.
    PubMed     Abstract available


  62. MARIANO IHM, Silva BF, Machado MDS, Blanco RM, et al
    Analysis of LruC lipoprotein and identification of peptides candidates for vaccine development and diagnosis of leptospirosis.
    PLoS One. 2023;18:e0281344.
    PubMed     Abstract available


  63. COLVIN KM, Camara KS, Adams LS, Sarpong AP, et al
    Profiles of COVID-19 vaccine hesitancy by race and ethnicity in eastern Pennsylvania.
    PLoS One. 2023;18:e0280245.
    PubMed     Abstract available


  64. CHAMORRO G, Kawabata A, Carvalho MDG, Pimenta FC, et al
    Nasopharyngeal colonization by Streptococcus pneumoniae in children and adults before the introduction of the 10-valent conjugate vaccine, Paraguay.
    PLoS One. 2023;18:e0280722.
    PubMed     Abstract available


  65. LONCAREVIC GS, Jovanovic AL, Kanazir MS, Kisic Tepavcevic DB, et al
    Are pediatricians responsible for maintaining high MMR vaccination coverage? Nationwide survey on parental knowledge and attitudes towards MMR vaccine in Serbia.
    PLoS One. 2023;18:e0281495.
    PubMed     Abstract available


  66. YEO M, Seo J, Lim J
    The impact of the COVID-19 pandemic and the expansion of free vaccination policy on influenza vaccination coverage: An analysis of vaccination behavior in South Korea.
    PLoS One. 2023;18:e0281812.
    PubMed     Abstract available


  67. HORN M, Theilacker C, Sprenger R, von Eiff C, et al
    Mathematical modeling of pneumococcal transmission dynamics in response to PCV13 infant vaccination in Germany predicts increasing IPD burden due to serotypes included in next-generation PCVs.
    PLoS One. 2023;18:e0281261.
    PubMed     Abstract available


  68. CHOURPILIADIS C, Lovik A, Kahler AK, Valdimarsdottir UA, et al
    Short-term improvement of mental health after a COVID-19 vaccination.
    PLoS One. 2023;18:e0280587.
    PubMed     Abstract available


  69. LEONG DP, Zhang A, Breznik JA, Clare R, et al
    Comparison of three dosing intervals for the primary vaccination of the SARS-CoV-2 mRNA Vaccine (BNT162b2) on magnitude, neutralization capacity and durability of the humoral immune response in health care workers: A prospective cohort study.
    PLoS One. 2023;18:e0281673.
    PubMed     Abstract available


  70. AL-TAMIMI M, Tarifi AA, Qaqish A, Abbas MM, et al
    Immunoglobulins response of COVID-19 patients, COVID-19 vaccine recipients, and random individuals.
    PLoS One. 2023;18:e0281689.
    PubMed     Abstract available


  71. HALDANE V, Ariyarajah A, Berry I, Loutet M, et al
    Global inequity creates local insufficiency: A qualitative study of COVID-19 vaccine implementation challenges in low-and-middle-income countries.
    PLoS One. 2023;18:e0281358.
    PubMed     Abstract available


  72. CORREA-PADILLA E, Hernandez-Cano A, Cuevas G, Acevedo-Betancur Y, et al
    Modifications in the piperazine ring of nucleozin affect anti-influenza activity.
    PLoS One. 2023;18:e0277073.
    PubMed     Abstract available


  73. ZHANG Q, Yi GY, Chen LP, He W, et al
    Sentiment analysis and causal learning of COVID-19 tweets prior to the rollout of vaccines.
    PLoS One. 2023;18:e0277878.
    PubMed     Abstract available


  74. ZEZELJ I, Petrovic M, Ivanovic A, Kurcubic P, et al
    I trust my immunity more than your vaccines: "Appeal to nature" bias strongly predicts questionable health behaviors in the COVID-19 pandemic.
    PLoS One. 2023;18:e0279122.
    PubMed     Abstract available


  75. BALLOUZ T, Menges D, Kaufmann M, Amati R, et al
    Post COVID-19 condition after Wildtype, Delta, and Omicron SARS-CoV-2 infection and prior vaccination: Pooled analysis of two population-based cohorts.
    PLoS One. 2023;18:e0281429.
    PubMed     Abstract available


  76. PARK MY, Park SY, Hartog A, van Hoffen E, et al
    Study protocol for cholera vaccination as a model to measure the inflammatory response in the gut: A case of modulation with a Lactobacillus plantarum K8 lysate.
    PLoS One. 2023;18:e0281817.
    PubMed     Abstract available


  77. CHEON S, Methiyothin T, Ahn I
    Analysis of COVID-19 vaccine adverse event using language model and unsupervised machine learning.
    PLoS One. 2023;18:e0282119.
    PubMed     Abstract available


  78. MANGAT HS, Rippon B, Reddy NT, Syed AA, et al
    Reported rates of all-cause serious adverse events following immunization with BNT-162b in 5-17-year-old children in the United States.
    PLoS One. 2023;18:e0281993.
    PubMed     Abstract available


  79. SUPRENANT MP, Nyankesha E, Moreno-Garcia R, Buj V, et al
    Assessing the relationship between operationally defined zero-dose communities and access to selected primary healthcare services for children and pregnant women in emergency settings.
    PLoS One. 2023;18:e0281764.
    PubMed     Abstract available


  80. LO PRESTI A, Carannante A, Fazio C, Neri A, et al
    FHbp variants among meningococci of serogroup B in Italy: Evolution and selective pressure, 2014-2017.
    PLoS One. 2023;18:e0277976.
    PubMed     Abstract available


  81. BASHIR S, Phuoc NN, Herath T, Basit A, et al
    An oral pH-responsive Streptococcus agalactiae vaccine formulation provides protective immunity to pathogen challenge in tilapia: A proof-of-concept study.
    PLoS One. 2023;18:e0278277.
    PubMed     Abstract available


  82. NICHOL B, McCready JL, Steen M, Unsworth J, et al
    Barriers and facilitators of vaccine hesitancy for COVID-19, influenza, and pertussis during pregnancy and in mothers of infants under two years: An umbrella review.
    PLoS One. 2023;18:e0282525.
    PubMed     Abstract available


  83. COSTA-FONT J, Garcia-Hombrados J, Nicinska A
    The institutional origins of vaccines distrust: Evidence from former-Soviet countries.
    PLoS One. 2023;18:e0282420.
    PubMed     Abstract available


  84. RACHMAN A, Iriani A, Sukrisman L, Rajabto W, et al
    A comparative study of the COVID-19 vaccine efficacy among cancer patients: mRNA versus non-mRNA.
    PLoS One. 2023;18:e0281907.
    PubMed     Abstract available


  85. HOVI P, Palmu AA, Nieminen TA, Artama M, et al
    Incidence of sinus thrombosis with thrombocytopenia-A nation-wide register study.
    PLoS One. 2023;18:e0282226.
    PubMed     Abstract available


  86. GANEM F, Folch C, Colom-Cadena A, Bordas A, et al
    Determinants of COVID-19 vaccine hesitancy among students and parents in Sentinel Schools Network of Catalonia, Spain.
    PLoS One. 2023;18:e0282871.
    PubMed     Abstract available


  87. MOMANI A, Hamaideh SH, Masadeh AB, Alhalaiqa F, et al
    The effect of COVID-19 vaccine tele-educational program on vaccine hesitancy and receiving the vaccine among women planning for pregnancy, pregnant or breast-feeding mothers.
    PLoS One. 2023;18:e0282627.
    PubMed     Abstract available


  88. ALATRANY SSJ, Falaiyah AM, Zuhairawi RHM, Ogden R, et al
    A cross-sectional analysis of the predictors of COVID-19 vaccine uptake and vaccine hesitancy in Iraq.
    PLoS One. 2023;18:e0282523.
    PubMed     Abstract available


  89. LIOZNOV D, Amosova I, Sheetikov SA, Zornikova KV, et al
    Immunogenicity and safety of a recombinant adenovirus type-5 COVID-19 vaccine in adults: Data from a randomised, double-blind, placebo-controlled, single-dose, phase 3 trial in Russia.
    PLoS One. 2023;18:e0278878.
    PubMed     Abstract available


  90. RODRIGUEZ-AVIAL I, Garcia-Salguero C, Bermejo L, Teja J, et al
    Evolution of antibody titers after two doses of mRNA Pfizer-BioNTech vaccine and effect of the third dose in nursing home residents.
    PLoS One. 2023;18:e0282388.
    PubMed     Abstract available


  91. KOSIYAPORN H, Netrpukdee C, Pangkariya N, Chandrasiri O, et al
    The impact of vaccine information and other factors on COVID-19 vaccine acceptance in the Thai population.
    PLoS One. 2023;18:e0276238.
    PubMed     Abstract available


  92. WILLIAMS SN, Armitage CJ, Dienes K, Drury J, et al
    Public decisions about COVID-19 vaccines: A UK-based qualitative study.
    PLoS One. 2023;18:e0277360.
    PubMed     Abstract available


  93. ABIMBOLA TO, Van Handel M, Tie Y, Ouyang L, et al
    Cost-effectiveness of expanded hepatitis A vaccination among adults with diagnosed HIV, United States.
    PLoS One. 2023;18:e0282972.
    PubMed     Abstract available


  94. FISHMAN J, Mandell DS, Salmon MK, Candon M, et al
    Large and small financial incentives may motivate COVID-19 vaccination: A randomized, controlled survey experiment.
    PLoS One. 2023;18:e0282518.
    PubMed     Abstract available


  95. WAWERU KM, Omia DO, Kiganane L, Miroro O, et al
    Socio-economic and structural barriers in Newcastle disease vaccines uptake by smallholder women farmers in Southeastern Kenya.
    PLoS One. 2023;18:e0283076.
    PubMed     Abstract available


  96. SRIVASTAVA S, Verma S, Kamthania M, Saxena AK, et al
    Exploring the structural basis to develop efficient multi-epitope vaccines displaying interaction with HLA and TAP and TLR3 molecules to prevent NIPAH infection, a global threat to human health.
    PLoS One. 2023;18:e0282580.
    PubMed     Abstract available


  97. DHAKAL R, Shapkota S, Shrestha P, Adhikari P, et al
    Pregnant women's awareness, perception, and acceptability of COVID-19 vaccine attending antenatal clinics in Bharatpur, Nepal.
    PLoS One. 2023;18:e0278694.
    PubMed     Abstract available


  98. VAITHILINGAM S, Hwang LA, Nair M, Ng JWJ, et al
    COVID-19 vaccine hesitancy and its drivers: An empirical study of the vaccine hesitant group in Malaysia.
    PLoS One. 2023;18:e0282520.
    PubMed     Abstract available


  99. HONSKUS M, Krizova P, Okonji Z, Musilek M, et al
    Whole genome analysis of Neisseria meningitidis isolates from invasive meningococcal disease collected in the Czech Republic over 28 years (1993-2020).
    PLoS One. 2023;18:e0282971.
    PubMed     Abstract available


  100. TAGHIOFF SM, Slavin BR, Mehra S, Holton T, et al
    The impact of influenza vaccination on surgical outcomes in COVID-19 positive patients: An analysis of 43,580 patients.
    PLoS One. 2023;18:e0281990.
    PubMed     Abstract available


  101. CHOI J, Markham C, Tami-Maury I, Kim S, et al
    Maternal perceptions of vaccinating boys against human papillomavirus (HPV) in Seoul, South Korea: A descriptive exploratory qualitative study.
    PLoS One. 2023;18:e0282811.
    PubMed     Abstract available


  102. NAPIT R, Poudel A, Pradhan SM, Manandhar P, et al
    Newcastle disease burden in Nepal and efficacy of Tablet I2 vaccine in commercial and backyard poultry production.
    PLoS One. 2023;18:e0280688.
    PubMed     Abstract available


  103. NEIGHBORS CE, Sloane R, Pieper CF, Wixted D, et al
    Mitigation behavior prior to COVID-19 vaccination availability is associated with COVID-19 infection and time to vaccination.
    PLoS One. 2023;18:e0283381.
    PubMed     Abstract available


  104. KOLLAMPARAMBIL U, Oyenubi A, Nwosu C
    Mental distress, COVID19 vaccine distrust and vaccine hesitancy in South Africa: A causal mediation regression analysis.
    PLoS One. 2023;18:e0278218.
    PubMed     Abstract available


  105. YANG MC, Wang CC, Tang WC, Chen KM, et al
    Immunogenicity of a spike protein subunit-based COVID-19 vaccine with broad protection against various SARS-CoV-2 variants in animal studies.
    PLoS One. 2023;18:e0283473.
    PubMed     Abstract available


  106. KUMAR R, Gupta M, Agarwal A, Mukherjee A, et al
    Epidemic efficacy of Covid-19 vaccination against Omicron: An innovative approach using enhanced residual recurrent neural network.
    PLoS One. 2023;18:e0280026.
    PubMed     Abstract available


  107. MAKI KO, Karlsson LC, Kaakinen JK, Schmid P, et al
    Tailoring interventions to suit self-reported format preference does not decrease vaccine hesitancy.
    PLoS One. 2023;18:e0283030.
    PubMed     Abstract available


  108. MCCREADY J, Comparcini D, Nichol B, Steen M, et al
    Understanding the barriers and facilitators of COVID-19 vaccine hesitancy amongst healthcare workers and healthcare students worldwide: An umbrella review protocol.
    PLoS One. 2023;18:e0283897.
    PubMed     Abstract available


  109. SIMMONS AE, Amoako A, Grima AA, Murison KR, et al
    Vaccine effectiveness against hospitalization among adolescent and pediatric SARS-CoV-2 cases between May 2021 and January 2022 in Ontario, Canada: A retrospective cohort study.
    PLoS One. 2023;18:e0283715.
    PubMed     Abstract available


  110. GOSLING J, Colbourn T
    What is associated with reported acute respiratory infection in children under 5 and PCV vaccination in children aged 1-36 months in Malawi? A secondary data analysis using the Malawi 2014 MICS survey.
    PLoS One. 2023;18:e0283760.
    PubMed     Abstract available


  111. ANDERSON R, Kim S, Roberts N, Petrou S, et al
    Systematic review of economic evaluations of varicella vaccination programmes.
    PLoS One. 2023;18:e0282327.
    PubMed     Abstract available


  112. MITTEREDER LR, Swoboda J, De Pascalis R, Elkins KL, et al
    IL-12p40 is essential but not sufficient for Francisella tularensis LVS clearance in chronically infected mice.
    PLoS One. 2023;18:e0283161.
    PubMed     Abstract available


  113. RADRIZZANI S, Fonseca C, Woollard A, Pettitt J, et al
    Both trust in, and polarization of trust in, relevant sciences have increased through the COVID-19 pandemic.
    PLoS One. 2023;18:e0278169.
    PubMed     Abstract available


  114. SEDIGHI B, Haghdoost A, Jangipour Afshar P, Abna Z, et al
    Multiple sclerosis and COVID-19: A retrospective study in Iran.
    PLoS One. 2023;18:e0283538.
    PubMed     Abstract available


  115. LI J, Nakagawa T, Kojima M, Nishikimi A, et al
    Underlying medical conditions and anti-SARS-CoV-2 spike IgG antibody titers after two doses of BNT162b2 vaccination: A cross-sectional study.
    PLoS One. 2023;18:e0283658.
    PubMed     Abstract available


  116. DOUCETTE EJ, Gray J, Fonseca K, Charlton C, et al
    A longitudinal seroepidemiology study to evaluate antibody response to SARS-CoV-2 virus infection and vaccination in children in Calgary, Canada from July 2020 to April 2022: Alberta COVID-19 Childhood Cohort (AB3C) Study.
    PLoS One. 2023;18:e0284046.
    PubMed     Abstract available


  117. KRAUTMANN M, Davis B, Leroueil PR
    A model for estimating costs and benefits of new vaccine technologies from the perspective of both buyers and sellers.
    PLoS One. 2023;18:e0283977.
    PubMed     Abstract available


  118. MOHANTY S, Podmore B, Cunado Moral A, Matthews I, et al
    Healthcare resource utilisation and cost of pneumococcal disease from 2003 to 2019 in children
    PLoS One. 2023;18:e0283084.
    PubMed     Abstract available


  119. GOLOS AM, Guntuku SC, Piltch-Loeb R, Leininger LJ, et al
    Dear Pandemic: A topic modeling analysis of COVID-19 information needs among readers of an online science communication campaign.
    PLoS One. 2023;18:e0281773.
    PubMed     Abstract available


  120. ROY DN, Azam MS, Islam E
    Multi-dimensional potential factors influencing COVID-19 vaccine booster acceptance and hesitancy among university academic community in Bangladesh: A cross-sectional comparative study.
    PLoS One. 2023;18:e0281395.
    PubMed     Abstract available


  121. ALMHEIRI S, Hazari A, Kumar P, Kumar S, et al
    A comprehensive survey on the beliefs, perceptions, and clinical manifestations of pre and post Covid-19 vaccinations among physiotherapy students in the United Arab Emirates.
    PLoS One. 2023;18:e0282385.
    PubMed     Abstract available


  122. MCCREADY JL, Nichol B, Steen M, Unsworth J, et al
    Understanding the barriers and facilitators of vaccine hesitancy towards the COVID-19 vaccine in healthcare workers and healthcare students worldwide: An Umbrella Review.
    PLoS One. 2023;18:e0280439.
    PubMed     Abstract available


  123. ECKER UKH, Sharkey CXM, Swire-Thompson B
    Correcting vaccine misinformation: A failure to replicate familiarity or fear-driven backfire effects.
    PLoS One. 2023;18:e0281140.
    PubMed     Abstract available


  124. KYEI-ARTHUR F, Agyekum MW, Afrifa-Anane GF, Larbi RT, et al
    Perceptions about COVID-19 preventive measures among Ghanaian women.
    PLoS One. 2023;18:e0284362.
    PubMed     Abstract available


  125. MORRISON LTR, Anderson B, Brower A, Talbird SE, et al
    Macroeconomic impact of Ebola outbreaks in Sub-Saharan Africa and potential mitigation of GDP loss with prophylactic Ebola vaccination programs.
    PLoS One. 2023;18:e0283721.
    PubMed     Abstract available


  126. ANONUEVO LE, Lachica ZPT, Amistas DA, Lato JIE, et al
    Transmission dynamics and baseline epidemiological parameter estimates of Coronavirus disease 2019 pre-vaccination: Davao City, Philippines.
    PLoS One. 2023;18:e0283068.
    PubMed     Abstract available


  127. BOBADILLA ML, Villagra V, Ortiz V, Deluca G, et al
    High prevalence and co-infection of high-risk Human Papillomavirus genotypes among unvaccinated young women from Paraguay.
    PLoS One. 2023;18:e0283542.
    PubMed     Abstract available


  128. MARTINEZ-OLIVARES CE, Hernandez-Pando R, Mixcoha E
    In silico EsxG EsxH rational epitope selection: Candidate epitopes for vaccine design against pulmonary tuberculosis.
    PLoS One. 2023;18:e0284264.
    PubMed     Abstract available


  129. O'NEILL E, Brody AK, Ricketts T
    Inoculum source dependent effects of ericoid, mycorrhizal fungi on flowering and reproductive success in highbush blueberry (Vaccinium corymbosum).
    PLoS One. 2023;18:e0284631.
    PubMed     Abstract available


  130. UNDELIKWO VA, Shilton S, Folayan MO, Alaba O, et al
    COVID-19 self-testing in Nigeria: Stakeholders' opinions and perspectives on its value for case detection.
    PLoS One. 2023;18:e0282570.
    PubMed     Abstract available


  131. NI YH, Xu ZH, Wang J
    Understanding vaccine hesitancy with PCV13 in children: Results of a survey in Shanghai, China.
    PLoS One. 2023;18:e0284810.
    PubMed     Abstract available


  132. MOHAMED NA, Solehan HM, Mohd Rani MD, Ithnin M, et al
    Understanding COVID-19 vaccine hesitancy in Malaysia: Public perception, knowledge, and acceptance.
    PLoS One. 2023;18:e0284973.
    PubMed     Abstract available


  133. DES JARLAIS DC, Lieff S, Grivel M, Meltzer G, et al
    COVID-19 stigmatization after the development of effective vaccines: Vaccination behavior, attitudes, and news sources.
    PLoS One. 2023;18:e0283467.
    PubMed     Abstract available


  134. PRADO ADS, Kohls E, Baldofski S, Bianchi AS, et al
    How are Brazilian university students coping with the COVID-19 pandemic? Results of an online survey on psychosocial well-being, perceived burdens, and attitudes toward social distancing and vaccination.
    PLoS One. 2023;18:e0284190.
    PubMed     Abstract available


  135. KABAYIZA JC, Nilsson S, Andersson M
    Rotavirus infections and their genotype distribution in Rwanda before and after the introduction of rotavirus vaccination.
    PLoS One. 2023;18:e0284934.
    PubMed     Abstract available


  136. YAMANA TK, Galanti M, Pei S, Di Fusco M, et al
    The impact of COVID-19 vaccination in the US: Averted burden of SARS-COV-2-related cases, hospitalizations and deaths.
    PLoS One. 2023;18:e0275699.
    PubMed     Abstract available


  137. MAHMOODI S, Amirzakaria JZ, Ghasemian A
    In silico design and validation of a novel multi-epitope vaccine candidate against structural proteins of Chikungunya virus using comprehensive immunoinformatics analyses.
    PLoS One. 2023;18:e0285177.
    PubMed     Abstract available


  138. TEYMOORZADEH M, Daneshfar N, Yazdanparast R
    Biochemical and histopathological evaluation of ChAdOx1-S and BBIBP-CorV vaccination in normal and streptozotocin-induced diabetic Wistar rats.
    PLoS One. 2023;18:e0284601.
    PubMed     Abstract available


  139. MAGEN H, Avigdor A, Nevo L, Fried S, et al
    Anti-RBD IgG antibodies and neutralizing antibody levels after the second BNT162b2 dose in patients with plasma cell disorders.
    PLoS One. 2023;18:e0284925.
    PubMed     Abstract available


  140. HALFON P, Jordana S, Blachier S, Cartlamy P, et al
    Anti-spike protein to determine SARS-CoV-2 antibody levels: Is there a specific threshold conferring protection in immunocompromised patients?
    PLoS One. 2023;18:e0281257.
    PubMed     Abstract available


  141. SUNTRONWONG N, Vichaiwattana P, Klinfueng S, Puenpa J, et al
    SARS-CoV-2 infection- induced seroprevalence among children and associated risk factors during the pre- and omicron-dominant wave, from January 2021 through December 2022, Thailand: A longitudinal study.
    PLoS One. 2023;18:e0279147.
    PubMed     Abstract available


  142. LORIA J, Albani VVL, Coutinho FAB, Covas DT, et al
    Time-dependent vaccine efficacy estimation quantified by a mathematical model.
    PLoS One. 2023;18:e0285466.
    PubMed     Abstract available


  143. INTAWONG K, Chariyalertsak S, Chalom K, Wonghirundecha T, et al
    Waning vaccine response to severe COVID-19 outcomes during omicron predominance in Thailand.
    PLoS One. 2023;18:e0284130.
    PubMed     Abstract available


  144. KUZNETSOVA N, Siniavin A, Butenko A, Larichev V, et al
    Development and characterization of chimera of yellow fever virus vaccine strain and Tick-Borne encephalitis virus.
    PLoS One. 2023;18:e0284823.
    PubMed     Abstract available


  145. PRANIC SM, Vasanthan LT, Thompson JY, Mishra V, et al
    Protocol of a scoping review of systematic reviews and meta-analyses about COVID-19 vaccines and associated adverse events from vaccination.
    PLoS One. 2023;18:e0285442.
    PubMed     Abstract available


  146. MITI S, Shato T, Asante C, Baumann A, et al
    Leveraging health infrastructure to optimize HPV vaccination for adolescents in Zambia: Protocol for an implementation study.
    PLoS One. 2023;18:e0285031.
    PubMed     Abstract available


  147. ENGLER RJM, Montgomery JR, Spooner CE, Nelson MR, et al
    Myocarditis and pericarditis recovery following smallpox vaccine 2002-2016: A comparative observational cohort study in the military health system.
    PLoS One. 2023;18:e0283988.
    PubMed     Abstract available


  148. ROBINSON RE, Myerscough C, He N, Hill H, et al
    Comprehensive review of safety in Experimental Human Pneumococcal Challenge.
    PLoS One. 2023;18:e0284399.
    PubMed     Abstract available


  149. KONTOWICZ E, Moreno-Madrinan M, Ragland D, Beauvais W, et al
    A stochastic compartmental model to simulate intra- and inter-species influenza transmission in an indoor swine farm.
    PLoS One. 2023;18:e0278495.
    PubMed     Abstract available


  150. AMICK III BC, Allen JL, Brown CC, Goudie A, et al
    Racial differences in COVID-19 vaccine acceptance in Arkansas.
    PLoS One. 2023;18:e0268876.
    PubMed     Abstract available


  151. LYONS J, Nafilyan V, Akbari A, Bedston S, et al
    An external validation of the QCOVID3 risk prediction algorithm for risk of hospitalisation and death from COVID-19: An observational, prospective cohort study of 1.66m vaccinated adults in Wales, UK.
    PLoS One. 2023;18:e0285979.
    PubMed     Abstract available


  152. PERMPIKUL P, Tongyoo S, Chaimayo C, Kanpai P, et al
    Anti-SARS-CoV-2 antibody among SARS-CoV-2 vaccinated vs post-infected blood donors in a tertiary hospital, Bangkok, Thailand.
    PLoS One. 2023;18:e0285737.
    PubMed     Abstract available


  153. ZAHARI M, Offeddu V, Smith GJD, Tam CC, et al
    Determinants of influenza and pneumococcal vaccine uptake among preschool children in Singapore.
    PLoS One. 2023;18:e0285561.
    PubMed     Abstract available


  154. COBB J, Soliman SSM, Retuerto M, Quijano JC, et al
    Changes in the gut microbiota of NOD mice in response to an oral Salmonella-based vaccine against type 1 diabetes.
    PLoS One. 2023;18:e0285905.
    PubMed     Abstract available


  155. BALOGUN FM, Bamgboye EA, Orimadegun AE
    Trends of infant vaccination timeliness and completion in selected urban slum communities in Ibadan, Southwestern Nigeria: A four-year review.
    PLoS One. 2023;18:e0285805.
    PubMed     Abstract available


  156. GATTI A, Zizzo G, De Paschale M, Tamburello A, et al
    Assessing SARS-CoV-2-specific T-cell reactivity in late convalescents and vaccinees: Comparison and combination of QuantiFERON and activation-induced marker assays, and relation with antibody status.
    PLoS One. 2023;18:e0285728.
    PubMed     Abstract available


  157. SANAMI S, Nazarian S, Ahmad S, Raeisi E, et al
    In silico design and immunoinformatics analysis of a universal multi-epitope vaccine against monkeypox virus.
    PLoS One. 2023;18:e0286224.
    PubMed     Abstract available


  158. QURESHI A, Syed Sulaiman SA, Rehman W, Mehmood A, et al
    Prevalence of post-vaccine side effects among COVID-19 immunized community of Southern Pakistan.
    PLoS One. 2023;18:e0285736.
    PubMed     Abstract available


  159. TENE L, Karasik A, Chodick G, Pereira DIA, et al
    Iron deficiency and the effectiveness of the BNT162b2 vaccine for SARS-CoV-2 infection: A retrospective, longitudinal analysis of real-world data.
    PLoS One. 2023;18:e0285606.
    PubMed     Abstract available


  160. STEFFENS MS, Bullivant B, Kaufman J, King C, et al
    Testing persuasive messages about booster doses of COVID-19 vaccines on intention to vaccinate in Australian adults: A randomised controlled trial.
    PLoS One. 2023;18:e0286799.
    PubMed     Abstract available


  161. MOUNIER-JACK S, Paterson P, Bell S, Letley L, et al
    Covid-19 vaccine roll-out in England: A qualitative evaluation.
    PLoS One. 2023;18:e0286529.
    PubMed     Abstract available


  162. ALI Z, Harastani H, Hammadi M, Reslan L, et al
    Erratum: Rotavirus Genotypes and Vaccine Effectiveness from a Sentinel, Hospital-Based, Surveillance Study for Three Consecutive Rotavirus Seasons in Lebanon.
    PLoS One. 2023;18:e0286701.
    PubMed     Abstract available


  163. MASA'DEH R, Momani A, Rayan A, Hamaideh SH, et al
    COVID-19 vaccine hesitancy among women planning for pregnancy, pregnant or breastfeeding mothers in Jordan: A cross-sectional study.
    PLoS One. 2023;18:e0286289.
    PubMed     Abstract available


  164. JAY A, Kwilas SA, Josleyn M, Ricks K, et al
    Humoral immunogenicity of a Coronavirus Disease 2019 (COVID-19) DNA vaccine in rhesus macaques (Macaca mulatta) delivered using needle-free jet injection.
    PLoS One. 2023;18:e0275082.
    PubMed     Abstract available


  165. SCHRODER D, Muller F, Heesen G, Hummers E, et al
    Feasibility of self-organized blood sample collection in adults for study purposes in a primary care setting.
    PLoS One. 2023;18:e0286014.
    PubMed     Abstract available


  166. ISLAM MR, Haque MA, Ahamed B, Tanbir M, et al
    Assessment of vaccine perception and vaccination intention of Mpox infection among the adult males in Bangladesh: A cross-sectional study findings.
    PLoS One. 2023;18:e0286322.
    PubMed     Abstract available


  167. KABORE OD, Poda A, Ouattara CA, Michodigni FN, et al
    Seroprevalence of SARS-CoV-2 IgG and associated factors among people living with HIV over the first 12 months following the outbreak of COVID-19 in Burkina Faso, a sub-Saharan African country.
    PLoS One. 2023;18:e0286665.
    PubMed     Abstract available


  168. RICK AM, Lentscher A, Xu L, Wilkins MS, et al
    Impact of maternal SARS-CoV-2 booster vaccination on blood and breastmilk antibodies.
    PLoS One. 2023;18:e0287103.
    PubMed     Abstract available


  169. GOLEC M, Zembala-John J, Fronczek M, Konka A, et al
    Relationship between anthropometric and body composition parameters and anti-SARS-CoV-2 specific IgG titers in females vaccinated against COVID-19 according to the heterologous vaccination course: A cohort study.
    PLoS One. 2023;18:e0287128.
    PubMed     Abstract available


  170. RAJAMOORTHY Y, Taib NM, Harapan H, Wagner AL, et al
    Application of the double bounded dichotomous choice model to the estimation of parent's willingness to pay for the hand foot mouth disease vaccination: A survey in Selangor, Malaysia.
    PLoS One. 2023;18:e0286924.
    PubMed     Abstract available


  171. STOECKEL F, Thompson J, Szewach P, Stockli S, et al
    Correlates of support for international vaccine solidarity during the COVID-19 pandemic: Cross-sectional survey evidence from Germany.
    PLoS One. 2023;18:e0287257.
    PubMed     Abstract available


  172. HATCH BA, Kenzie E, Ramalingam N, Sullivan E, et al
    Impact of the COVID-19 vaccination mandate on the primary care workforce and differences between rural and urban settings to inform future policy decision-making.
    PLoS One. 2023;18:e0287553.
    PubMed     Abstract available


  173. PALMBORG A, Skovdal M, Molden T, Ahman H, et al
    Invasive pneumococcal disease among the elderly in the later era of paediatric pneumococcal conjugate vaccination-A longitudinal study over 10 years based on public surveillance data in the Nordics.
    PLoS One. 2023;18:e0287378.
    PubMed     Abstract available


  174. FERNANDEZ-SANCHEZ H, Zahoui Z, Jones J, Marfo EA, et al
    Access, acceptability, and uptake of the COVID-19 vaccine among global migrants: A rapid review.
    PLoS One. 2023;18:e0287884.
    PubMed     Abstract available


  175. GHAZAL S, Soyiri IN
    The effect of geographical variation in income measures on measles-mumps-rubella uptake and coverage in England; a protocol for an ecological study.
    PLoS One. 2023;18:e0280008.
    PubMed     Abstract available


  176. WIN SY, Murata S, Fujisawa S, Seo H, et al
    Characterization of cysteine proteases from poultry red mite, tropical fowl mite, and northern fowl mite to assess the feasibility of developing a broadly efficacious vaccine against multiple mite species.
    PLoS One. 2023;18:e0288565.
    PubMed     Abstract available


  177. SNYDER J, Zenone M
    Vaccine related crowdfunding on a 'Freedom Fundraising' platform.
    PLoS One. 2023;18:e0288539.
    PubMed     Abstract available


  178. RACEY CS, Donken R, Fox E, Porter I, et al
    Characterization of vaccine confidence among teachers in British Columbia, Canada: A population-based survey.
    PLoS One. 2023;18:e0288107.
    PubMed     Abstract available


  179. FELD Y, Hartmann AK
    Large-deviations of disease spreading dynamics with vaccination.
    PLoS One. 2023;18:e0287932.
    PubMed     Abstract available


  180. ADUGNA A, Demeke G, Toru M, Tsehay D, et al
    Reduced protective efficacy of hepatitis B vaccine among fully vaccinated children in Ethiopia.
    PLoS One. 2023;18:e0288355.
    PubMed     Abstract available


  181. BARAL P, Ahmed T, Amor Fernandez P, Peters MA, et al
    Vaccine hesitancy among healthcare workers in low- and middle-income countries during the COVID-19 pandemic: Results from facility surveys across six countries.
    PLoS One. 2023;18:e0288124.
    PubMed     Abstract available


  182. ZARABI N, Aldven M, Sjolander S, Fues Wahl H, et al
    Clinical and economic burden of pneumococcal disease among adults in Sweden: A population-based register study.
    PLoS One. 2023;18:e0287581.
    PubMed     Abstract available


  183. STRBAC M, Vukovic V, Pustahija T, Nikolic N, et al
    Motives and attitudes of parents toward HPV vaccination: Results from the initial period of HPV vaccine rollout in Serbia.
    PLoS One. 2023;18:e0287295.
    PubMed     Abstract available


  184. MOTAMEDI H, Alvandi A, Fathollahi M, Ari MM, et al
    In silico designing and immunoinformatics analysis of a novel peptide vaccine against metallo-beta-lactamase (VIM and IMP) variants.
    PLoS One. 2023;18:e0275237.
    PubMed     Abstract available


  185. SEPOTOKELE KM, O'Kennedy MM, Wandrag DBR, Abolnik C, et al
    Optimization of infectious bronchitis virus-like particle expression in Nicotiana benthamiana as potential poultry vaccines.
    PLoS One. 2023;18:e0288970.
    PubMed     Abstract available


  186. DUBE E, Trottier ME, Gagnon D, Bettinger JA, et al
    Exploring parents' views of the use of narratives to promote childhood vaccination online.
    PLoS One. 2023;18:e0284107.
    PubMed     Abstract available


  187. LUAN M, Qi Q, Shi W, Tao Z, et al
    Differential impacts of vaccine scandal by ethnic and socioeconomic factors: Evidence from China.
    PLoS One. 2023;18:e0288841.
    PubMed     Abstract available


  188. CUNHA NSP, de Olinda RA, Fahrat SCL, Barbieri CLA, et al
    Spatial analysis of vaccine coverage in children under the age of 1 year by mesoregions in Paraiba a northeastern Brazilian state.
    PLoS One. 2023;18:e0288651.
    PubMed     Abstract available


  189. MAYANJA Y, Rida W, Kimani J, Ssetala A, et al
    Hepatitis B status and associated factors among participants screened for simulated HIV vaccine efficacy trials in Kenya and Uganda.
    PLoS One. 2023;18:e0288604.
    PubMed     Abstract available


  190. LAOTEE S, Duangkaew M, Jivapetthai A, Tharakhet K, et al
    CHO-produced RBD-Fc subunit vaccines with alternative adjuvants generate immune responses against SARS-CoV-2.
    PLoS One. 2023;18:e0288486.
    PubMed     Abstract available


  191. AMELLAL H, Assaid N, Charoute H, Akarid K, et al
    Kinetics of specific anti-SARS-CoV-2 IgM, IgA, and IgG responses during the first 12 months after SARS-CoV-2 infection: A prospective longitudinal study.
    PLoS One. 2023;18:e0288557.
    PubMed     Abstract available


  192. XIE Z, Qalati SA, Limon MLS, Sulaiman MABA, et al
    Understanding factors influencing healthcare workers' intention towards the COVID-19 vaccine.
    PLoS One. 2023;18:e0286794.
    PubMed     Abstract available


  193. BAM V, Mohammed A, Kusi-Amponsah A, Armah J, et al
    Caregivers' perception and acceptance of malaria vaccine for Children.
    PLoS One. 2023;18:e0288686.
    PubMed     Abstract available


  194. KIM S, Lee J, Yang H, Kim H, et al
    Acceptance of and hesitancy about COVID-19 vaccination among nursing students in clinical practice.
    PLoS One. 2023;18:e0286640.
    PubMed     Abstract available


  195. GENERAAL E, van Santen DKD, Campman SL, Booij MJ, et al
    Low prevalence of current and past SARS-CoV-2 infections among visitors and staff members of homelessness services in Amsterdam at the end of the second wave of infections in the Netherlands.
    PLoS One. 2023;18:e0288610.
    PubMed     Abstract available


  196. GRAM MA, Steenhard N, Cohen AS, Vangsted AM, et al
    Patterns of testing in the extensive Danish national SARS-CoV-2 test set-up.
    PLoS One. 2023;18:e0281972.
    PubMed     Abstract available


  197. WARIRI O, Utazi CE, Okomo U, Sogur M, et al
    Timeliness of routine childhood vaccination among 12-35 months old children in The Gambia: Analysis of national immunisation survey data, 2019-2020.
    PLoS One. 2023;18:e0288741.
    PubMed     Abstract available


  198. KIKUT AI
    The doctor knows or the evidence shows: An online survey experiment testing the effects of source trust, pro-vaccine evidence, and dual-processing in expert messages recommending child COVID-19 vaccination to parents.
    PLoS One. 2023;18:e0288272.
    PubMed     Abstract available


  199. RYKOWSKA D, Sobierajski T, Okarska-Napierala M, Wanke-Rytt M, et al
    Influenza vaccination from the perspective of health care workers at university hospitals.
    PLoS One. 2023;18:e0288470.
    PubMed     Abstract available


  200. SCHNYDER SK, Molina JJ, Yamamoto R, Turner MS, et al
    Rational social distancing in epidemics with uncertain vaccination timing.
    PLoS One. 2023;18:e0288963.
    PubMed     Abstract available


  201. FERESHTEH S, Haririzadeh Jouriani F, Noori Goodarzi N, Torkamaneh M, et al
    Defeating a superbug: A breakthrough in vaccine design against multidrug-resistant Pseudomonas aeruginosa using reverse vaccinology.
    PLoS One. 2023;18:e0289609.
    PubMed     Abstract available


  202. HERNANDEZ BAUTISTA PF, Grajales Muniz C, Cabrera Gaytan DA, Rojas Mendoza T, et al
    Impact of vaccination on infection or death from COVID-19 in individuals with laboratory-confirmed cases: Case-control study.
    PLoS One. 2023;18:e0265698.
    PubMed     Abstract available


  203. KOWATSCH MM, Lajoie J, Mwangi L, Omollo K, et al
    Hydroxychloroquine reduces T cells activation recall antigen responses.
    PLoS One. 2023;18:e0287738.
    PubMed     Abstract available


  204. VAN DEN BOOM W, van Dijk M, Snijders B, Luijben G, et al
    Cohort profile: The Corona Behavioral Unit cohort, a longitudinal mixed-methods study on COVID-19-related behavior, well-being and policy support in the Netherlands.
    PLoS One. 2023;18:e0289294.
    PubMed     Abstract available


  205. KIGONGO E, Kabunga A, Tumwesigye R, Musinguzi M, et al
    Prevalence and predictors of COVID-19 vaccination hesitancy among healthcare workers in Sub-Saharan Africa: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0289295.
    PubMed     Abstract available


  206. FROZANFAR MK, Hamajima N, Fayaz SH, Rahimzad AD, et al
    Factors associated with pentavalent vaccine coverage among 12-23-month-old children in Afghanistan: A cross-sectional study.
    PLoS One. 2023;18:e0289744.
    PubMed     Abstract available


  207. BATOOL R, Qureshi S, Haq Z, Yousafzai MT, et al
    Coverage survey of typhoid conjugate vaccine among children aged 6 months to 15 years in an urban slum settlement of Lyari Town Karachi, Pakistan.
    PLoS One. 2023;18:e0289582.
    PubMed     Abstract available


  208. ALHUDIRI I, Abusrewil Z, Dakhil O, Zwaik MA, et al
    Impact of vaccination and risk factors on COVID-19 mortality amid delta wave in Libya: A single center cohort study.
    PLoS One. 2023;18:e0289490.
    PubMed     Abstract available


  209. KURTZ SL, Ryden P, Elkins KL
    Transcriptional signatures measured in whole blood correlate with protection against tuberculosis in inbred and outbred mice.
    PLoS One. 2023;18:e0289358.
    PubMed     Abstract available


  210. SHEIKH NS, Touseef M, Sultan R, Cheema KH, et al
    Understanding COVID-19 vaccine hesitancy in Pakistan: The paradigm of confidence, convenience, and complacency; A cross-sectional study.
    PLoS One. 2023;18:e0289678.
    PubMed     Abstract available


  211. JANG J, Jeong H, Kim BH, An S, et al
    Vaccine effectiveness in symptom and viral load mitigation in COVID-19 breakthrough infections in South Korea.
    PLoS One. 2023;18:e0290154.
    PubMed     Abstract available


  212. ALOYSIA D'COR N, Siddaiah P, Mohapatra S, Dhaded SM, et al
    Safety and immunogenicity of a new formulation of a pentavalent DTwP-HepB-Hib vaccine in healthy Indian infants-A randomized study.
    PLoS One. 2023;18:e0284898.
    PubMed     Abstract available


  213. VANSTONE M, Correia RH, Howard M, Darling E, et al
    How do perceptions of Covid-19 risk impact pregnancy-related health decisions? A convergent parallel mixed-methods study protocol.
    PLoS One. 2023;18:e0288952.
    PubMed     Abstract available


  214. SHAYEGH S, Andreu-Perez J, Akoth C, Bosch-Capblanch X, et al
    Prioritizing COVID-19 vaccine allocation in resource poor settings: Towards an Artificial Intelligence-enabled and Geospatial-assisted decision support framework.
    PLoS One. 2023;18:e0275037.
    PubMed     Abstract available


  215. YIN Z, Li M, Niu C, Yu M, et al
    Design of multi-epitope vaccine candidate against Brucella type IV secretion system (T4SS).
    PLoS One. 2023;18:e0286358.
    PubMed     Abstract available


  216. FADLYANA E, Dhamayanti M, Tarigan R, Prodjosoewojo S, et al
    Immunogenicity and safety of Quadrivalent Influenza HA vaccine compared with Trivalent Influenza HA vaccine and evaluation of Quadrivalent Influenza HA vaccine batch-to-batch consistency in Indonesian children and adults.
    PLoS One. 2023;18:e0281566.
    PubMed     Abstract available


  217. HOPKEN MW, Gilfillan D, Gilbert AT, Piaggio AJ, et al
    Biodiversity indices and Random Forests reveal the potential for striped skunk (Mephitis mephitis) fecal microbial communities to function as a biomarker for oral rabies vaccination.
    PLoS One. 2023;18:e0285852.
    PubMed     Abstract available


  218. GUPTA MD, Kunal S, M P G, Goyal D, et al
    Impact of COVID-19 vaccination on mortality after acute myocardial infarction.
    PLoS One. 2023;18:e0291090.
    PubMed     Abstract available


  219. SLOTKIN R, Kyriakides TC, Kundu A, Stack G, et al
    Correlation of a commercial platform's results with post-vaccination SARS-CoV-2 neutralizing antibody response and clinical host factors.
    PLoS One. 2023;18:e0289713.
    PubMed     Abstract available


  220. MEUNIER M, Spillmann A, Rousseaux C, Schwamborn K, et al
    An oral cholera vaccine in the prevention and/or treatment of inflammatory bowel disease.
    PLoS One. 2023;18:e0283489.
    PubMed     Abstract available


  221. LIU H, Han X, Lin X, Zhu X, et al
    Impact of vaccine measures on the transmission dynamics of COVID-19.
    PLoS One. 2023;18:e0290640.
    PubMed     Abstract available


  222. ZAVRAKLI E, Parnell A, Malone D, Duffy K, et al
    Optimal age-specific vaccination control for COVID-19: An Irish case study.
    PLoS One. 2023;18:e0290974.
    PubMed     Abstract available


  223. ZOLA MATUVANGA T, Marien J, Lariviere Y, Osang'ir BI, et al
    Low seroprevalence of Ebola virus in health care providers in an endemic region (Tshuapa province) of the Democratic Republic of the Congo.
    PLoS One. 2023;18:e0286479.
    PubMed     Abstract available


  224. SCALA A, Cavallo P
    Measuring the efficacy of a vaccine during an epidemic.
    PLoS One. 2023;18:e0290652.
    PubMed     Abstract available


  225. NYANDELE JP, Kibondo UA, Issa F, Van Geertruyden JP, et al
    Pre-vaccination monocyte-to-lymphocyte ratio as a biomarker for the efficacy of malaria candidate vaccines: A subgroup analysis of pooled clinical trial data.
    PLoS One. 2023;18:e0291244.
    PubMed     Abstract available


  226. MOIN AT, Rani NA, Ullah MA, Patil RB, et al
    An immunoinformatics and extended molecular dynamics approach for designing a polyvalent vaccine against multiple strains of Human T-lymphotropic virus (HTLV).
    PLoS One. 2023;18:e0287416.
    PubMed     Abstract available


  227. NARANJO D, Kimball E, Nelson J, Samore M, et al
    Differences in perceptions and acceptance of COVID-19 vaccination between vaccine hesitant and non-hesitant persons.
    PLoS One. 2023;18:e0290540.
    PubMed     Abstract available


  228. HU W, Jia N, Meng W, Zhou T, et al
    Safety analysis of a live attenuated mumps vaccine in healthy adolescents in China: A phase 4, observational, open-label trial.
    PLoS One. 2023;18:e0291730.
    PubMed     Abstract available


  229. STERNBERG MR, Johnson A, King J, Ali AR, et al
    Application of a life table approach to assess duration of BNT162b2 vaccine-derived immunity by age using COVID-19 case surveillance data during the Omicron variant period.
    PLoS One. 2023;18:e0291678.
    PubMed     Abstract available


  230. LENDE SSF, Barnkob NM, Hansen RW, Bansia H, et al
    Discovery of neutralizing SARS-CoV-2 antibodies enriched in a unique antigen specific B cell cluster.
    PLoS One. 2023;18:e0291131.
    PubMed     Abstract available


  231. MURPHY R, Pomerantz L, Kuruppumullage Don P, Sung Kim J, et al
    Age and political leaning predict COVID-19 vaccination status at a large, multi-campus, public university in Pennsylvania: A cross-sectional survey.
    PLoS One. 2023;18:e0291974.
    PubMed     Abstract available


  232. TAKAHASHI T, Ai T, Saito K, Nojiri S, et al
    Assessment of antibody dynamics and neutralizing activity using serological assay after SARS-CoV-2 infection and vaccination.
    PLoS One. 2023;18:e0291670.
    PubMed     Abstract available



  233. Editorial Note: School-Located Influenza Vaccination Reduces Community Risk for Influenza and Influenza-Like Illness Emergency Care Visits.
    PLoS One. 2023;18:e0291903.
    PubMed    


  234. EVANS WD, Bingenheimer JB, Long M, Ndiaye K, et al
    Outcomes of a social media campaign to promote COVID-19 vaccination in Nigeria.
    PLoS One. 2023;18:e0290757.
    PubMed     Abstract available


  235. LAO T, Avalos I, Rodriguez EM, Zamora Y, et al
    Production and characterization of a chimeric antigen, based on nucleocapsid of SARS-CoV-2 fused to the extracellular domain of human CD154 in HEK-293 cells as a vaccine candidate against COVID-19.
    PLoS One. 2023;18:e0288006.
    PubMed     Abstract available


  236. KATZMAN C, Morgan T, de Roche A, Harris J, et al
    Longitudinal assessment of COVID-19 vaccine uptake: A two-wave survey of a nationally representative U.S. sample.
    PLoS One. 2023;18:e0289541.
    PubMed     Abstract available


  237. KALITA N, Corr PG, Ward MC, Xavier J, et al
    Identifying facilitators and barriers to culturally responsive communication for racial, ethnic, sexual, and gender minoritized patients when screened for COVID-19 vaccinations: A scoping review protocol.
    PLoS One. 2023;18:e0290514.
    PubMed     Abstract available


  238. YUSUF M, Destiarani W, Widayat W, Yosua Y, et al
    Coarse-grained molecular dynamics-guided immunoinformatics to explain the binder and non-binder classification of Cytotoxic T-cell epitope for SARS-CoV-2 peptide-based vaccine discovery.
    PLoS One. 2023;18:e0292156.
    PubMed     Abstract available


  239. PEREZ CHACON G, Fathima P, Jones M, Estcourt MJ, et al
    Association between pertussis vaccination in infancy and childhood asthma: A population-based record linkage cohort study.
    PLoS One. 2023;18:e0291483.
    PubMed     Abstract available


  240. AQUINO VH, Fumagalli MJ, Silva A, de Moura Negrini BV, et al
    Linear epitope mapping in the E and NS1 proteins of dengue and Zika viruses: Prospection of peptides for vaccines and diagnostics.
    PLoS One. 2023;18:e0292451.
    PubMed     Abstract available


  241. MATHEW JL, Wagner AL, Ratho RK, Patel PN, et al
    Maternally transmitted anti-measles antibodies, and susceptibility to disease among infants in Chandigarh, India: A prospective birth cohort study.
    PLoS One. 2023;18:e0287110.
    PubMed     Abstract available


  242. FRANCESCHI J, Pareschi L, Bellodi E, Gavanelli M, et al
    Modeling opinion polarization on social media: Application to Covid-19 vaccination hesitancy in Italy.
    PLoS One. 2023;18:e0291993.
    PubMed     Abstract available


  243. QAQISH A, Abdo N, Abbas MM, Saadeh N, et al
    Awareness and knowledge of physicians and residents on the non-sexual routes of human papilloma virus (HPV) infection and their perspectives on anti-HPV vaccination in Jordan.
    PLoS One. 2023;18:e0291643.
    PubMed     Abstract available


  244. RAVINDRAN R, Kang H, McReynolds C, Sanghar GK, et al
    Dynamics of temporal immune responses in nonhuman primates and humans immunized with COVID-19 vaccines.
    PLoS One. 2023;18:e0287377.
    PubMed     Abstract available


  245. DEMSASH AW, Chereka AA, Walle AD, Kassie SY, et al
    Machine learning algorithms' application to predict childhood vaccination among children aged 12-23 months in Ethiopia: Evidence 2016 Ethiopian Demographic and Health Survey dataset.
    PLoS One. 2023;18:e0288867.
    PubMed     Abstract available


  246. TURMUKHAMBETOVA A, Yegorov S, Korshukov I, Barkhanskaya V, et al
    The impact of Gam-COVID-Vac, an Adv5/Adv26 COVID-19 vaccine, on the biomarkers of endothelial function, coagulation and platelet activation.
    PLoS One. 2023;18:e0293074.
    PubMed     Abstract available


  247. BUTT AIK, Imran M, Aslam J, Batool S, et al
    Computational analysis of control of hepatitis B virus disease through vaccination and treatment strategies.
    PLoS One. 2023;18:e0288024.
    PubMed     Abstract available


  248. PENOT P, Chateauneuf J, Auperin I, Cordel H, et al
    Socioeconomic impact of the COVID-19 crisis and early perceptions of COVID-19 vaccines among immigrant and nonimmigrant people living with HIV followed up in public hospitals in Seine-Saint-Denis, France.
    PLoS One. 2023;18:e0276038.
    PubMed     Abstract available


  249. LEUNG V, Gill S, Llanes A, Khawaja A, et al
    A retrospective cohort study of prescribing outcomes in outpatients treated with nirmatrelvir-Ritonavir for COVID-19 in an interdisciplinary community clinic.
    PLoS One. 2023;18:e0293302.
    PubMed     Abstract available


  250. BAKKABULINDI P, Ampeire I, Ayebale L, Mubiri P, et al
    Engagement of community health workers to improve immunization coverage through addressing inequities and enhancing data quality and use is a feasible and effective approach: An implementation study in Uganda.
    PLoS One. 2023;18:e0292053.
    PubMed     Abstract available


  251. DARAMOLA T, Szatkowski L
    Association between women's experience of domestic violence and childhood vaccination in West Africa: Cross-sectional analysis of Demographic and Health Survey data.
    PLoS One. 2023;18:e0293900.
    PubMed     Abstract available


  252. HAU D, Pflughoeft KJ, Gates-Hollingsworth MA, Kaur S, et al
    Serum antibody levels to SARS-CoV-2 receptor-binding domain (RBD) in convalescent patients and vaccinated individuals of northern Nevada.
    PLoS One. 2023;18:e0288713.
    PubMed     Abstract available


  253. MORADPOUR J, Shajarizadeh A, Carter J, Chit A, et al
    The impact of national income and vaccine hesitancy on country-level COVID-19 vaccine uptake.
    PLoS One. 2023;18:e0293184.
    PubMed     Abstract available


  254. FEODOROVA VA, Zaitsev SS, Lyapina AM, Kichemazova NV, et al
    Whole genome sequencing characteristics of Chlamydia psittaci caprine AMK-16 strain, a promising killed whole cell veterinary vaccine candidate against chlamydia infection.
    PLoS One. 2023;18:e0293612.
    PubMed     Abstract available


  255. KASWANDANI N, Medise BE, Leonard E, Satari HI, et al
    Safety profile of inactivated COVID-19 in healthy adults aged >/= 18 years: A passive surveillance in Indonesia.
    PLoS One. 2023;18:e0286484.
    PubMed     Abstract available


  256. MAHUMUD RA, Alam K, Afroz S, Ormsby GM, et al
    Correction: Cost-effectiveness evaluations of the 9-Valent human papillomavirus (HPV) vaccine: Evidence from a systematic review.
    PLoS One. 2023;18:e0294379.
    PubMed     Abstract available


  257. SHRESTHA NK, Burke PC, Nowacki AS, Gordon SM, et al
    Risk of Coronavirus Disease 2019 (COVID-19) among those up-to-date and not up-to-date on COVID-19 vaccination by US CDC criteria.
    PLoS One. 2023;18:e0293449.
    PubMed     Abstract available


  258. NASIRATU I, Pencille LB, Khuzwayo N, Aboagye RG, et al
    Predictors of COVID-19 vaccine uptake among persons aged 18 years and above in Ga North Municipality, Ghana using the Health Belief Model: A community-based cross-sectional study.
    PLoS One. 2023;18:e0293350.
    PubMed     Abstract available


  259. NAQID IA, Mosa AA, Ibrahim SV, Ibrahim NH, et al
    Hepatitis B vaccination status and knowledge, attitude, and practice towards Hepatitis B virus among medical sciences students: A cross-sectional study.
    PLoS One. 2023;18:e0293822.
    PubMed     Abstract available


  260. WEAVER KL, Bitzer GJ, Wolf MA, Pyles GM, et al
    Intranasal challenge with B. pertussis leads to more severe disease manifestations in mice than aerosol challenge.
    PLoS One. 2023;18:e0286925.
    PubMed     Abstract available


  261. BOLOTIN S, Hughes SL, Savage RD, McLachlan E, et al
    Maternal varicella antibodies in children aged less than one year: Assessment of antibody decay.
    PLoS One. 2023;18:e0287765.
    PubMed     Abstract available


  262. FATIMA S, Ismail M, Ejaz T, Shah Z, et al
    Association between long COVID and vaccination: A 12-month follow-up study in a low- to middle-income country.
    PLoS One. 2023;18:e0294780.
    PubMed     Abstract available


  263. AIMAN S, Ahmad A, Khan A, Ali Y, et al
    Vaccinomics-aided next-generation novel multi-epitope-based vaccine engineering against multidrug resistant Shigella Sonnei: Immunoinformatics and chemoinformatics approaches.
    PLoS One. 2023;18:e0289773.
    PubMed     Abstract available


  264. KLAESSON J, Lobo J, Mellander C
    Social interactions and COVID-19 vaccine hesitancy: Evidence from a full population study in Sweden.
    PLoS One. 2023;18:e0289309.
    PubMed     Abstract available


  265. MWILA-KAZIMBAYA K, Bosomprah S, Chilyabanyama ON, Chisenga CC, et al
    Association of biomarkers of enteric dysfunction, systemic inflammation, and growth hormone resistance with seroconversion to oral rotavirus vaccine: A lasso for inference approach.
    PLoS One. 2023;18:e0293101.
    PubMed     Abstract available


  266. WUBSHET E, Dagnaw A, Gebrelibanos H, Tefera M, et al
    Assessment of COVID-19 vaccine acceptance and its associated factors in Debre Berhan City, Ethiopia, 2022.
    PLoS One. 2023;18:e0288321.
    PubMed     Abstract available


  267. GHOSH S, Ogueda-Oliva A, Ghosh A, Banerjee M, et al
    Understanding the implications of under-reporting, vaccine efficiency and social behavior on the post-pandemic spread using physics informed neural networks: A case study of China.
    PLoS One. 2023;18:e0290368.
    PubMed     Abstract available


  268. O'REILLY S, Kenny G, Alrawahneh T, Francois N, et al
    Development of a novel medium throughput flow-cytometry based micro-neutralisation test for SARS-CoV-2 with applications in clinical vaccine trials and antibody screening.
    PLoS One. 2023;18:e0294262.
    PubMed     Abstract available


  269. MENA G, Casas I, Casan C, Aunon M, et al
    Correction: Influenza vaccination coverage and factors associated with severe laboratory-confirmed influenza-related illness in patients receiving care at a tertiary hospital in Catalonia (Spain) during the 2018-2019 epidemic season.
    PLoS One. 2023;18:e0295454.
    PubMed     Abstract available


  270. KASAHUN AW, Zewdie A, Mose A, Adane HA, et al
    Health professionals' knowledge on vaccine cold chain management and associated factors in Ethiopia: Systematic review and meta-analysis.
    PLoS One. 2023;18:e0293122.
    PubMed     Abstract available


  271. ANDERSON EM
    Obscured inequity: How focusing on rates of disparities can conceal inequities in the reasons why adolescents are unvaccinated.
    PLoS One. 2023;18:e0293928.
    PubMed     Abstract available



  272. Correction: Protection provided by vaccination, booster doses and previous infection against covid-19 infection, hospitalisation or death over time in Czechia.
    PLoS One. 2023;18:e0295159.
    PubMed     Abstract available


  273. KIM SE, Park SH, Park WJ, Kim G, et al
    Evaluation of immunogenicity-induced DNA vaccines against different SARS-CoV-2 variants.
    PLoS One. 2023;18:e0295594.
    PubMed     Abstract available


  274. MAHUMUD RA, Alam K, Dunn J, Gow J, et al
    Correction: The cost-effectiveness of controlling cervical cancer using a new 9-valent human papillomavirus vaccine among school-aged girls in Australia.
    PLoS One. 2023;18:e0295688.
    PubMed     Abstract available


  275. FRANCISCO AG, Reyes JCB, Tabios IKB, Cruz CJG, et al
    Seroprevalence of human adenovirus type 5 neutralizing antibodies in the Philippines.
    PLoS One. 2023;18:e0293046.
    PubMed     Abstract available


  276. MAYITO J, Meya DB, Miriam A, Dhikusooka F, et al
    Monocyte to Lymphocyte ratio is highly specific in diagnosing latent tuberculosis and declines significantly following tuberculosis preventive therapy: A cross-sectional and nested prospective observational study.
    PLoS One. 2023;18:e0291834.
    PubMed     Abstract available


  277. PARKER CH, Sadhir S, Swanson Z, McGrosky A, et al
    Effect of influenza vaccination on resting metabolic rate and c-reactive protein concentrations in healthy young adults.
    PLoS One. 2023;18:e0295540.
    PubMed     Abstract available


  278. MILANI B, Dos Santos TW, Guerra MES, Oliveira S, et al
    Fusion of PspA to detoxified pneumolysin enhances pneumococcal vaccine coverage.
    PLoS One. 2023;18:e0291203.
    PubMed     Abstract available


  279. ANWAR T, Ismail S, Parvaiz F, Abbasi SW, et al
    Computational design of experimentally validated multi-epitopes vaccine against hepatitis E virus: An immunological approach.
    PLoS One. 2023;18:e0294663.
    PubMed     Abstract available


  280. ZAKHOUR R, Tamim H, Faytrouni F, Makki M, et al
    Determinants of human papillomavirus vaccine hesitancy among Lebanese parents.
    PLoS One. 2023;18:e0295644.
    PubMed     Abstract available


  281. SACRE A, Bambra C, Wildman JM, Thomson K, et al
    Socioeconomic inequalities in vaccine uptake: A global umbrella review.
    PLoS One. 2023;18:e0294688.
    PubMed     Abstract available


  282. MOIN AT, Rani NA, Ullah MA, Patil RB, et al
    Correction: An immunoinformatics and extended molecular dynamics approach for designing a polyvalent vaccine against multiple strains of Human T-lymphotropic virus (HTLV).
    PLoS One. 2023;18:e0295830.
    PubMed     Abstract available


  283. BATMUNKH B, Otgonbayar D, Shaarii S, Khaidav N, et al
    RBD-specific antibody response after two doses of different SARS-CoV-2 vaccines during the mass vaccination campaign in Mongolia.
    PLoS One. 2023;18:e0295167.
    PubMed     Abstract available


  284. BRODY C, Szieff J, Abu-Alrub B
    "If it wasn't forced upon me, I would have given it a second thought": Understanding COVID-19 vaccine hesitancy in an outlier county in the Bay Area, California.
    PLoS One. 2023;18:e0290469.
    PubMed     Abstract available


  285. KRASTEV S, Krajden O, Vang ZM, Perez-Gay Juarez F, et al
    Navigating the uncertainty: A novel taxonomy of vaccine hesitancy in the context of COVID-19.
    PLoS One. 2023;18:e0295912.
    PubMed     Abstract available


  286. PATWARY MM, Disha AS, Hasan M, Bardhan M, et al
    Integrating health belief model and theory of planned behavior to assess COVID-19 vaccine acceptance among urban slum people in Bangladesh.
    PLoS One. 2023;18:e0290412.
    PubMed     Abstract available


  287. BIRHANU F, Yitbarek K
    Wealth-based inequity in full child vaccination coverage: An experience from Mali, Bangladesh, and South Africa. A multilevel poison regression.
    PLoS One. 2023;18:e0293522.
    PubMed     Abstract available


  288. WANG E, Hagberg O, Malmstrom PU
    The association between BCG treatment in patients with bladder cancer and subsequent risk of developing Alzheimer and other dementia.-A Swedish nationwide cohort study from 1997 to 2019.
    PLoS One. 2023;18:e0292174.
    PubMed     Abstract available


  289. MACGREGOR-FAIRLIE M, De Gomes P, Weston D, Rickard JJS, et al
    Hybrid use of Raman spectroscopy and artificial neural networks to discriminate Mycobacterium bovis BCG and other Mycobacteriales.
    PLoS One. 2023;18:e0293093.
    PubMed     Abstract available


  290. FARRENKOPF BA, Zhou X, Shet A, Olayinka F, et al
    Understanding household-level risk factors for zero dose immunization in 82 low- and middle-income countries.
    PLoS One. 2023;18:e0287459.
    PubMed     Abstract available


    January 2022
  291. BAJOS N, Spire A, Silberzan L
    The social specificities of hostility toward vaccination against Covid-19 in France.
    PLoS One. 2022;17:e0262192.
    PubMed     Abstract available


  292. PATEL SM, Shaik-Dasthagirisaheb YB, Congdon M, Young RR, et al
    Evolution of pneumococcal serotype epidemiology in Botswana following introduction of 13-valent pneumococcal conjugate vaccine.
    PLoS One. 2022;17:e0262225.
    PubMed     Abstract available


  293. NG OMBE H, Simuyandi M, Mwaba J, Luchen CC, et al
    Immunogenicity and waning immunity from the oral cholera vaccine (Shanchol) in adults residing in Lukanga Swamps of Zambia.
    PLoS One. 2022;17:e0262239.
    PubMed     Abstract available


  294. RINTA-KOKKO H, Palmu AA, Ruokokoski E, Nieminen H, et al
    Evaluation of the indirect impact of the 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine in a cluster-randomised trial.
    PLoS One. 2022;17:e0261750.
    PubMed     Abstract available


  295. YOUNG-XU Y, Smith J, Nealon J, Mahmud SM, et al
    Influenza vaccine in chronic obstructive pulmonary disease among elderly male veterans.
    PLoS One. 2022;17:e0262072.
    PubMed     Abstract available


  296. LEE C, Holroyd TA, Gur-Arie R, Sauer M, et al
    COVID-19 vaccine acceptance among Bangladeshi adults: Understanding predictors of vaccine intention to inform vaccine policy.
    PLoS One. 2022;17:e0261929.
    PubMed     Abstract available


  297. AKTHER T, Nur T
    A model of factors influencing COVID-19 vaccine acceptance: A synthesis of the theory of reasoned action, conspiracy theory belief, awareness, perceived usefulness, and perceived ease of use.
    PLoS One. 2022;17:e0261869.
    PubMed     Abstract available


  298. GHADDAR A, Khandaqji S, Awad Z, Kansoun R, et al
    Conspiracy beliefs and vaccination intent for COVID-19 in an infodemic.
    PLoS One. 2022;17:e0261559.
    PubMed     Abstract available


  299. SIEWE N, Friedman A
    Combination therapy for mCRPC with immune checkpoint inhibitors, ADT and vaccine: A mathematical model.
    PLoS One. 2022;17:e0262453.
    PubMed     Abstract available


  300. TEERAWATTANANON Y, Anothaisintawee T, Pheerapanyawaranun C, Botwright S, et al
    A systematic review of methodological approaches for evaluating real-world effectiveness of COVID-19 vaccines: Advising resource-constrained settings.
    PLoS One. 2022;17:e0261930.
    PubMed     Abstract available


  301. SEO J, Lim J
    The impact of free vaccination policies under the Korean Influenza National Immunization Program: Trends in influenza vaccination rates in South Korea from 2010 to 2019.
    PLoS One. 2022;17:e0262594.
    PubMed     Abstract available


  302. STRICKLAND JC, Reed DD, Hursh SR, Schwartz LP, et al
    Behavioral economic methods to inform infectious disease response: Prevention, testing, and vaccination in the COVID-19 pandemic.
    PLoS One. 2022;17:e0258828.
    PubMed     Abstract available


  303. WISNEWSKI AV, Liu J, Lucas C, Klein J, et al
    Development and utilization of a surrogate SARS-CoV-2 viral neutralization assay to assess mRNA vaccine responses.
    PLoS One. 2022;17:e0262657.
    PubMed     Abstract available


  304. YOKOTA H, Hayashi H, Hanaguri J, Yamagami S, et al
    Effect of prorenin peptide vaccine on the early phase of diabetic retinopathy in a murine model of type 2 diabetes.
    PLoS One. 2022;17:e0262568.
    PubMed     Abstract available


  305. DIRIRSA K, Makuria M, Mulu E, Deriba BS, et al
    Assessment of vaccination timeliness and associated factors among children in Toke Kutaye district, central Ethiopia: A Mixed study.
    PLoS One. 2022;17:e0262320.
    PubMed     Abstract available


  306. RAUT S, Apte A, Srinivasan M, Dudeja N, et al
    Determinants of maternal influenza vaccination in the context of low- and middle-income countries: A systematic review.
    PLoS One. 2022;17:e0262871.
    PubMed     Abstract available


  307. MOSE A, Haile K, Timerga A
    COVID-19 vaccine hesitancy among medical and health science students attending Wolkite University in Ethiopia.
    PLoS One. 2022;17:e0263081.
    PubMed     Abstract available


  308. RAMATILLAH DL, Gan SH, Pratiwy I, Syed Sulaiman SA, et al
    Impact of cytokine storm on severity of COVID-19 disease in a private hospital in West Jakarta prior to vaccination.
    PLoS One. 2022;17:e0262438.
    PubMed     Abstract available


  309. LIAO CC, Tai YH, Yeh CC, Hsu YH, et al
    Effect of influenza vaccination on the outcomes of hospitalization for kidney disease in a geriatric population: A propensity-score matched study.
    PLoS One. 2022;17:e0262420.
    PubMed     Abstract available


  310. AMINUDDIN F, Zaimi NA, Mohd Nor Sham Kunusagaran MSJ, Bahari MS, et al
    Cost-effectiveness and budget impact analysis of PPV23 vaccination for the Malaysian Hajj pilgrims.
    PLoS One. 2022;17:e0262949.
    PubMed     Abstract available


  311. BELL S, Clarke RM, Ismail SA, Ojo-Aromokudu O, et al
    COVID-19 vaccination beliefs, attitudes, and behaviours among health and social care workers in the UK: A mixed-methods study.
    PLoS One. 2022;17:e0260949.
    PubMed     Abstract available


  312. NERY N JR, Ticona JPA, Cardoso CW, Prates APPB, et al
    COVID-19 vaccine hesitancy and associated factors according to sex: A population-based survey in Salvador, Brazil.
    PLoS One. 2022;17:e0262649.
    PubMed     Abstract available


  313. NISAR MI, Jehan F, Shahid S, Ahmed S, et al
    Serotype-specific effectiveness against pneumococcal carriage and serotype replacement after ten-valent Pneumococcal Conjugate Vaccine (PCV10) introduction in Pakistan.
    PLoS One. 2022;17:e0262466.
    PubMed     Abstract available


  314. OCAN M, Acheng F, Otike C, Beinomugisha J, et al
    Antibody levels and protection after Hepatitis B vaccine in adult vaccinated healthcare workers in northern Uganda.
    PLoS One. 2022;17:e0262126.
    PubMed     Abstract available


  315. KORANG SK, von Rohden E, Veroniki AA, Ong G, et al
    Vaccines to prevent COVID-19: A living systematic review with Trial Sequential Analysis and network meta-analysis of randomized clinical trials.
    PLoS One. 2022;17:e0260733.
    PubMed     Abstract available


  316. OHMURA H
    Analysis of social combinations of COVID-19 vaccination: Evidence from a conjoint analysis.
    PLoS One. 2022;17:e0261426.
    PubMed     Abstract available


  317. CHEN PY, Chuang PN, Chiang CH, Chang HH, et al
    Impact of Coronavirus Infectious Disease (COVID-19) pandemic on willingness of immunization-A community-based questionnaire study.
    PLoS One. 2022;17:e0262660.
    PubMed     Abstract available


  318. TLALE LB, Gabaitiri L, Totolo LK, Smith G, et al
    Acceptance rate and risk perception towards the COVID-19 vaccine in Botswana.
    PLoS One. 2022;17:e0263375.
    PubMed     Abstract available


  319. PETROVIC V, Vukovic V, Patic A, Markovic M, et al
    Immunogenicity of BNT162b2, BBIBP-CorV and Gam-COVID-Vac vaccines and immunity after natural SARS-CoV-2 infection-A comparative study from Novi Sad, Serbia.
    PLoS One. 2022;17:e0263468.
    PubMed     Abstract available


  320. BEARTH A, Berthold A, Siegrist M
    People's perceptions of, willingness-to-take preventive remedies and their willingness-to-vaccinate during times of heightened health threats.
    PLoS One. 2022;17:e0263351.
    PubMed     Abstract available


  321. VOIGT A, Omholt S, Almaas E
    Comparing the impact of vaccination strategies on the spread of COVID-19, including a novel household-targeted vaccination strategy.
    PLoS One. 2022;17:e0263155.
    PubMed     Abstract available


  322. PRATAMA NR, Wafa IA, Budi DS, Putra M, et al
    mRNA Covid-19 vaccines in pregnancy: A systematic review.
    PLoS One. 2022;17:e0261350.
    PubMed     Abstract available


  323. RONCHINI C, Gandini S, Pasqualato S, Mazzarella L, et al
    Lower probability and shorter duration of infections after COVID-19 vaccine correlate with anti-SARS-CoV-2 circulating IgGs.
    PLoS One. 2022;17:e0263014.
    PubMed     Abstract available


  324. MEMIRIE ST, Yigezu A, Zewdie SA, Mirkuzie AH, et al
    Hospitalization costs for COVID-19 in Ethiopia: Empirical data and analysis from Addis Ababa's largest dedicated treatment center.
    PLoS One. 2022;17:e0260930.
    PubMed     Abstract available


  325. JANOWSKI AB, Polgreen PM, Beekmann SE, Newland JG, et al
    Perceptions of risk of SARS-CoV-2 transmission in social and educational activities by infectious diseases and general pediatric healthcare providers, a pre-vaccine risk perception cross-sectional survey.
    PLoS One. 2022;17:e0263767.
    PubMed     Abstract available


  326. MAOR Y, Caspi S
    Attitudes towards influenza, and COVID-19 vaccines during the COVID-19 pandemic among a representative sample of the Jewish Israeli population.
    PLoS One. 2022;17:e0255495.
    PubMed     Abstract available


  327. HOSSIAN M, Khan MAS, Nazir A, Nabi MH, et al
    Factors affecting intention to take COVID-19 vaccine among Pakistani University Students.
    PLoS One. 2022;17:e0262305.
    PubMed     Abstract available


  328. DAVIS B, Krautmann M, Leroueil PR
    A method for estimating the impact of new vaccine technologies on vaccination coverage rates.
    PLoS One. 2022;17:e0263612.
    PubMed     Abstract available


  329. BASSI J, Giannini O, Silacci-Fregni C, Pertusini L, et al
    Poor neutralization and rapid decay of antibodies to SARS-CoV-2 variants in vaccinated dialysis patients.
    PLoS One. 2022;17:e0263328.
    PubMed     Abstract available


  330. ALHENDYANI F, Jolly K, Jones LL
    Views and experiences of maternal healthcare providers regarding influenza vaccine during pregnancy globally: A systematic review and qualitative evidence synthesis.
    PLoS One. 2022;17:e0263234.
    PubMed     Abstract available


  331. MONSTED B, Lehmann S
    Characterizing polarization in online vaccine discourse-A large-scale study.
    PLoS One. 2022;17:e0263746.
    PubMed     Abstract available


  332. SINGH K, Lima G, Cha M, Cha C, et al
    Misinformation, believability, and vaccine acceptance over 40 countries: Takeaways from the initial phase of the COVID-19 infodemic.
    PLoS One. 2022;17:e0263381.
    PubMed     Abstract available


  333. JUNG BK, An YH, Jang JJ, Jeon JH, et al
    The human ACE-2 receptor binding domain of SARS-CoV-2 express on the viral surface of the Newcastle disease virus as a non-replicating viral vector vaccine candidate.
    PLoS One. 2022;17:e0263684.
    PubMed     Abstract available


  334. EGLOFF C, Couffignal C, Cordier AG, Deruelle P, et al
    Pregnant women's perceptions of the COVID-19 vaccine: A French survey.
    PLoS One. 2022;17:e0263512.
    PubMed     Abstract available


  335. ZHOU L, Ampon-Wireko S, Xu X, Quansah PE, et al
    Media attention and Vaccine Hesitancy: Examining the mediating effects of Fear of COVID-19 and the moderating role of Trust in leadership.
    PLoS One. 2022;17:e0263610.
    PubMed     Abstract available


  336. BANU B, Akter N, Chowdhury SH, Islam KR, et al
    Infection and vaccination status of COVID-19 among healthcare professionals in academic platform: Prevision vs. reality of Bangladesh context.
    PLoS One. 2022;17:e0263078.
    PubMed     Abstract available


  337. LAMORI J, Feng X, Pericone CD, Mesa-Frias M, et al
    Hepatitis vaccination adherence and completion rates and factors associated with low compliance: A claims-based analysis of U.S. adults.
    PLoS One. 2022;17:e0264062.
    PubMed     Abstract available


  338. JAMISON AF, McCormick BJJ, Hussain E, Thomas ED, et al
    Determinants of vaccine coverage and timeliness in a northern Pakistani village.
    PLoS One. 2022;17:e0263712.
    PubMed     Abstract available


  339. ROBERTS HA, Clark DA, Kalina C, Sherman C, et al
    To vax or not to vax: Predictors of anti-vax attitudes and COVID-19 vaccine hesitancy prior to widespread vaccine availability.
    PLoS One. 2022;17:e0264019.
    PubMed     Abstract available


  340. KANE PB, Moyer H, MacPherson A, Papenburg J, et al
    Relationship between lay and expert perceptions of COVID-19 vaccine development timelines in Canada and USA.
    PLoS One. 2022;17:e0262740.
    PubMed     Abstract available


  341. DIEHL C, Hunkler C
    Vaccination-related attitudes and behavior across birth cohorts: Evidence from Germany.
    PLoS One. 2022;17:e0263871.
    PubMed     Abstract available


  342. BUDZIAR W, Gembara K, Harhala M, Szymczak A, et al
    Hidden fraction of Polish population immune to SARS-CoV-2 in May 2021.
    PLoS One. 2022;17:e0253638.
    PubMed     Abstract available


  343. ENYEW EB, Tareke AA
    Vaccination status and factors associated among children age 12-23 months in Ethiopia, based on 2016 EDHS: Logit based multinomial logistic regression analysis.
    PLoS One. 2022;17:e0264004.
    PubMed     Abstract available


  344. ADEDEJI-ADENOLA H, Olugbake OA, Adeosun SA
    Factors influencing COVID-19 vaccine uptake among adults in Nigeria.
    PLoS One. 2022;17:e0264371.
    PubMed     Abstract available


  345. MAMUTI S, Tabu C, Marete I, Opili D, et al
    Measles containing vaccine coverage and factors associated with its uptake among children aged 24-59 months in Cherangany Sub County, Trans Nzoia County, Kenya.
    PLoS One. 2022;17:e0263780.
    PubMed     Abstract available


  346. YOUSSEF D, Abou-Abbas L, Berry A, Youssef J, et al
    Determinants of acceptance of Coronavirus disease-2019 (COVID-19) vaccine among Lebanese health care workers using health belief model.
    PLoS One. 2022;17:e0264128.
    PubMed     Abstract available


  347. BSOUL EA, Loomer PM
    COVID-19 vaccination experience among United States dental professionals and students: Safety, confidence, concerns, and side effects.
    PLoS One. 2022;17:e0264323.
    PubMed     Abstract available


  348. BONHOMME ME, Bonhomme CJ, Strelow L, Chaudhari A, et al
    Robust validation and performance comparison of immunogenicity assays assessing IgG and neutralizing antibodies to SARS-CoV-2.
    PLoS One. 2022;17:e0262922.
    PubMed     Abstract available


  349. LI H, Ren H, Zhou Y, Zhang Y, et al
    HRSV prefusion-F protein with Adju-Phos adjuvant induces long-lasting Th2-biased immunity in mice.
    PLoS One. 2022;17:e0262231.
    PubMed     Abstract available


  350. ACKHTER MM, Shahid ASMSB, Ahmed T, Palit P, et al
    Characteristics of severely malnourished under-five children immunized with Bacillus Calmette-Guerin following Expanded Programme on Immunization schedule and their outcomes during hospitalization at an urban diarrheal treatment centre, Bangladesh.
    PLoS One. 2022;17:e0262391.
    PubMed     Abstract available


  351. STRUPAT C, Shigute Z, Bedi AS, Rieger M, et al
    Willingness to take COVID-19 vaccination in low-income countries: Evidence from Ethiopia.
    PLoS One. 2022;17:e0264633.
    PubMed     Abstract available


  352. ROMERO-IBARGUENGOITIA ME, Rivera-Salinas D, Hernandez-Ruiz YG, Armendariz-Vazquez AG, et al
    Effect of the third dose of BNT162b2 vaccine on quantitative SARS-CoV-2 spike 1-2 IgG antibody titers in healthcare personnel.
    PLoS One. 2022;17:e0263942.
    PubMed     Abstract available


  353. PAVIC Z, Suljok A
    Vaccination conspiracy beliefs among social science & humanities and STEM educated people-An analysis of the mediation paths.
    PLoS One. 2022;17:e0264722.
    PubMed     Abstract available


  354. FOJNICA A, Osmanovic A, Duzic N, Fejzic A, et al
    COVID-19 vaccine acceptance and rejection in an adult population in Bosnia and Herzegovina.
    PLoS One. 2022;17:e0264754.
    PubMed     Abstract available


  355. SANDOR J, Vincze F, Shrikant ML, Korosi L, et al
    COVID-19 vaccination coverage in deprived populations living in segregated colonies: A nationwide cross-sectional study in Hungary.
    PLoS One. 2022;17:e0264363.
    PubMed     Abstract available


  356. TSUNETSUGU-YOKOTA Y, Ito S, Adachi Y, Onodera T, et al
    Saliva as a useful tool for evaluating upper mucosal antibody response to influenza.
    PLoS One. 2022;17:e0263419.
    PubMed     Abstract available


  357. ELIES A, Bonneau C, Houzard S, Rouzier R, et al
    Impact of catch-up human papillomavirus vaccination on cervical conization rate in a real-life population in France.
    PLoS One. 2022;17:e0264821.
    PubMed     Abstract available


  358. FREUDENBERGER CATANZARO KC, Lahmers KK, Allen IC, Inzana TJ, et al
    Alginate microencapsulation of an attenuated O-antigen mutant of Francisella tularensis LVS as a model for a vaccine delivery vehicle.
    PLoS One. 2022;17:e0259807.
    PubMed     Abstract available


  359. GEORGE CE, Inbaraj LR, Rajukutty S, Joan RF, et al
    Seroprevalence of COVID-19 infection among vaccine naive population after the second surge (June 2020) in a rural district of South India: A community-based cross-sectional study.
    PLoS One. 2022;17:e0265236.
    PubMed     Abstract available


  360. CHUKWU CA, Mahmood K, Elmakki S, Gorton J, et al
    Evaluating the antibody response to SARS-COV-2 vaccination amongst kidney transplant recipients at a single nephrology centre.
    PLoS One. 2022;17:e0265130.
    PubMed     Abstract available


  361. GREYLING T, Rossouw S
    Positive attitudes towards COVID-19 vaccines: A cross-country analysis.
    PLoS One. 2022;17:e0264994.
    PubMed     Abstract available


  362. TOLOSSA T, Wakuma B, Turi E, Mulisa D, et al
    Attitude of health professionals towards COVID-19 vaccination and associated factors among health professionals, Western Ethiopia: A cross-sectional survey.
    PLoS One. 2022;17:e0265061.
    PubMed     Abstract available


  363. KUGELER KJ, Williamson J, Curns AT, Healy JM, et al
    Estimating the number of symptomatic SARS-CoV-2 infections among vaccinated individuals in the United States-January-July, 2021.
    PLoS One. 2022;17:e0264179.
    PubMed     Abstract available


  364. ORTIZ-PAREDES D, Varsaneux O, Worthington J, Park H, et al
    Reasons for COVID-19 vaccine refusal among people incarcerated in Canadian federal prisons.
    PLoS One. 2022;17:e0264145.
    PubMed     Abstract available


  365. TZOU PL, Tao K, Pond SLK, Shafer RW, et al
    Coronavirus Resistance Database (CoV-RDB): SARS-CoV-2 susceptibility to monoclonal antibodies, convalescent plasma, and plasma from vaccinated persons.
    PLoS One. 2022;17:e0261045.
    PubMed     Abstract available


  366. ROCHA FILHO TM, Mendes JFF, Murari TB, Nascimento Filho AS, et al
    Optimization of COVID-19 vaccination and the role of individuals with a high number of contacts: A model based approach.
    PLoS One. 2022;17:e0262433.
    PubMed     Abstract available


  367. HABIBZADEH F, Chumakov K, Sajadi MM, Yadollahie M, et al
    Use of oral polio vaccine and the incidence of COVID-19 in the world.
    PLoS One. 2022;17:e0265562.
    PubMed     Abstract available


  368. XIAO S, Nayak B, Samuel A, Paldurai A, et al
    Correction: Generation by Reverse Genetics of an Effective, Stable, Live-Attenuated Newcastle Disease Virus Vaccine Based on a Currently Circulating, Highly Virulent Indonesian Strain.
    PLoS One. 2022;17:e0265578.
    PubMed     Abstract available


  369. HAMILTON K, Hagger MS
    The Vaccination Concerns in COVID-19 Scale (VaCCS): Development and validation.
    PLoS One. 2022;17:e0264784.
    PubMed     Abstract available


  370. BEG BM, Hussain T, Ahmad M, Areej S, et al
    Perceived risk and perceptions of COVID-19 vaccine: A survey among general public in Pakistan.
    PLoS One. 2022;17:e0266028.
    PubMed     Abstract available


  371. REINHARDT B, Taylor R, Dawkins C, Banks T, et al
    The use of dried blood spot cards to assess serologic responses of individuals vaccinated against measles, hepatitis A, tetanus, influenza and varicella zoster.
    PLoS One. 2022;17:e0265813.
    PubMed     Abstract available


  372. SAJID M, Marriam S, Mukhtar H, Sohail S, et al
    Epitope-based peptide vaccine design and elucidation of novel compounds against 3C like protein of SARS-CoV-2.
    PLoS One. 2022;17:e0264700.
    PubMed     Abstract available


  373. ROY DN, Biswas M, Islam E, Azam MS, et al
    Potential factors influencing COVID-19 vaccine acceptance and hesitancy: A systematic review.
    PLoS One. 2022;17:e0265496.
    PubMed     Abstract available


  374. DHAOUADI S, Kharroubi G, Cherif A, Cherif I, et al
    Knowledge attitudes and practices toward seasonal influenza vaccine among pregnant women during the 2018/2019 influenza season in Tunisia.
    PLoS One. 2022;17:e0265390.
    PubMed     Abstract available


  375. SPRENGER R, Hackl D, Kossack N, Schiffner-Rohe J, et al
    Pneumococcal vaccination rates in immunocompromised patients in Germany: A retrospective cohort study to assess sequential vaccination rates and changes over time.
    PLoS One. 2022;17:e0265433.
    PubMed     Abstract available


  376. PURSELL T, Spencer Clinton JL, Tan J, Peng R, et al
    Modified vaccinia Ankara expressing EEHV1A glycoprotein B elicits humoral and cell-mediated immune responses in mice.
    PLoS One. 2022;17:e0265424.
    PubMed     Abstract available


  377. HIMBERT S, Gastaldo IP, Ahmed R, Pomier KM, et al
    Erythro-VLPs: Anchoring SARS-CoV-2 spike proteins in erythrocyte liposomes.
    PLoS One. 2022;17:e0263671.
    PubMed     Abstract available


  378. HARTMANN W, Brunn ML, Stetter N, Gabriel G, et al
    Pre-existing helminth infection impairs the efficacy of adjuvanted influenza vaccination in mice.
    PLoS One. 2022;17:e0266456.
    PubMed     Abstract available


  379. CHRISTODOULOU J, Fehrenbacher AE, Shaw EH, Vincent EM, et al
    COVID-19 prevention behaviors, trust, and intent to vaccinate among youth at risk for HIV.
    PLoS One. 2022;17:e0266321.
    PubMed     Abstract available


  380. NEWMAN PA, Reid L, Tepjan S, Fantus S, et al
    COVID-19 vaccine hesitancy among marginalized populations in the U.S. and Canada: Protocol for a scoping review.
    PLoS One. 2022;17:e0266120.
    PubMed     Abstract available


  381. AL-DAHSHAN A, Selim N, Al-Kubaisi N, Mahfoud Z, et al
    Primary care physicians' knowledge of travel vaccine and malaria chemoprophylaxis and associated predictors in Qatar.
    PLoS One. 2022;17:e0265953.
    PubMed     Abstract available


  382. KREPS S, Kriner DL
    Communication about vaccine efficacy and COVID-19 vaccine choice: Evidence from a survey experiment in the United States.
    PLoS One. 2022;17:e0265011.
    PubMed     Abstract available


  383. THIRUMURTHY H, Milkman KL, Volpp KG, Buttenheim AM, et al
    Association between statewide financial incentive programs and COVID-19 vaccination rates.
    PLoS One. 2022;17:e0263425.
    PubMed     Abstract available


  384. NOURANI L, Abouie Mehrizi A, Zakeri S, Djadid ND, et al
    Untangling population structure and genetic diversity of reticulocyte binding protein 2b (PvRBP2b) erythrocytic stage vaccine candidate in worldwide Plasmodium vivax isolates.
    PLoS One. 2022;17:e0266067.
    PubMed     Abstract available


  385. HAJEK A, Konig HH
    Level and correlates of empathy and altruism during the Covid-19 pandemic. Evidence from a representative survey in Germany.
    PLoS One. 2022;17:e0265544.
    PubMed     Abstract available


  386. GRASO M
    The new normal: Covid-19 risk perceptions and support for continuing restrictions past vaccinations.
    PLoS One. 2022;17:e0266602.
    PubMed     Abstract available


  387. YACOUTI A, Elkhoudri N, El Got A, Benider A, et al
    Awareness, attitudes and acceptability of the HPV vaccine among female university students in Morocco.
    PLoS One. 2022;17:e0266081.
    PubMed     Abstract available


  388. RAJA SM, Osman ME, Musa AO, Hussien AA, et al
    COVID-19 vaccine acceptance, hesitancy, and associated factors among medical students in Sudan.
    PLoS One. 2022;17:e0266670.
    PubMed     Abstract available


  389. FISKE A, Schonweitz F, Eichinger J, Zimmermann B, et al
    The COVID-19 Vaccine: Trust, doubt, and hope for a future beyond the pandemic in Germany.
    PLoS One. 2022;17:e0266659.
    PubMed     Abstract available


  390. HASSOUNEH L, Dunsiger S
    The impact of mental distress on influenza vaccine coverage.
    PLoS One. 2022;17:e0266692.
    PubMed     Abstract available


  391. KAINE G, Wright V, Greenhalgh S
    Predicting willingness to be vaccinated for Covid-19: Evidence from New Zealand.
    PLoS One. 2022;17:e0266485.
    PubMed     Abstract available


  392. OCHWEDO KO, Onyango SA, Omondi CJ, Orondo PW, et al
    Signatures of selection and drivers for novel mutation on transmission-blocking vaccine candidate Pfs25 gene in western Kenya.
    PLoS One. 2022;17:e0266394.
    PubMed     Abstract available


  393. NAVAZI F, Yuan Y, Archer N
    The effect of the Ontario stay-at-home order on Covid-19 third wave infections including vaccination considerations: An interrupted time series analysis.
    PLoS One. 2022;17:e0265549.
    PubMed     Abstract available


  394. JENSEN UT, Ayers S, Koskan AM
    Video-based messages to reduce COVID-19 vaccine hesitancy and nudge vaccination intentions.
    PLoS One. 2022;17:e0265736.
    PubMed     Abstract available


  395. REN Z, Nishimura M, Tjan LH, Furukawa K, et al
    Large-scale serosurveillance of COVID-19 in Japan: Acquisition of neutralizing antibodies for Delta but not for Omicron and requirement of booster vaccination to overcome the Omicron's outbreak.
    PLoS One. 2022;17:e0266270.
    PubMed     Abstract available


  396. SHARMA R, Anand A
    The effect of pandemic prevalence on the reported efficacy of SARS-CoV-2 vaccines.
    PLoS One. 2022;17:e0266271.
    PubMed     Abstract available


  397. ALHATIM N, Al-Bashaireh AM, Alqudah O
    Knowledge, attitude, and practice of seasonal influenza and influenza vaccine immunization among people visiting primary healthcare centers in Riyadh, Saudi Arabia.
    PLoS One. 2022;17:e0266440.
    PubMed     Abstract available


  398. KIHL P, Krych L, Deng L, Hansen LH, et al
    Effect of gluten-free diet and antibiotics on murine gut microbiota and immune response to tetanus vaccination.
    PLoS One. 2022;17:e0266719.
    PubMed     Abstract available


  399. MEYERHARDT JA, Yue H, Nowak RP, Brais L, et al
    Serological testing for SARS-CoV-2 antibodies of employees shows low transmission working in a cancer center.
    PLoS One. 2022;17:e0266791.
    PubMed     Abstract available


  400. RAHIMI BA, Ishaq N, Mudaser GM, Taylor WR, et al
    Outcome of acute bacterial meningitis among children in Kandahar, Afghanistan: A prospective observational cohort study.
    PLoS One. 2022;17:e0265487.
    PubMed     Abstract available


  401. SEDEGAH M, Porter C, Hollingdale MR, Ganeshan H, et al
    CHARM: COVID-19 Health Action Response for Marines-Association of antigen-specific interferon-gamma and IL2 responses with asymptomatic and symptomatic infections after a positive qPCR SARS-CoV-2 test.
    PLoS One. 2022;17:e0266691.
    PubMed     Abstract available


  402. SARGENT RH, Laurie S, Moncada L, Weakland LF, et al
    Masks, money, and mandates: A national survey on efforts to increase COVID-19 vaccination intentions in the United States.
    PLoS One. 2022;17:e0267154.
    PubMed     Abstract available


  403. SAITO Y
    The role of vaccination in a model of asset pricing during a pandemic.
    PLoS One. 2022;17:e0266511.
    PubMed     Abstract available


  404. RABIL MJ, Tunc S, Bish DR, Bish EK, et al
    Benefits of integrated screening and vaccination for infection control.
    PLoS One. 2022;17:e0267388.
    PubMed     Abstract available


  405. MUNDAGOWA PT, Tozivepi SN, Chiyaka ET, Mukora-Mutseyekwa F, et al
    Assessment of COVID-19 vaccine hesitancy among Zimbabweans: A rapid national survey.
    PLoS One. 2022;17:e0266724.
    PubMed     Abstract available


  406. BARMPOUNAKIS P, Demiris N, Kontoyiannis I, Pavlakis GN, et al
    Evaluating the effects of second-dose vaccine-delay policies in European countries: A simulation study based on data from Greece.
    PLoS One. 2022;17:e0263977.
    PubMed     Abstract available


  407. SHUKLA A, Welch K, Villa A
    Assessment of the willingness of dentists in the state of Indiana to administer vaccines.
    PLoS One. 2022;17:e0267167.
    PubMed     Abstract available


  408. LIN GSS, Lee HY, Leong JZ, Sulaiman MM, et al
    COVID-19 vaccination acceptance among dental students and dental practitioners: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0267354.
    PubMed     Abstract available


  409. ABED ELHADI SHAHBARI N, Gesser-Edelsburg A, Davidovitch N, Brammli-Greenberg S, et al
    Risk perceptions regarding inclusion of seasonal influenza vaccinations in the school immunization program in Israel: Arab vs. Jewish mothers.
    PLoS One. 2022;17:e0267279.
    PubMed     Abstract available


  410. CHAM J, Pandey AC, New J, Huynh T, et al
    6 month serologic response to the Pfizer-BioNTech COVID-19 vaccine among healthcare workers.
    PLoS One. 2022;17:e0266781.
    PubMed     Abstract available


  411. GAULTIER GN, Nix EB, Thorgrimson J, Boreham D, et al
    Naturally acquired antibodies against 7 Streptococcus pneumoniae serotypes in Indigenous and non-Indigenous adults.
    PLoS One. 2022;17:e0267051.
    PubMed     Abstract available


  412. ANASTASSOPOULOU C, Antoni D, Manoussopoulos Y, Stefanou P, et al
    Age and sex associations of SARS-CoV-2 antibody responses post BNT162b2 vaccination in healthcare workers: A mixed effects model across two vaccination periods.
    PLoS One. 2022;17:e0266958.
    PubMed     Abstract available


  413. JIAMSIRI S, Rhee C, Ahn HS, Poudyal N, et al
    A community intervention effectiveness study of single dose or two doses of bivalent HPV vaccine (CERVARIX(R)) in female school students in Thailand.
    PLoS One. 2022;17:e0267294.
    PubMed     Abstract available


  414. BUCZEL M, Szyszka PD, Siwiak A, Szpitalak M, et al
    Vaccination against misinformation: The inoculation technique reduces the continued influence effect.
    PLoS One. 2022;17:e0267463.
    PubMed     Abstract available


  415. RIGHOLT CH, Willows K, Kliewer EV, Mahmud SM, et al
    Incidence of anogenital warts after the introduction of the quadrivalent HPV vaccine program in Manitoba, Canada.
    PLoS One. 2022;17:e0267646.
    PubMed     Abstract available


  416. WIGGEN TD, Bohn B, Ulrich AK, Stovitz SD, et al
    SARS-CoV-2 seroprevalence among healthcare workers.
    PLoS One. 2022;17:e0266410.
    PubMed     Abstract available


  417. RICHARDSON JR, Gotz R, Mayr V, Lohse MJ, et al
    SARS-CoV2 wild type and mutant specific humoral and T cell immunity is superior after vaccination than after natural infection.
    PLoS One. 2022;17:e0266701.
    PubMed     Abstract available


  418. CHANSAENROJ J, Yorsaeng R, Puenpa J, Wanlapakorn N, et al
    Long-term persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein-specific and neutralizing antibodies in recovered COVID-19 patients.
    PLoS One. 2022;17:e0267102.
    PubMed     Abstract available


  419. MBULAWA ZZA, Phohlo K, Garcia-Jardon M, Williamson AL, et al
    High human papillomavirus (HPV)-35 prevalence among South African women with cervical intraepithelial neoplasia warrants attention.
    PLoS One. 2022;17:e0264498.
    PubMed     Abstract available


  420. HONG H, Malfeld S, Smit S, Makhathini L, et al
    A retrospective 5-year review of rubella in South Africa prior to the introduction of a rubella-containing vaccine.
    PLoS One. 2022;17:e0265870.
    PubMed     Abstract available


  421. ASSI S, Arafat B, Abbas I, Evans K, et al
    Evaluation of portable near-infrared spectroscopy for authentication of mRNA based COVID-19 vaccines.
    PLoS One. 2022;17:e0267214.
    PubMed     Abstract available


  422. STOCKLI S, Spalti AK, Phillips J, Stoeckel F, et al
    Which vaccine attributes foster vaccine uptake? A cross-country conjoint experiment.
    PLoS One. 2022;17:e0266003.
    PubMed     Abstract available


  423. DONG L, Bogart LM, Gandhi P, Aboagye JB, et al
    A qualitative study of COVID-19 vaccine intentions and mistrust in Black Americans: Recommendations for vaccine dissemination and uptake.
    PLoS One. 2022;17:e0268020.
    PubMed     Abstract available


  424. BICHER M, Rippinger C, Zechmeister M, Jahn B, et al
    An iterative algorithm for optimizing COVID-19 vaccination strategies considering unknown supply.
    PLoS One. 2022;17:e0265957.
    PubMed     Abstract available


  425. FLOREA A, Sy LS, Luo Y, Qian L, et al
    Durability of mRNA-1273 against COVID-19 in the time of Delta: Interim results from an observational cohort study.
    PLoS One. 2022;17:e0267824.
    PubMed     Abstract available


  426. STOTO MA, Schlageter S, Kraemer JD
    COVID-19 mortality in the United States: It's been two Americas from the start.
    PLoS One. 2022;17:e0265053.
    PubMed     Abstract available


  427. HONSKUS M, Okonji Z, Musilek M, Krizova P, et al
    Whole genome sequencing of Neisseria meningitidis Y isolates collected in the Czech Republic in 1993-2018.
    PLoS One. 2022;17:e0265066.
    PubMed     Abstract available


  428. OLU-ABIODUN O, Abiodun O, Okafor N
    COVID-19 vaccination in Nigeria: A rapid review of vaccine acceptance rate and the associated factors.
    PLoS One. 2022;17:e0267691.
    PubMed     Abstract available


  429. FREUND O, Tau L, Weiss TE, Zornitzki L, et al
    Associations of vaccine status with characteristics and outcomes of hospitalized severe COVID-19 patients in the booster era.
    PLoS One. 2022;17:e0268050.
    PubMed     Abstract available


  430. FARIA DE CARVALHO R, de Siqueira Penna Quintaes L, de Cassia de Souza Su T, Mitiko Kobayashi L, et al
    Short communication: Feasibility of dengue vaccine to infect different human cell lines: An alternative potency test using HEK293T cells.
    PLoS One. 2022;17:e0267653.
    PubMed     Abstract available


  431. HIJANO DR, Hoffman JM, Tang L, Schultz-Cherry SL, et al
    An adaptive, asymptomatic SARS-CoV-2 workforce screening program providing real-time, actionable monitoring of the COVID-19 pandemic.
    PLoS One. 2022;17:e0268237.
    PubMed     Abstract available


  432. OKUNLOLA OA, Oyeyemi OT
    Malaria transmission in Africa: Its relationship with yellow fever and measles.
    PLoS One. 2022;17:e0268080.
    PubMed     Abstract available


  433. MURUGESAN M, Mathews P, Paul H, Karthik R, et al
    Protective effect conferred by prior infection and vaccination on COVID-19 in a healthcare worker cohort in South India.
    PLoS One. 2022;17:e0268797.
    PubMed     Abstract available


  434. SSEKAMATTE T, Isunju JB, Mutyoba JN, Tetui M, et al
    Predictors of Hepatitis B screening and vaccination status of young psychoactive substance users in informal settlements in Kampala, Uganda.
    PLoS One. 2022;17:e0267953.
    PubMed     Abstract available


  435. DAZA-TORRES ML, Garcia YE, Schmidt AJ, Pollock BH, et al
    The impact of COVID-19 vaccination on California's return to normalcy.
    PLoS One. 2022;17:e0264195.
    PubMed     Abstract available


  436. OSUJI VC, Galante EM, Mischoulon D, Slaven JE, et al
    COVID-19 vaccine: A 2021 analysis of perceptions on vaccine safety and promise in a U.S. sample.
    PLoS One. 2022;17:e0268784.
    PubMed     Abstract available


  437. BONNER KE, Ssekyanzi H, Sicsic J, Mueller JE, et al
    What drives willingness to receive a new vaccine that prevents an emerging infectious disease? A discrete choice experiment among university students in Uganda.
    PLoS One. 2022;17:e0268063.
    PubMed     Abstract available


  438. WITUS LS, Larson E
    A randomized controlled trial of a video intervention shows evidence of increasing COVID-19 vaccination intention.
    PLoS One. 2022;17:e0267580.
    PubMed     Abstract available


  439. GUZMAN-HOLST A, Luna-Casas G, Burguete Garcia A, Madrid-Marina V, et al
    Burden of disease and associated complications of hepatitis a in children and adults in Mexico: A retrospective database study.
    PLoS One. 2022;17:e0268469.
    PubMed     Abstract available


  440. ACKAH M, Ameyaw L, Gazali Salifu M, Afi Asubonteng DP, et al
    COVID-19 vaccine acceptance among health care workers in Africa: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0268711.
    PubMed     Abstract available


  441. IWAMOTO M, Ukimura A, Ogawa T, Kawanishi F, et al
    Association between history of HBV vaccine response and anti-SARS-CoV-2 spike antibody response to the BioNTech/Pfizer's BNT162b2 mRNA SARS-CoV-2 vaccine among healthcare workers in Japan: A prospective observational study.
    PLoS One. 2022;17:e0268529.
    PubMed     Abstract available


  442. EL DEEB O, Jalloul M
    Efficacy versus abundancy: Comparing vaccination schemes.
    PLoS One. 2022;17:e0267840.
    PubMed     Abstract available


  443. WINARTO H, Habiburrahman M, Dorothea M, Wijaya A, et al
    Knowledge, attitudes, and practices among Indonesian urban communities regarding HPV infection, cervical cancer, and HPV vaccination.
    PLoS One. 2022;17:e0266139.
    PubMed     Abstract available


  444. SEREDA AD, Kazakova AS, Dmitrenko VV, Kolbasov DV, et al
    Search for additional tests for immunobiological evaluation of the candidate vaccines against African swine fever.
    PLoS One. 2022;17:e0265819.
    PubMed     Abstract available


  445. MERMIN-BUNNELL K, Ahn WK
    It's Time to be disgusting about COVID-19: Effect of disgust priming on COVID-19 public health compliance among liberals and conservatives.
    PLoS One. 2022;17:e0267735.
    PubMed     Abstract available


  446. BUTLER JZ, Carson M, Rios-Fetchko F, Vargas R, et al
    COVID-19 vaccination readiness among multiple racial and ethnic groups in the San Francisco Bay Area: A qualitative analysis.
    PLoS One. 2022;17:e0266397.
    PubMed     Abstract available


  447. ASRI A, Asri V, Renerte B, Follmi-Heusi F, et al
    Which hospital workers do (not) want the jab? Behavioral correlates of COVID-19 vaccine willingness among employees of Swiss hospitals.
    PLoS One. 2022;17:e0268775.
    PubMed     Abstract available


  448. AHETO JMK, Pannell O, Dotse-Gborgbortsi W, Trimner MK, et al
    Multilevel analysis of predictors of multiple indicators of childhood vaccination in Nigeria.
    PLoS One. 2022;17:e0269066.
    PubMed     Abstract available


  449. SPRENGHOLZ P, Henkel L, Betsch C
    Payments and freedoms: Effects of monetary and legal incentives on COVID-19 vaccination intentions in Germany.
    PLoS One. 2022;17:e0268911.
    PubMed     Abstract available


  450. SILVA EKVB, Bomfim CG, Barbosa AP, Noda P, et al
    Immunization with SARS-CoV-2 Nucleocapsid protein triggers a pulmonary immune response in rats.
    PLoS One. 2022;17:e0268434.
    PubMed     Abstract available


  451. RAQIB R, Sarker P, Akhtar E, Nurul Huda TM, et al
    Seroprevalence of SARS-CoV-2 infection and associated factors among Bangladeshi slum and non-slum dwellers in pre-COVID-19 vaccination era: October 2020 to February 2021.
    PLoS One. 2022;17:e0268093.
    PubMed     Abstract available


  452. NG JWJ, Vaithilingam S, Nair M, Hwang LA, et al
    Key predictors of COVID-19 vaccine hesitancy in Malaysia: An integrated framework.
    PLoS One. 2022;17:e0268926.
    PubMed     Abstract available


  453. NISHIMURA M, Sugawa S, Ota S, Suematsu E, et al
    Detection of silent infection of severe acute respiratory syndrome coronavirus 2 by serological tests.
    PLoS One. 2022;17:e0267566.
    PubMed     Abstract available


  454. AGHAMIR SMK, Khatami F, Farrokhpour H, Oliveira Reis L, et al
    Oncologic outcomes of Bacillus Calmette-Guerin therapy in elderly patients with non-muscle-invasive bladder cancer: A meta-analysis.
    PLoS One. 2022;17:e0267934.
    PubMed     Abstract available


  455. GEBRETNSAE H, Hadgu T, Ayele B, Gebre-Egziabher E, et al
    Knowledge of vaccine handlers and status of cold chain and vaccine management in primary health care facilities of Tigray region, Northern Ethiopia: Institutional based cross-sectional study.
    PLoS One. 2022;17:e0269183.
    PubMed     Abstract available


  456. ROGERS BG, Tao J, Almonte A, Toma E, et al
    Statewide evaluation of COVID-19 vaccine hesitancy in Rhode Island.
    PLoS One. 2022;17:e0268587.
    PubMed     Abstract available


  457. PILTCH-LOEB R, Silver DR, Kim Y, Norris H, et al
    Determinants of the COVID-19 vaccine hesitancy spectrum.
    PLoS One. 2022;17:e0267734.
    PubMed     Abstract available


  458. AHIAKPA JK, Cosmas NT, Anyiam FE, Enalume KO, et al
    COVID-19 vaccines uptake: Public knowledge, awareness, perception and acceptance among adult Africans.
    PLoS One. 2022;17:e0268230.
    PubMed     Abstract available


  459. JOSHI A, Surapaneni KM, Kaur M, Bhatt A, et al
    A cross sectional study to examine factors influencing COVID-19 vaccine acceptance, hesitancy and refusal in urban and rural settings in Tamil Nadu, India.
    PLoS One. 2022;17:e0269299.
    PubMed     Abstract available


  460. PATRICK L, Bakeera-Kitaka S, Rujumba J, Malande OO, et al
    Encouraging improvement in HPV vaccination coverage among adolescent girls in Kampala, Uganda.
    PLoS One. 2022;17:e0269655.
    PubMed     Abstract available


  461. HILLS SL, Soeung SC, Sarath S, Morn C, et al
    An evaluation of adverse events following an immunization campaign with the live, attenuated SA14-14-2 Japanese encephalitis vaccine in Cambodia.
    PLoS One. 2022;17:e0269480.
    PubMed     Abstract available


  462. ERCHICK DJ, Gupta M, Blunt M, Bansal A, et al
    Understanding determinants of vaccine hesitancy and acceptance in India: A qualitative study of government officials and civil society stakeholders.
    PLoS One. 2022;17:e0269606.
    PubMed     Abstract available


  463. KHAIRKHAH N, Bolhassani A, Agi E, Namvar A, et al
    Immunological investigation of a multiepitope peptide vaccine candidate based on main proteins of SARS-CoV-2 pathogen.
    PLoS One. 2022;17:e0268251.
    PubMed     Abstract available


  464. BITZENHOFER M, Suter-Riniker F, Moor MB, Sidler D, et al
    Humoral response to mRNA vaccines against SARS-CoV-2 in patients with humoral immunodeficiency disease.
    PLoS One. 2022;17:e0268780.
    PubMed     Abstract available


  465. DARKWA S, de Wildt G, Dalaba M, Vidzro E, et al
    "I would have to sell things in order to get the money": A qualitative exploration of willingness to pay for the RTS,S/AS01 malaria vaccine in the Volta region, Ghana.
    PLoS One. 2022;17:e0268009.
    PubMed     Abstract available


  466. VILLANUEVA P, Wadia U, Crawford NW, Messina NL, et al
    The safety of co-administration of Bacille Calmette-Guerin (BCG) and influenza vaccines.
    PLoS One. 2022;17:e0268042.
    PubMed     Abstract available


  467. MOSE A, Wasie A, Shitu S, Haile K, et al
    Determinants of COVID-19 vaccine acceptance in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0269273.
    PubMed     Abstract available


  468. DE ANDRADE PEREIRA SILVA M, Ribeiro HF, Oliveira RR, Pelloso FC, et al
    Factors associated with vaccination against Covid-19 in pregnant and hospitalized postpartum women: A retrospective cohort study.
    PLoS One. 2022;17:e0269091.
    PubMed     Abstract available


  469. BOHN-GOLDBAUM E, Owen KB, Lee VYJ, Booy R, et al
    Physical activity and acute exercise benefit influenza vaccination response: A systematic review with individual participant data meta-analysis.
    PLoS One. 2022;17:e0268625.
    PubMed     Abstract available


  470. GU M, Taylor B, Pollack HA, Schneider JA, et al
    A pilot study on COVID-19 vaccine hesitancy among healthcare workers in the US.
    PLoS One. 2022;17:e0269320.
    PubMed     Abstract available


  471. RANI MDM, Mohamed NA, Solehan HM, Ithnin M, et al
    Assessment of acceptability of the COVID-19 vaccine based on the health belief model among Malaysians-A qualitative approach.
    PLoS One. 2022;17:e0269059.
    PubMed     Abstract available


  472. PAPANEOPHYTOU C, Nicolaou A, Pieri M, Nicolaidou V, et al
    Seroprevalence of immunoglobulin G antibodies against SARS-CoV-2 in Cyprus.
    PLoS One. 2022;17:e0269885.
    PubMed     Abstract available


  473. RANGELOVA V, Raycheva R, Sariyan S, Kevorkyan A, et al
    Reporting adverse events of COVID-19 vaccines: The case of Bulgaria.
    PLoS One. 2022;17:e0269727.
    PubMed     Abstract available


  474. KOBASHI Y, Shimazu Y, Kawamura T, Nishikawa Y, et al
    Factors associated with anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein antibody titer and neutralizing activity among healthcare workers following vaccination with the BNT162b2 vaccine.
    PLoS One. 2022;17:e0269917.
    PubMed     Abstract available


  475. PAWASKAR M, Fergie J, Harley C, Samant S, et al
    Impact of universal varicella vaccination on the use and cost of antibiotics and antivirals for varicella management in the United States.
    PLoS One. 2022;17:e0269916.
    PubMed     Abstract available


  476. MA Y, Zhao Y, Chen R, Sun W, et al
    Mucosal immunity of mannose-modified chitosan microspheres loaded with the nontyepable Haemophilus influenzae outer membrane protein P6 in BALB/c mice.
    PLoS One. 2022;17:e0269153.
    PubMed     Abstract available


  477. DESALEGN M, Garoma G, Tamrat H, Desta A, et al
    The prevalence of AstraZeneca COVID-19 vaccine side effects among Nigist Eleni Mohammed memorial comprehensive specialized hospital health workers. Cross sectional survey.
    PLoS One. 2022;17:e0265140.
    PubMed     Abstract available


  478. CERVANTES-LUEVANO K, Espino-Vazquez AN, Flores-Acosta G, Bernaldez-Sarabia J, et al
    Neutralizing antibodies levels are increased in individuals with heterologous vaccination and hybrid immunity with Ad5-nCoV in the north of Mexico.
    PLoS One. 2022;17:e0269032.
    PubMed     Abstract available


  479. SIEWCHAISAKUL P, Sarakarn P, Nanthanangkul S, Longkul J, et al
    Role of literacy, fear and hesitancy on acceptance of COVID-19 vaccine among village health volunteers in Thailand.
    PLoS One. 2022;17:e0270023.
    PubMed     Abstract available


  480. MOONEY J, Price J, Bain C, Bawa JT, et al
    Healthcare provider perspectives on delivering next generation rotavirus vaccines in five low-to-middle-income countries.
    PLoS One. 2022;17:e0270369.
    PubMed     Abstract available


  481. LANIER HD, Diaz MI, Saleh SN, Lehmann CU, et al
    Analyzing COVID-19 disinformation on Twitter using the hashtags #scamdemic and #plandemic: Retrospective study.
    PLoS One. 2022;17:e0268409.
    PubMed     Abstract available


  482. BACURAU AGM, Sato APS, Francisco PMSB
    Correction: Reasons for nonadherence to vaccination for influenza among older people in Brazil.
    PLoS One. 2022;17:e0270443.
    PubMed     Abstract available


  483. TAKEUCHI M, Esaki A, Higa Y, Nakazono A, et al
    Temporal changes in spike IgG levels after two doses of BNT162b2 vaccine in Japanese healthcare workers: Do spike IgG levels at 3 months predict levels 6 or 8 months after vaccination?
    PLoS One. 2022;17:e0263486.
    PubMed     Abstract available


  484. ACHENBACH CJ, Caputo M, Hawkins C, Balmert LC, et al
    Clinical evaluation of the Diagnostic Analyzer for Selective Hybridization (DASH): A point-of-care PCR test for rapid detection of SARS-CoV-2 infection.
    PLoS One. 2022;17:e0270060.
    PubMed     Abstract available


  485. ABAY ES, Belew MD, Ketsela BS, Mengistu EE, et al
    Assessment of attitude towards COVID-19 vaccine and associated factors among clinical practitioners in Ethiopia: A cross-sectional study.
    PLoS One. 2022;17:e0269923.
    PubMed     Abstract available


  486. AWUNI JA, Ayamga M, Dagunga G
    Covid-19 vaccination intensions among literate Ghanaians: Still the need to dissipate fear and build trust on vaccine efficacy?
    PLoS One. 2022;17:e0270742.
    PubMed     Abstract available


  487. SAAD E, Sadiq S, Jamil R, Rustam F, et al
    Novel extreme regression-voting classifier to predict death risk in vaccinated people using VAERS data.
    PLoS One. 2022;17:e0270327.
    PubMed     Abstract available


  488. BURGER MN, Mayer M, Steimanis I
    Repeated information of benefits reduces COVID-19 vaccination hesitancy: Experimental evidence from Germany.
    PLoS One. 2022;17:e0270666.
    PubMed     Abstract available


  489. RAHMAN MM, Chisty MA, Alam MA, Sakib MS, et al
    Knowledge, attitude, and hesitancy towards COVID-19 vaccine among university students of Bangladesh.
    PLoS One. 2022;17:e0270684.
    PubMed     Abstract available


  490. AMOUR MA, Rees CA, Munseri PJ, Said J, et al
    Serial T-SPOT.TB responses in Tanzanian adolescents: Transient, persistent and irregular conversions.
    PLoS One. 2022;17:e0268685.
    PubMed     Abstract available


  491. FERGIE J, Pawaskar M, Veeranki P, Samant S, et al
    Recognition & management of varicella infections and accuracy of antimicrobial recommendations: Case vignettes study in the US.
    PLoS One. 2022;17:e0269596.
    PubMed     Abstract available


  492. ATSAWASUWAN P, Del Campo DM, Del Campo LM, Viana G, et al
    Positivity rates of SAR-CoV-2 infection in orthodontic patients at the orthodontic clinic, University of Illinois Chicago.
    PLoS One. 2022;17:e0270311.
    PubMed     Abstract available


  493. PRAKASH A, Jeyakumar Nathan R, Kini S, Victor V, et al
    Message framing and COVID-19 vaccine acceptance among millennials in South India.
    PLoS One. 2022;17:e0269487.
    PubMed     Abstract available


  494. OKAI GA, Abekah-Nkrumah G
    The level and determinants of COVID-19 vaccine acceptance in Ghana.
    PLoS One. 2022;17:e0270768.
    PubMed     Abstract available


  495. MAGEE L, Knights F, Mckechnie DGJ, Al-Bedaery R, et al
    Facilitators and barriers to COVID-19 vaccination uptake among ethnic minorities: A qualitative study in primary care.
    PLoS One. 2022;17:e0270504.
    PubMed     Abstract available


  496. JAFAR A, Dambul R, Dollah R, Sakke N, et al
    COVID-19 vaccine hesitancy in Malaysia: Exploring factors and identifying highly vulnerable groups.
    PLoS One. 2022;17:e0270868.
    PubMed     Abstract available


  497. FIERRO A, Romano S, Liccardo A
    Vaccination and variants: Retrospective model for the evolution of Covid-19 in Italy.
    PLoS One. 2022;17:e0265159.
    PubMed     Abstract available


  498. BEREC L, Smid M, Pribylova L, Majek O, et al
    Protection provided by vaccination, booster doses and previous infection against covid-19 infection, hospitalisation or death over time in Czechia.
    PLoS One. 2022;17:e0270801.
    PubMed     Abstract available


  499. BAIDEN F, Fleck S, Leigh B, Ayieko P, et al
    Prevalence of malaria and helminth infections in rural communities in northern Sierra Leone, a baseline study to inform Ebola vaccine study protocols.
    PLoS One. 2022;17:e0270968.
    PubMed     Abstract available


  500. WANG J, Xu Z, Gao Q
    Varicella outbreaks in schools and kindergartens in Shanghai, China from 2011 to 2020.
    PLoS One. 2022;17:e0270630.
    PubMed     Abstract available


  501. ABO SHAMA NM, Mahmoud SH, Bagato O, AbdElsalam ET, et al
    Incidence and neutralizing antibody seroprevalence of influenza B virus in Egypt: Results of a community-based cohort study.
    PLoS One. 2022;17:e0269321.
    PubMed     Abstract available


  502. DROPKIN G
    Variation in COVID-19 booster uptake in England: An ecological study.
    PLoS One. 2022;17:e0270624.
    PubMed     Abstract available


  503. KUMAR CK, Balasubramanian R, Ongarello S, Carmona S, et al
    SARS-CoV-2 testing strategies for outbreak mitigation in vaccinated populations.
    PLoS One. 2022;17:e0271103.
    PubMed     Abstract available


  504. BEYEN MW, Bulto GA, Chaka EE, Debelo BT, et al
    Human papillomavirus vaccination uptake and its associated factors among adolescent school girls in Ambo town, Oromia region, Ethiopia, 2020.
    PLoS One. 2022;17:e0271237.
    PubMed     Abstract available


  505. TEGEGNE MD, Girma S, Mengistu S, Mesfin T, et al
    Willingness to receive COVID-19 vaccine and associated factors among adult chronic patients. A cross-sectional study in Northwest Ethiopia.
    PLoS One. 2022;17:e0269942.
    PubMed     Abstract available


  506. KONISHI T
    Mutations in SARS-CoV-2 are on the increase against the acquired immunity.
    PLoS One. 2022;17:e0271305.
    PubMed     Abstract available


  507. EL MANSOURI N, Ferrera L, Kharbach A, Achbani A, et al
    Awareness and knowledge associated to Human papillomavirus infection among university students in Morocco: A cross-sectional study.
    PLoS One. 2022;17:e0271222.
    PubMed     Abstract available


  508. SEREDA AD, Kazakova AS, Namsrayn SG, Vlasov ME, et al
    The attenuated ASFV strains MK-200 and FK-32/135 as possible models for investigation of protective immunity by ASFV infection.
    PLoS One. 2022;17:e0270641.
    PubMed     Abstract available


  509. GUJJULA KR, Gong J, Segundo B, Ntaimo L, et al
    COVID-19 vaccination policies under uncertain transmission characteristics using stochastic programming.
    PLoS One. 2022;17:e0270524.
    PubMed     Abstract available


  510. LIU B, Zhang M, Li X, Liu L, et al
    Influence of epidemic situation on COVID-19 vaccination between urban and rural residents in China-Vietnam border area: A cross-sectional survey.
    PLoS One. 2022;17:e0270345.
    PubMed     Abstract available


  511. HERMAN B, Wong MC, Viwattanakulvanid P
    Vaccination status, favipiravir, and micronutrient supplementation roles in post-COVID symptoms: A longitudinal study.
    PLoS One. 2022;17:e0271385.
    PubMed     Abstract available


  512. SIEGERS KE, van Herwaarden AE, de Waard JH, Del Nogal B, et al
    The metabolic hormone adiponectin affects the correlation between nutritional status and pneumococcal vaccine response in vulnerable indigenous children.
    PLoS One. 2022;17:e0270736.
    PubMed     Abstract available


  513. HANSON CK, Liu K
    Think about your friends and family: The disparate impacts of relationship-centered messages on privacy concerns, protective health behavior, and vaccination against Covid-19.
    PLoS One. 2022;17:e0270279.
    PubMed     Abstract available


  514. JUNGE M, Li S, Samaranayake S, Zalesak M, et al
    Safe reopening of university campuses is possible with COVID-19 vaccination.
    PLoS One. 2022;17:e0270106.
    PubMed     Abstract available


  515. ZHANG A, Li D, Song C, Jing H, et al
    Evaluation of different combination of pam2CSK4, poly (I:C) and imiquimod enhance immune responses to H9N2 avian influenza antigen in dendritic cells and duck.
    PLoS One. 2022;17:e0271746.
    PubMed     Abstract available


  516. ABUHAMMAD S, Khabour OF, Alzoubi KH, Hamaideh S, et al
    The public's attitude to and acceptance of periodic doses of the COVID-19 vaccine: A survey from Jordan.
    PLoS One. 2022;17:e0271625.
    PubMed     Abstract available


  517. FATIMA S, Zafar A, Afzal H, Ejaz T, et al
    COVID-19 infection among vaccinated and unvaccinated: Does it make any difference?
    PLoS One. 2022;17:e0270485.
    PubMed     Abstract available


  518. ABD EL FADEEL MR, Soliman EM, Allam AM, ElKersh MF, et al
    Efficacy and durability of bovine virus diarrhea (BVD) virus killed vaccine adjuvanted with monolaurin.
    PLoS One. 2022;17:e0269031.
    PubMed     Abstract available


  519. TRAJMAN A, Lachapelle-Chisholm S, Zikos T, Werneck GL, et al
    Efficacy and effectiveness of SARS-CoV-2 vaccines for death prevention: A protocol for a systematic review and meta-analysis.
    PLoS One. 2022;17:e0265414.
    PubMed     Abstract available


  520. KADYROVA I, Yegorov S, Negmetzhanov B, Kolesnikova Y, et al
    High SARS-CoV-2 seroprevalence in Karaganda, Kazakhstan before the launch of COVID-19 vaccination.
    PLoS One. 2022;17:e0272008.
    PubMed     Abstract available


  521. HWANG J, Su MH, Jiang X, Lian R, et al
    Vaccine discourse during the onset of the COVID-19 pandemic: Topical structure and source patterns informing efforts to combat vaccine hesitancy.
    PLoS One. 2022;17:e0271394.
    PubMed     Abstract available


  522. GOTO T, Tani N, Ikematsu H, Gondo K, et al
    Post-vaccination antibody evaluation for nosocomial SARS-CoV-2 delta variant breakthrough infection.
    PLoS One. 2022;17:e0272056.
    PubMed     Abstract available


  523. KHOKHAR F, Pickard D, Dyson Z, Iqbal J, et al
    Multiplex PCR assay to detect high risk lineages of Salmonella Typhi and Paratyphi A.
    PLoS One. 2022;17:e0267805.
    PubMed     Abstract available


  524. AL-OBAYDI S, Hennrikus E, Mohammad N, Lehman EB, et al
    Hesitancy and reactogenicity to mRNA-based COVID-19 vaccines-Early experience with vaccine rollout in a multi-site healthcare system.
    PLoS One. 2022;17:e0272691.
    PubMed     Abstract available


  525. THORPE A, Fagerlin A, Butler J, Stevens V, et al
    Communicating about COVID-19 vaccine development and safety.
    PLoS One. 2022;17:e0272426.
    PubMed     Abstract available


  526. FACCIN M, Gargiulo F, Atlani-Duault L, Ward JK, et al
    Assessing the influence of French vaccine critics during the two first years of the COVID-19 pandemic.
    PLoS One. 2022;17:e0271157.
    PubMed     Abstract available


  527. KAN Y, Asada M, Uesawa Y
    Trends in reporting embolic and thrombotic events after COVID-19 vaccination: A retrospective, pharmacovigilance study.
    PLoS One. 2022;17:e0269268.
    PubMed     Abstract available


  528. SUMALI B, Mitsukura Y, Nishimura T
    Contactless continuous heart rate monitoring system using ballistocardiography.
    PLoS One. 2022;17:e0272072.
    PubMed     Abstract available


  529. OTUNUGA OM
    Analysis of multi-strain infection of vaccinated and recovered population through epidemic model: Application to COVID-19.
    PLoS One. 2022;17:e0271446.
    PubMed     Abstract available


  530. LEE HW, Leng CH, Chan TC
    Determinants of personal vaccination hesitancy before and after the mid-2021 COVID-19 outbreak in Taiwan.
    PLoS One. 2022;17:e0270349.
    PubMed     Abstract available


  531. NAKAMANYA S, Kawuma R, Kibuuka D, Kusemererwa S, et al
    Assessing acceptability of pre-exposure prophylaxis (PrEP) among participants in an HIV vaccine preparedness study in southwestern Uganda.
    PLoS One. 2022;17:e0271104.
    PubMed     Abstract available


  532. SABZIAN-MOLAEI F, Nasiri Khalili MA, Sabzian-Molaei M, Shahsavarani H, et al
    Urtica dioica Agglutinin: A plant protein candidate for inhibition of SARS-COV-2 receptor-binding domain for control of Covid19 Infection.
    PLoS One. 2022;17:e0268156.
    PubMed     Abstract available


  533. CHEN J, Chou SY, Yu TH, Rizqi ZU, et al
    System dynamics analysis on the effectiveness of vaccination and social mobilization policies for COVID-19 in the United States.
    PLoS One. 2022;17:e0268443.
    PubMed     Abstract available


  534. SHUI X, Wang F, Li L, Liang Q, et al
    COVID-19 vaccine acceptance among healthcare workers in China: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0273112.
    PubMed     Abstract available


  535. HUIBERTS A, van Cleef B, Tjon-A-Tsien A, Dijkstra F, et al
    Influenza vaccination of school teachers: A scoping review and an impact estimation.
    PLoS One. 2022;17:e0272332.
    PubMed     Abstract available


  536. RAYAMAJHI S, Rafi MA, Tripathi N, Dongol AS, et al
    Adverse events following immunization with ChAdOx1 nCoV-19 and BBIBP-CorV vaccine: A comparative study among healthcare professionals of Nepal.
    PLoS One. 2022;17:e0272729.
    PubMed     Abstract available


  537. MEGHANI A, Agarwal S, Zapf AJ, Edwards JG, et al
    Schooling amidst a pandemic in the United States: Parents' perceptions about reopening schools and anticipated challenges during COVID-19.
    PLoS One. 2022;17:e0268427.
    PubMed     Abstract available


  538. NKA AD, Ka'e AC, Bouba Y, Ngoufack Jagni Semengue E, et al
    Global burden of SARS-CoV-2 infection, hospitalization and case fatality rate among COVID-19 vaccinated individuals and its associated factors: A systematic review and meta-analysis protocol.
    PLoS One. 2022;17:e0272839.
    PubMed     Abstract available


  539. ALSAGABY SA, Alharbi NK, Alhumaydhi FA, Alsubaie F, et al
    Risk factors of SARS-CoV-2 infection in cancer patients pre- and post-vaccination.
    PLoS One. 2022;17:e0272869.
    PubMed     Abstract available


  540. AEMRO A, Fentie B, Wassie M
    Adherence to Covid-19 mitigation measures and its associated factors among health care workers at referral hospitals in Amhara regional state of Ethiopia.
    PLoS One. 2022;17:e0272570.
    PubMed     Abstract available


  541. SADEGHI K, Poorolajal J, Doosti-Irani A
    Prevalence of modifiable risk factors of tuberculosis and their population attributable fraction in Iran: A cross-sectional study.
    PLoS One. 2022;17:e0271511.
    PubMed     Abstract available


  542. SALVI N, Itta KC, Lachyan A, Hasan AZ, et al
    Experiences of sharing results of community based serosurvey with participants in a district of Maharashtra, India.
    PLoS One. 2022;17:e0271920.
    PubMed     Abstract available


  543. RAYHAN MRI, Liza JM, Rahman MM
    Assessment of COVID-19 vaccination-related medical waste management practices in Bangladesh.
    PLoS One. 2022;17:e0273053.
    PubMed     Abstract available


  544. AFRIFA-ANANE GF, Larbi RT, Addo B, Agyekum MW, et al
    Facilitators and barriers to COVID-19 vaccine uptake among women in two regions of Ghana: A qualitative study.
    PLoS One. 2022;17:e0272876.
    PubMed     Abstract available


  545. HUSAIN F, Powys VR, White E, Jones R, et al
    COVID-19 vaccination uptake in 441 socially and ethnically diverse pregnant women.
    PLoS One. 2022;17:e0271834.
    PubMed     Abstract available


  546. LEONE V, Meisinger C, Temizel S, Kling E, et al
    Longitudinal change in SARS-CoV-2 seroprevalence in 3-to 16-year-old children: The Augsburg Plus study.
    PLoS One. 2022;17:e0272874.
    PubMed     Abstract available


  547. YAKUM MN, Funwie AD, Ajong AB, Tsafack M, et al
    Factors associated with routine vaccination card retention among children aged 0-59 months in Yaounde-Cameroon: A cross-sectional survey.
    PLoS One. 2022;17:e0273515.
    PubMed     Abstract available


  548. ZHANG M, Tian J, Li H, Cang M, et al
    The comparative genomic analysis provides insights into the phylogeny and virulence of tick-borne encephalitis virus vaccine strain Senzhang.
    PLoS One. 2022;17:e0273565.
    PubMed     Abstract available


  549. APIWATTANAKUL M, Suanprasert N, Rojana-Udomsart A, Termglinchan T, et al
    Good recovery of immunization stress-related responses presenting as a cluster of stroke-like events following CoronaVac and ChAdOx1 vaccinations.
    PLoS One. 2022;17:e0266118.
    PubMed     Abstract available


  550. KUMAR N, Sulaiman SAS, Hashmi FK, Qureshi A, et al
    Survey data of public in Sindh Pakistan regarding willingness to accept COVID-19 vaccination.
    PLoS One. 2022;17:e0270900.
    PubMed     Abstract available


  551. LUBEYA MK, Mwanahamuntu M, Chibwesha C, Mukosha M, et al
    Implementation strategies to increase human papillomavirus vaccination uptake for adolescent girls in sub-Saharan Africa: A scoping review protocol.
    PLoS One. 2022;17:e0267617.
    PubMed     Abstract available


  552. SEN SR, Sanders EC, Santos AM, Bhuvan K, et al
    Evidence for deleterious effects of immunological history in SARS-CoV-2.
    PLoS One. 2022;17:e0272163.
    PubMed     Abstract available


  553. NUZHATH T, Hotez PJ, Damania A, Liu PS, et al
    Creation of a Global Vaccine Risk Index.
    PLoS One. 2022;17:e0272784.
    PubMed     Abstract available


  554. HERRMANN-WERNER A, Festl-Wietek T, Gille C, Zipfel S, et al
    Medical student attitudes on vaccination relevance: A mixed-method study.
    PLoS One. 2022;17:e0273529.
    PubMed     Abstract available


  555. OTENG AGYEMAN F, Ma Z, Li M, Kwasi Sampene A, et al
    Relevance of COVID-19 vaccine on the tourism industry: Evidence from China.
    PLoS One. 2022;17:e0269200.
    PubMed     Abstract available


  556. ASRATIE MH, Kassie BA, Belay DG, Endalew M, et al
    Perception of risk regarding the use of COVID-19 vaccine among pregnant women in Motta town and Hulet Eji Enese district, northwest Ethiopia.
    PLoS One. 2022;17:e0269591.
    PubMed     Abstract available


  557. DARWISH I, Harrison LB, Passos-Castilho AM, Labbe AC, et al
    In-hospital outcomes of SARS-CoV-2-infected health care workers in the COVID-19 pandemic first wave, Quebec, Canada.
    PLoS One. 2022;17:e0272953.
    PubMed     Abstract available


  558. HOSSAIN MS, Islam MS, Pardhan S, Banik R, et al
    Beliefs, barriers and hesitancy towards the COVID-19 vaccine among Bangladeshi residents: Findings from a cross-sectional study.
    PLoS One. 2022;17:e0269944.
    PubMed     Abstract available


  559. CHOQUE-GUEVARA R, Poma-Acevedo A, Montesinos-Millan R, Rios-Matos D, et al
    Squalene in oil-based adjuvant improves the immunogenicity of SARS-CoV-2 RBD and confirms safety in animal models.
    PLoS One. 2022;17:e0269823.
    PubMed     Abstract available


  560. ROJAS CONVERSO T, Goulart C, Rodriguez D, Guerra MES, et al
    Immune response induced in mice by a hybrid rPotD-PdT pneumococcal protein.
    PLoS One. 2022;17:e0273017.
    PubMed     Abstract available


  561. STERNJAKOB-MARTHALER A, Berko-Gottel B, Rissland J, Schope J, et al
    Human papillomavirus vaccination of girls in the German model region Saarland: Insurance data-based analysis and identification of starting points for improving vaccination rates.
    PLoS One. 2022;17:e0273332.
    PubMed     Abstract available


  562. BURATTO A, Muttoni M, Wrzaczek S, Freiberger M, et al
    Should the COVID-19 lockdown be relaxed or intensified in case a vaccine becomes available?
    PLoS One. 2022;17:e0273557.
    PubMed     Abstract available


  563. JIANG F, Zhao Y, Bai J, Yang X, et al
    Perceived health literacy and COVID-19 vaccine acceptance among Chinese college students: A mediation analysis.
    PLoS One. 2022;17:e0273285.
    PubMed     Abstract available


  564. WASSERBAUER M, Hlava S, Trojanek M, Stovicek J, et al
    Efficacy and safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease on immunosuppressive and biological therapy: Prospective observational study.
    PLoS One. 2022;17:e0273612.
    PubMed     Abstract available


  565. LEE KW, Gew LT, Siau CS, Peh SC, et al
    COVID-19 vaccine hesitancy and its associated factors in Malaysia.
    PLoS One. 2022;17:e0266925.
    PubMed     Abstract available


  566. WAGGLE KD, Griffith MP, Zhu L, Cooper VS, et al
    Genomic characterization of SARS-CoV-2 from vaccine breakthrough cases in Allegheny County, Pennsylvania.
    PLoS One. 2022;17:e0272954.
    PubMed     Abstract available


  567. BEHMARD E, Abdulabbas HT, Abdalkareem Jasim S, Najafipour S, et al
    Design of a novel multi-epitope vaccine candidate against hepatitis C virus using structural and nonstructural proteins: An immunoinformatics approach.
    PLoS One. 2022;17:e0272582.
    PubMed     Abstract available


  568. NASIRI O, Hajihassani M, Noori Goodarzi N, Fereshteh S, et al
    Reverse vaccinology approach to identify novel and immunogenic targets against Porphyromonas gingivalis: An in silico study.
    PLoS One. 2022;17:e0273770.
    PubMed     Abstract available


  569. SANNEH B, Sanneh S, Lareef-Jah S, Darboe B, et al
    Practice of preventive measures and vaccine hesitance for COVID 19 among households in The Gambia, 2021: Study protocol.
    PLoS One. 2022;17:e0270304.
    PubMed     Abstract available


  570. KYEI-ARTHUR F, Kyei-Gyamfi S, Agyekum MW, Afrifa-Anane GF, et al
    Parents' and guardians' acceptability of COVID-19 vaccination for children in Ghana: An online survey.
    PLoS One. 2022;17:e0272801.
    PubMed     Abstract available


  571. SCHNEPF J
    Does perceived scarcity of COVID-19 vaccines increase vaccination willingness? Results of an experimental study with German respondents in times of a national vaccine shortage.
    PLoS One. 2022;17:e0273441.
    PubMed     Abstract available


  572. SAELEE C, Hanthamrongwit J, Soe PT, Khaenam P, et al
    Toll-like receptor-mediated innate immune responses by recognition of the recombinant dormancy-associated Mycobacterium tuberculosis proteins Rv2659c and Rv1738.
    PLoS One. 2022;17:e0273517.
    PubMed     Abstract available


  573. HOANG PT, Luong QXT, Cho S, Lee Y, et al
    Enhancing neutralizing activity against influenza H1N1/PR8 by engineering a single-domain VL-M2 specific into a bivalent form.
    PLoS One. 2022;17:e0273934.
    PubMed     Abstract available


  574. GUNAWARDHANA N, Baecher K, Boutwell A, Pekwarake S, et al
    COVID-19 vaccine acceptance and perceived risk among pregnant and non-pregnant adults in Cameroon, Africa.
    PLoS One. 2022;17:e0274541.
    PubMed     Abstract available


  575. MACHADO A, Kislaya I, Rodrigues AP, Sequeira D, et al
    COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infections, COVID-19 related hospitalizations and deaths, among individuals aged >/=65 years in Portugal: A cohort study based on data-linkage of national registries February-September 2021
    PLoS One. 2022;17:e0274008.
    PubMed     Abstract available


  576. REBITSCHEK FG, Ellermann C, Jenny MA, Siegel NA, et al
    Fact boxes that inform individual decisions may contribute to a more positive evaluation of COVID-19 vaccinations at the population level.
    PLoS One. 2022;17:e0274186.
    PubMed     Abstract available


  577. DESANTIS SM, Leon-Novelo LG, Swartz MD, Yaseen AS, et al
    Methodology to estimate natural- and vaccine-induced antibodies to SARS-CoV-2 in a large geographic region.
    PLoS One. 2022;17:e0273694.
    PubMed     Abstract available


  578. SEMENZATO L, Botton J, Baricault B, Deloumeaux J, et al
    Vaccine effectiveness against severe COVID-19 outcomes within the French overseas territories: A cohort study of 2-doses vaccinated individuals matched to unvaccinated ones followed up until September 2021 and based on the National Health Data System.
    PLoS One. 2022;17:e0274309.
    PubMed     Abstract available


  579. VALDES-DONOSO P, Jarvis LS
    Combining epidemiology and economics to assess control of a viral endemic animal disease: Porcine Reproductive and Respiratory Syndrome (PRRS).
    PLoS One. 2022;17:e0274382.
    PubMed     Abstract available


  580. GOGOI M, Wobi F, Qureshi I, Al-Oraibi A, et al
    "The vaccination is positive; I don't think it's the panacea": A qualitative study on COVID-19 vaccine attitudes among ethnically diverse healthcare workers in the United Kingdom.
    PLoS One. 2022;17:e0273687.
    PubMed     Abstract available


  581. ISMAIL N, Tavoschi L, Moazen B, Rosello A, et al
    COVID-19 vaccine for people who live and work in prisons worldwide: A scoping review.
    PLoS One. 2022;17:e0267070.
    PubMed     Abstract available


  582. FULLER A, Hancox J, Vedhara K, Card T, et al
    Barriers and facilitators to vaccination uptake against COVID-19, influenza, and pneumococcal pneumonia in immunosuppressed adults with immune-mediated inflammatory diseases: A qualitative interview study during the COVID-19 pandemic.
    PLoS One. 2022;17:e0267769.
    PubMed     Abstract available


  583. YANG IN, Lu CL, Tang HJ, Kuo YC, et al
    Safety of ChAdOx1 nCoV-19 vaccination in patients with end-stage renal disease on hemodialysis.
    PLoS One. 2022;17:e0273676.
    PubMed     Abstract available


  584. HUHN G, Poorbaugh J, Zhang L, Beasley S, et al
    COVID-19 symptom relationship to antibody response and ACE2 neutralization in recovered health systems employees before and after mRNA BNT162b2 COVID-19 vaccine.
    PLoS One. 2022;17:e0273323.
    PubMed     Abstract available


  585. MOON YJ, Cho KS, Jeong JY, Chung DY, et al
    Effects of intravesical BCG maintenance therapy duration on recurrence rate in high-risk non-muscle invasive bladder cancer (NMIBC): Systematic review and network meta-analysis according to EAU COVID-19 recommendations.
    PLoS One. 2022;17:e0273733.
    PubMed     Abstract available


  586. BENNETT NG, Bloom DE, Ferranna M
    Factors underlying COVID-19 vaccine and booster hesitancy and refusal, and incentivizing vaccine adoption.
    PLoS One. 2022;17:e0274529.
    PubMed     Abstract available


  587. AGOSTI F, Toffolutti V, Cavalli N, Nivakoski S, et al
    Information and vaccine hesitancy: Evidence from the early stage of the vaccine roll-out in 28 European countries.
    PLoS One. 2022;17:e0273555.
    PubMed     Abstract available


  588. LIMAYE RJ, Balgobin K, Michel A, Schulz G, et al
    What message appeal and messenger are most persuasive for COVID-19 vaccine uptake: Results from a 5-country survey in India, Indonesia, Kenya, Nigeria, and Ukraine.
    PLoS One. 2022;17:e0274966.
    PubMed     Abstract available


  589. WU H, Xue M, Wu C, Lu Q, et al
    Trend of hand, foot, and mouth disease from 2010 to 2021 and estimation of the reduction in enterovirus 71 infection after vaccine use in Zhejiang Province, China.
    PLoS One. 2022;17:e0274421.
    PubMed     Abstract available


  590. LEDESMA JR, Lurie P, Yorlets RR, Daly G, et al
    Spurious early ecological association suggesting BCG vaccination effectiveness for COVID-19.
    PLoS One. 2022;17:e0274900.
    PubMed     Abstract available


  591. FRAUCHES TS, Costa CAS, Rodrigues CDS, de Azevedo MCVM, et al
    COVID-19 cross-sectional study in Marica, Brazil: The impact of vaccination coverage on viral incidence.
    PLoS One. 2022;17:e0269011.
    PubMed     Abstract available


  592. CAPPELLI L, Cinelli P, Giusti F, Ferlenghi I, et al
    Self-assembling protein nanoparticles and virus like particles correctly display beta-barrel from meningococcal factor H-binding protein through genetic fusion.
    PLoS One. 2022;17:e0273322.
    PubMed     Abstract available


  593. HEFELE L, Lai J, Vilivong K, Bounkhoun T, et al
    Haemophilus influenzae serotype b seroprevalence in central Lao PDR before and after vaccine introduction.
    PLoS One. 2022;17:e0274558.
    PubMed     Abstract available


  594. SERETI I, Shaw-Saliba K, Dodd LE, Dewar RL, et al
    Design of an observational multi-country cohort study to assess immunogenicity of multiple vaccine platforms (InVITE).
    PLoS One. 2022;17:e0273914.
    PubMed     Abstract available


  595. GRAVAGNA K, Wolfson C, Sulis G, Buchan SA, et al
    Influenza vaccine coverage and factors associated with non-vaccination among adults at high risk for severe outcomes: An analysis of the Canadian Longitudinal Study on Aging.
    PLoS One. 2022;17:e0275135.
    PubMed     Abstract available


  596. DE BOER J, Saade U, Granjon E, Trouillet-Assant S, et al
    A novel assessment method for COVID-19 humoral immunity duration using serial measurements in naturally infected and vaccinated subjects.
    PLoS One. 2022;17:e0274553.
    PubMed     Abstract available


  597. DAS P, Igoe M, Lenhart S, Luong L, et al
    Geographic disparities and determinants of COVID-19 incidence risk in the greater St. Louis Area, Missouri (United States).
    PLoS One. 2022;17:e0274899.
    PubMed     Abstract available


  598. AZAMI M, Nasirkandy MP, Esmaeili Gouvarchin Ghaleh H, Ranjbar R, et al
    COVID-19 vaccine acceptance among pregnant women worldwide: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0272273.
    PubMed     Abstract available


  599. FULLER S, Kazemian S, Algara C, Simmons DJ, et al
    Assessing the effectiveness of COVID-19 vaccine lotteries: A cross-state synthetic control methods approach.
    PLoS One. 2022;17:e0274374.
    PubMed     Abstract available


  600. ABDUL AZIZ NI, Flanders S, Nungsari M
    Social expectations and government incentives in Malaysia's COVID-19 vaccine uptake.
    PLoS One. 2022;17:e0275010.
    PubMed     Abstract available


  601. ALLEN JD, Priebe Rocha L, Rose R, Hoch A, et al
    Intention to obtain a COVID-19 vaccine among Brazilian immigrant women in the U.S.
    PLoS One. 2022;17:e0274912.
    PubMed     Abstract available


  602. NICHOL B, Simonetti V, McCready J, Steen M, et al
    Barriers and facilitators to vaccination for COVID-19, pertussis, and influenza during pregnancy: Protocol for an umbrella review.
    PLoS One. 2022;17:e0275105.
    PubMed     Abstract available


  603. BETOUKE ONGWE ME, Mouwenda YD, Stam KA, Kremsner PG, et al
    Investigation of urinary metabolomics in a phase I hookworm vaccine trial in Gabon.
    PLoS One. 2022;17:e0275013.
    PubMed     Abstract available


  604. YAKUBU AM, Aryee NA, Bonney EY, Kotey EN, et al
    Molecular characterization of haemagglutinin genes of influenza B viruses circulating in Ghana during 2016 and 2017.
    PLoS One. 2022;17:e0271321.
    PubMed     Abstract available


  605. KALIFF M, Lillsunde Larsson G, Helenius G, Karlsson MG, et al
    Full genotyping and FAM19A4/miR124-2 methylation analysis in high-risk human papillomavirus-positive samples from women over 30 years participating in cervical cancer screening in Orebro, Sweden.
    PLoS One. 2022;17:e0274825.
    PubMed     Abstract available


  606. OKRUSZEK L, Piejka A, Banasik-Jemielniak N, Jemielniak D, et al
    Climate change, vaccines, GMO: The N400 effect as a marker of attitudes toward scientific issues.
    PLoS One. 2022;17:e0273346.
    PubMed     Abstract available


  607. BOCKSTAL V, Shukarev G, McLean C, Goldstein N, et al
    First-in-human study to evaluate safety, tolerability, and immunogenicity of heterologous regimens using the multivalent filovirus vaccines Ad26.Filo and MVA-BN-Filo administered in different sequences and schedules: A randomized, controlled study.
    PLoS One. 2022;17:e0274906.
    PubMed     Abstract available


  608. LUN P, Gao J, Tang B, Yu CC, et al
    A social ecological approach to identify the barriers and facilitators to COVID-19 vaccination acceptance: A scoping review.
    PLoS One. 2022;17:e0272642.
    PubMed     Abstract available


  609. NIEMINEN H, Hakulinen T, Puumalainen T, Siren P, et al
    Time and labour costs of preventive health care, including vaccinations, in Finnish child health clinics.
    PLoS One. 2022;17:e0270835.
    PubMed     Abstract available


  610. PAUDEL YR, Du C, MacDonald SE
    The influence of place on COVID-19 vaccine coverage in Alberta: A multilevel analysis.
    PLoS One. 2022;17:e0276160.
    PubMed     Abstract available


  611. KAPAR B, Buigut S, Rana F
    Winners and losers from Pfizer and Biontech's vaccine announcement: Evidence from S&P 500 (Sub)sector indices.
    PLoS One. 2022;17:e0275773.
    PubMed     Abstract available


  612. SULIS G, Rodrigue V, Wolfson C, McMillan JM, et al
    Pneumococcal vaccination uptake and missed opportunities for vaccination among Canadian adults: A cross-sectional analysis of the Canadian Longitudinal Study on Aging (CLSA).
    PLoS One. 2022;17:e0275923.
    PubMed     Abstract available


  613. WANG B, Wu L, Hong X, Han Y, et al
    Risk perception and subsidy policy-based voluntary vaccination driven by multiple information sources.
    PLoS One. 2022;17:e0276177.
    PubMed     Abstract available


  614. STREETER AJ, Rodgers LR, Masoli J, Lin NX, et al
    Real-world effectiveness of pneumococcal vaccination in older adults: Cohort study using the UK Clinical Practice Research Datalink.
    PLoS One. 2022;17:e0275642.
    PubMed     Abstract available


  615. JEEWANDARA C, Aberathna IS, Dayarathna S, Nimasha T, et al
    Comparison of the kinetics and magnitude of antibody responses to different SARS-CoV-2 proteins in Sinopharm/BBIBP-CorV vaccinees following the BNT162b2 booster or natural infection.
    PLoS One. 2022;17:e0274845.
    PubMed     Abstract available


  616. BIKAAKO W, Kabahango P, Mugabi K, Yawe A, et al
    Breaking institutional barriers to enhance women's participation in and benefit from the Peste des Petits Ruminants and Newcastle Disease vaccine value chains for Sembabule district of Uganda.
    PLoS One. 2022;17:e0270518.
    PubMed     Abstract available


  617. HANDAYANI S, Rias YA, Kurniasari MD, Agustin R, et al
    Relationship of spirituality, health engagement, health belief and attitudes toward acceptance and willingness to pay for a COVID-19 vaccine.
    PLoS One. 2022;17:e0274972.
    PubMed     Abstract available


  618. PETROVIC V, Ristic M, Milosavljevic B, Djilas M, et al
    Pneumococcal carriage in adults aged 50 years and older in outpatient health care facility during pandemic COVID-19 in Novi Sad, Serbia.
    PLoS One. 2022;17:e0274674.
    PubMed     Abstract available


  619. SALMON DA, Schuh HB, Sargent RH, Konja A, et al
    Impact of vaccine pause due to Thrombosis with thrombocytopenia syndrome (TTS) following vaccination with the Ad26.COV2.S vaccine manufactured by Janssen/Johnson & Johnson on vaccine hesitancy and acceptance among the unvaccinated population.
    PLoS One. 2022;17:e0274443.
    PubMed     Abstract available


  620. BAEK K, Maharjan S, Akauliya M, Thapa B, et al
    Comparison of vaccination efficacy using live or ultraviolet-inactivated influenza viruses introduced by different routes in a mouse model.
    PLoS One. 2022;17:e0275722.
    PubMed     Abstract available


  621. ALMONGY HM, Almetwally EM, Haj Ahmad H, H Al-Nefaie A, et al
    Modeling of COVID-19 vaccination rate using odd Lomax inverted Nadarajah-Haghighi distribution.
    PLoS One. 2022;17:e0276181.
    PubMed     Abstract available


  622. MARTINELLI M, Veltri GA
    Shared understandings of vaccine hesitancy: How perceived risk and trust in vaccination frame individuals' vaccine acceptance.
    PLoS One. 2022;17:e0276519.
    PubMed     Abstract available


  623. PARKER SJ, DeLaroche AM, Hill AB, Arora R, et al
    Influenza vaccination coverage among an urban pediatric asthma population: Implications for population health.
    PLoS One. 2022;17:e0269415.
    PubMed     Abstract available


  624. TADROUS M, Chung H, Men S, Chu C, et al
    Risk of SARS-CoV-2 infection following initial COVID-19 vaccination: Population-based cohort study.
    PLoS One. 2022;17:e0273903.
    PubMed     Abstract available


  625. NAKAMURA A, Kotaki T, Nagai Y, Takazawa S, et al
    Construction and evaluation of a self-replicative RNA vaccine against SARS-CoV-2 using yellow fever virus replicon.
    PLoS One. 2022;17:e0274829.
    PubMed     Abstract available


  626. AMIN MB, Roy N, Meem AE, Hossain E, et al
    Trends and determinants of taking tetanus toxoid vaccine among women during last pregnancy in Bangladesh: Country representative survey from 2006 to 2019.
    PLoS One. 2022;17:e0276417.
    PubMed     Abstract available


  627. DAHAL S, Pokhrel S, Mehta S, Karki S, et al
    Acceptance and hesitancy of COVID-19 vaccine among Nepalese population: A cross-sectional study.
    PLoS One. 2022;17:e0275922.
    PubMed     Abstract available


  628. NICKEL O, Rockstroh A, Wolf J, Landgraf S, et al
    Evaluation of the systemic and mucosal immune response induced by COVID-19 and the BNT162b2 mRNA vaccine for SARS-CoV-2.
    PLoS One. 2022;17:e0263861.
    PubMed     Abstract available


  629. VANNI T, Thome BC, Sparrow E, Friede M, et al
    Dose-sparing effect of two adjuvant formulations with a pandemic influenza A/H7N9 vaccine: A randomized, double-blind, placebo-controlled, phase 1 clinical trial.
    PLoS One. 2022;17:e0274943.
    PubMed     Abstract available


  630. ALMANSOUR A, Hussein SM, Felemban SG, Mahamid AW, et al
    Acceptance and hesitancy of parents to vaccinate children against coronavirus disease 2019 in Saudi Arabia.
    PLoS One. 2022;17:e0276183.
    PubMed     Abstract available


  631. SEDEGAH M, Porter C, Goguet E, Ganeshan H, et al
    Cellular interferon-gamma and interleukin-2 responses to SARS-CoV-2 structural proteins are broader and higher in those vaccinated after SARS-CoV-2 infection compared to vaccinees without prior SARS-CoV-2 infection.
    PLoS One. 2022;17:e0276241.
    PubMed     Abstract available


  632. VARGAS-HERRERA N, Fernandez-Navarro M, Cabezudo NE, Soto-Becerra P, et al
    Immunogenicity and reactogenicity of a third dose of BNT162b2 vaccine for COVID-19 after a primary regimen with BBIBP-CorV or BNT162b2 vaccines in Lima, Peru.
    PLoS One. 2022;17:e0268419.
    PubMed     Abstract available


  633. GAUTAM US, Asrican R, Sempowski GD
    Targeted dose delivery of Mycobacterium tuberculosis in mice using silicon antifoaming agent via aerosol exposure system.
    PLoS One. 2022;17:e0276130.
    PubMed     Abstract available


  634. CONTRACTOR A, Shivaprakash S, Tiwari A, Setia MS, et al
    Effectiveness of Covid-19 vaccines (CovishieldTM and Covaxin (R)) in healthcare workers in Mumbai, India: A retrospective cohort analysis.
    PLoS One. 2022;17:e0276759.
    PubMed     Abstract available


  635. ARUFFO E, Yuan P, Tan Y, Gatov E, et al
    Community structured model for vaccine strategies to control COVID19 spread: A mathematical study.
    PLoS One. 2022;17:e0258648.
    PubMed     Abstract available


  636. TOBOLOWSKY FA, Waltenburg MA, Moritz ED, Haile M, et al
    Longitudinal serologic and viral testing post-SARS-CoV-2 infection and post-receipt of mRNA COVID-19 vaccine in a nursing home cohort-Georgia, October 2020April 2021.
    PLoS One. 2022;17:e0275718.
    PubMed     Abstract available


  637. ENDERS AM, Uscinski J, Klofstad C, Stoler J, et al
    On the relationship between conspiracy theory beliefs, misinformation, and vaccine hesitancy.
    PLoS One. 2022;17:e0276082.
    PubMed     Abstract available


  638. CHERENACK EM, Salazar AS, Nogueira NF, Raccamarich P, et al
    Infection with SARS-CoV-2 is associated with menstrual irregularities among women of reproductive age.
    PLoS One. 2022;17:e0276131.
    PubMed     Abstract available


  639. TARIMO EAM, Ambikile J, Munseri P, Bakari M, et al
    Personal experiences following acquiring HIV infection while volunteering in Phase I/II HIV vaccine trials: A qualitative study from Tanzania.
    PLoS One. 2022;17:e0276404.
    PubMed     Abstract available


  640. KIM YR, Choi YJ, Min Y
    A model of COVID-19 pandemic with vaccines and mutant viruses.
    PLoS One. 2022;17:e0275851.
    PubMed     Abstract available


  641. GOULART ROSA R, Spinardi J, Allen KE, Manfio J, et al
    BNT162b2 against COVID-19 in Brazil using a test-negative design: Study protocol and statistical analysis plan.
    PLoS One. 2022;17:e0276384.
    PubMed     Abstract available


  642. GOMBE B, Streatfield C, Leal L, Opio S, et al
    Optimization and validation of an ELISA assay for the determination of antibody responses to CN54gp140 and AIDSVAX BE for use in the Phase IIb PrEPVacc vaccine trial.
    PLoS One. 2022;17:e0275927.
    PubMed     Abstract available


  643. FERNANDEZ-SUAREZ A, Jimenez Coronado R, Clavijo Aroca C, Navarro Martin E, et al
    New insights into antibody levels against SARS-CoV-2 for healthcare personnel vaccinated with tozinameran (Comirnaty).
    PLoS One. 2022;17:e0276968.
    PubMed     Abstract available


  644. ABDELHAMID MHM, Almsellati IA, Annajar BB, Abdulhamid AH, et al
    Hospitalization among vaccines for SARS-CoV-2 breakthrough infection after dose sparing strategies in Libya: A cohort study.
    PLoS One. 2022;17:e0276425.
    PubMed     Abstract available


  645. AYNALEM ZB, Bogale TW, Bantie GM, Ayalew AF, et al
    Factors associated with willingness to take COVID-19 vaccine among pregnant women at Gondar town, Northwest Ethiopia: A multicenter institution-based cross-sectional study.
    PLoS One. 2022;17:e0276763.
    PubMed     Abstract available


  646. GETACHEW D, Yosef T, Solomon N, Tesfaye M, et al
    Predictors of unwillingness to receive COVID -19 vaccines among Ethiopian Medical students.
    PLoS One. 2022;17:e0276857.
    PubMed     Abstract available


  647. GANESAN S, Acosta H, Brigolin C, Orange K, et al
    Intranasal nanoemulsion adjuvanted S-2P vaccine demonstrates protection in hamsters and induces systemic, cell-mediated and mucosal immunity in mice.
    PLoS One. 2022;17:e0272594.
    PubMed     Abstract available


  648. KIM M, Kim JH, Jung YW, Seong SJ, et al
    Gynecologic problems and healthcare behavior by shift patterns in Korean nursing staff.
    PLoS One. 2022;17:e0276282.
    PubMed     Abstract available


  649. MAINA D, Omuse G, Ong'ete G, Mugaine P, et al
    Seroprevalence, correlates and kinetics of SARS-CoV-2 nucleocapsid IgG antibody in healthcare workers and nonclinical staff at a tertiary hospital: A prevaccine census study.
    PLoS One. 2022;17:e0267619.
    PubMed     Abstract available


  650. SAKAMOTO M, Ishizuka R, Ozawa C, Fukuda Y, et al
    Health information and COVID-19 vaccination: Beliefs and attitudes among Japanese university students.
    PLoS One. 2022;17:e0277435.
    PubMed     Abstract available


  651. OTHMAN B, Barakat M, Omar A, Al-Rawashdeh A, et al
    Evaluation of hepatitis B knowledge, practices, and beliefs among the Jordanian population: A cross-sectional study.
    PLoS One. 2022;17:e0277186.
    PubMed     Abstract available


  652. OLUSANYA OA, White B, Malik F, Hester KA, et al
    Healthcare professionals' perceptions and recommendations regarding adolescent vaccinations in Georgia and Tennessee during the COVID-19 pandemic: A qualitative research.
    PLoS One. 2022;17:e0277748.
    PubMed     Abstract available


  653. DARWEESH O, Khatab N, Kheder R, Mohammed T, et al
    Assessment of COVID-19 vaccination among healthcare workers in Iraq; adverse effects and hesitancy.
    PLoS One. 2022;17:e0274526.
    PubMed     Abstract available


  654. HOY C, Wood T, Moscoe E
    Addressing vaccine hesitancy in developing countries: Survey and experimental evidence.
    PLoS One. 2022;17:e0277493.
    PubMed     Abstract available


  655. STRACQUALURSI L, Agati P
    Covid-19 vaccines in Italian public opinion: Identifying key issues using Twitter and Natural Language Processing.
    PLoS One. 2022;17:e0277394.
    PubMed     Abstract available


  656. NEWCOMB K, Bilal S, Michael E
    Combining predictive models with future change scenarios can produce credible forecasts of COVID-19 futures.
    PLoS One. 2022;17:e0277521.
    PubMed     Abstract available


  657. BANU B, Akter N, Chowdhury SH, Islam KR, et al
    COVID-19 and Bangladeshi health professionals: Infection status, vaccination and its immediate health consequences.
    PLoS One. 2022;17:e0277022.
    PubMed     Abstract available


  658. PEREZ A, Johnson JK, Marquez DX, Keiser S, et al
    Factors related to COVID-19 vaccine intention in Latino communities.
    PLoS One. 2022;17:e0272627.
    PubMed     Abstract available


  659. LEE H, Noh EB, Kim JE, Oh J, et al
    Influencing factor of COVID-19 vaccination trust and hesitancy in Wonju city, South Korea.
    PLoS One. 2022;17:e0277016.
    PubMed     Abstract available


  660. KAREEM R, Sethi MR, Inayat S, Irfan M, et al
    The effect of COVID-19 vaccination on the menstrual pattern and mental health of the medical students: A mixed-methods study from a low and middle-income country.
    PLoS One. 2022;17:e0277288.
    PubMed     Abstract available


  661. BRACCI A, Nadini M, Aliapoulios M, McCoy D, et al
    Vaccines and more: The response of Dark Web marketplaces to the ongoing COVID-19 pandemic.
    PLoS One. 2022;17:e0275288.
    PubMed     Abstract available


  662. DABROWSKA-LEONIK N, Sawicka-Powierza J, Bernatowska E, Pac M, et al
    Lack of relationship between 25-hydoxyvitamin D concentration and a titer of antibodies to hepatitis B surface antigen in children under 12 years of age.
    PLoS One. 2022;17:e0277473.
    PubMed     Abstract available


  663. TAMIRE M, Addissie A, Gizaw S, Abebe T, et al
    Household fuel use and its association with potential respiratory pathogens among healthy mothers and children in Ethiopia.
    PLoS One. 2022;17:e0277348.
    PubMed     Abstract available


  664. COCCIA M, Burny W, Demoitie MA, Gillard P, et al
    Subsequent AS01-adjuvanted vaccinations induce similar transcriptional responses in populations with different disease statuses.
    PLoS One. 2022;17:e0276505.
    PubMed     Abstract available


  665. LIMANI F, Smith C, Wachepa R, Chafuwa H, et al
    Estimating the economic burden of typhoid in children and adults in Blantyre, Malawi: A costing cohort study.
    PLoS One. 2022;17:e0277419.
    PubMed     Abstract available


  666. GALDIKIENE L, Jaraite J, Kajackaite A
    Trust and vaccination intentions: Evidence from Lithuania during the COVID-19 pandemic.
    PLoS One. 2022;17:e0278060.
    PubMed     Abstract available


  667. SARRIGEORGIOU I, Moschandreou D, Dimitriadis A, Tsinti G, et al
    Combined monitoring of IgG and IgA anti-Spike and anti-Receptor binding domain long term responses following BNT162b2 mRNA vaccination in Greek healthcare workers.
    PLoS One. 2022;17:e0277827.
    PubMed     Abstract available


  668. LAKNEH EA, Mersha EA, Asresie MB, Belay HG, et al
    Knowledge, attitude, and uptake of human papilloma virus vaccine and associated factors among female preparatory school students in Bahir Dar City, Amhara Region, Ethiopia.
    PLoS One. 2022;17:e0276465.
    PubMed     Abstract available


  669. SULAIMAN SK, Musa MS, Tsiga-Ahmed FI, Dayyab FM, et al
    A systematic review and meta-analysis of the prevalence of caregiver acceptance of malaria vaccine for under-five children in low-income and middle-income countries (LMICs).
    PLoS One. 2022;17:e0278224.
    PubMed     Abstract available


  670. WINTERS M, Malik AA, Omer SB
    Attitudes towards Monkeypox vaccination and predictors of vaccination intentions among the US general public.
    PLoS One. 2022;17:e0278622.
    PubMed     Abstract available


  671. SAIGI-RUBIO F, Eguia H, Espelt A, Macip S, et al
    Hesitation about coronavirus vaccines in healthcare professionals and general population in Spain.
    PLoS One. 2022;17:e0277899.
    PubMed     Abstract available


  672. DELLA PIA A, Kim GYG, Ip A, Ahn J, et al
    Anti-spike antibody response to the COVID vaccine in lymphoma patients.
    PLoS One. 2022;17:e0266584.
    PubMed     Abstract available


  673. OCHE OM, Adamu H, Yahaya M, Illo HG, et al
    Perception and willingness to accept COVID-19 Vaccines: A cross-sectional survey of the general population of Sokoto State, Nigeria.
    PLoS One. 2022;17:e0278332.
    PubMed     Abstract available


  674. ABDULLAH M, Ahmad T, Kazmi T, Sultan F, et al
    Community engagement to increase vaccine uptake: Quasi-experimental evidence from Islamabad and Rawalpindi, Pakistan.
    PLoS One. 2022;17:e0274718.
    PubMed     Abstract available


  675. SRINIVASAN V, Weinstein SE, Bhimani A, Clemons NC, et al
    On variants and vaccines: The effectiveness of Covid-19 monoclonal antibody therapy during two distinct periods in the pandemic.
    PLoS One. 2022;17:e0278394.
    PubMed     Abstract available


  676. ALBANESE A, Fallucchi F, Verheyden B
    Can a supranational medicines agency restore trust after vaccine suspensions? The case of Vaxzevria.
    PLoS One. 2022;17:e0277554.
    PubMed     Abstract available


  677. TOPF KG, Sheppard M, Marx GE, Wiegand RE, et al
    Impact of the COVID-19 Vaccination Program on case incidence, emergency department visits, and hospital admissions among children aged 5-17 Years during the Delta and Omicron Periods-United States, December 2020 to April 2022.
    PLoS One. 2022;17:e0276409.
    PubMed     Abstract available


  678. DAGNEW BAYE N, Agegnehu Teshome A, Agimas Ayenew A, Tilahun Mulu A, et al
    Attitude and level of COVID-19 vaccination and its determinants among patients with chronic disease visiting Debre Tabor Comprehensive Specialized Hospital, Northwest Ethiopia: A cross-sectional study.
    PLoS One. 2022;17:e0278914.
    PubMed     Abstract available


  679. SEGNI MT, Demissie HF, Adem MK, Geleto AK, et al
    Post COVID-19 vaccination side effects and associated factors among vaccinated health care providers in Oromia region, Ethiopia in 2021.
    PLoS One. 2022;17:e0278334.
    PubMed     Abstract available


  680. LACY R, Puma J, Tubolino M, LaRocca D, et al
    Rural parents' attitudes and beliefs on the COVID-19 pediatric vaccine: An explanatory study.
    PLoS One. 2022;17:e0278611.
    PubMed     Abstract available


  681. BELAYACHI J, Obtel M, Mhayi A, Razine R, et al
    Long term effectiveness of inactivated vaccine BBIBP-CorV (Vero Cells) against COVID-19 associated severe and critical hospitalization in Morocco.
    PLoS One. 2022;17:e0278546.
    PubMed     Abstract available


  682. WALLACE M, Collins JP, Moline H, Plumb ID, et al
    Effectiveness of Pfizer-BioNTech COVID-19 vaccine as evidence for policy action: A rapid systematic review and meta-analysis of non-randomized studies.
    PLoS One. 2022;17:e0278624.
    PubMed     Abstract available


  683. VAN BERGEN I, Boger S, Beaudart C, Hiligsmann M, et al
    Beliefs regarding COVID-19 vaccinations of young adults in the United Kingdom: An interview study applying the Integrated Change Model.
    PLoS One. 2022;17:e0277109.
    PubMed     Abstract available


  684. DU L, Kou Z, Ma C, Tao X, et al
    Correction: A Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines.
    PLoS One. 2022;17:e0278474.
    PubMed     Abstract available


  685. SUMPAICO-TANCHANCO LBC, Sy JCY, Dy ABC, Levantino M, et al
    The prevalence of SARS-CoV-2 antibodies within the community of a private tertiary university in the Philippines: A serial cross sectional study.
    PLoS One. 2022;17:e0268145.
    PubMed     Abstract available


  686. MUHINDO R, Okoboi S, Kiragga A, King R, et al
    COVID-19 vaccine acceptability, and uptake among people living with HIV in Uganda.
    PLoS One. 2022;17:e0278692.
    PubMed     Abstract available


  687. PETERSON CE, Dykens JA, Weine SM, Holt HK, et al
    Assessing the interrelationship between stigma, social influence, and cervical cancer prevention in an urban underserved setting: An exploratory study.
    PLoS One. 2022;17:e0278538.
    PubMed     Abstract available


  688. MALKIN J, Allen Scott L, Alberga Machado A, Teare G, et al
    Factors influencing human papillomavirus school-based immunization in Alberta: A mixed-methods study protocol.
    PLoS One. 2022;17:e0278472.
    PubMed     Abstract available


  689. AWASTHI S, Kohli N, Agarwal M, Pandey CM, et al
    Effectiveness of 13-valent pneumococcal conjugate vaccine on radiological primary end-point pneumonia among cases of severe community acquired pneumonia in children: A prospective multi-site hospital-based test-negative study in Northern India.
    PLoS One. 2022;17:e0276911.
    PubMed     Abstract available


  690. FOX A, Choi Y, Lanthorn H, Croke K, et al
    Does highlighting COVID-19 disparities reduce or increase vaccine intentions? evidence from a survey experiment in a diverse sample in New York State prior to vaccine roll-out.
    PLoS One. 2022;17:e0277043.
    PubMed     Abstract available


  691. GEISSLER F, Hartmann F, Humphreys M, Kluver H, et al
    Public support for global vaccine sharing in the COVID-19 pandemic: Evidence from Germany.
    PLoS One. 2022;17:e0278337.
    PubMed     Abstract available


  692. OJEA QUINTANA I, Reimann R, Cheong M, Alfano M, et al
    Polarization and trust in the evolution of vaccine discourse on Twitter during COVID-19.
    PLoS One. 2022;17:e0277292.
    PubMed     Abstract available


  693. DEMONE J, Maltseva M, Nourimand M, Nasr-Sharif M, et al
    Scalable agroinfiltration-based production of SARS-CoV-2 antigens for use in diagnostic assays and subunit vaccines.
    PLoS One. 2022;17:e0277668.
    PubMed     Abstract available


  694. LUNGTEN L, Tenzin T, Rinchen S, Chedup K, et al
    Assessment of the rabies education among middle secondary school students of southeastern Bhutan.
    PLoS One. 2022;17:e0276862.
    PubMed     Abstract available


  695. MAHARLOUEI N, Hosseinpour P, Erfani A, Shahriarirad R, et al
    Factors associated with reluctancy to acquire COVID-19 vaccination: A cross-sectional study in Shiraz, Iran, 2022.
    PLoS One. 2022;17:e0278967.
    PubMed     Abstract available


  696. NORMAN DA, Danchin M, Blyth CC, Palasanthiran P, et al
    Australian hospital paediatricians and nurses' perspectives and practices for influenza vaccine delivery in children with medical comorbidities.
    PLoS One. 2022;17:e0277874.
    PubMed     Abstract available


  697. SANDOVAL M, Nguyen DT, Huang HJ, Yi SG, et al
    COVID-19 mortality may be reduced among fully vaccinated solid organ transplant recipients.
    PLoS One. 2022;17:e0279222.
    PubMed     Abstract available


  698. ABDEL-MONEIM YAS, Alghamdi HY, Alrashed AM, Jawhari AM, et al
    Menstrual cycle changes: A cross-sectional study of Saudi females following SARS-CoV-2 infection.
    PLoS One. 2022;17:e0279408.
    PubMed     Abstract available


  699. ARJUN MC, Singh AK, Pal D, Das K, et al
    Characteristics and predictors of Long COVID among diagnosed cases of COVID-19.
    PLoS One. 2022;17:e0278825.
    PubMed     Abstract available


  700. KHOO SP, Muhammad Ridzuan Tan NA, Rajasuriar R, Nasir NH, et al
    Changes in genital Human Papillomavirus (HPV) prevalence among urban females a decade after the Malaysian HPV vaccination program.
    PLoS One. 2022;17:e0278477.
    PubMed     Abstract available


  701. LEURS K, Goossens E, Christensen H, Mainil JG, et al
    Development of a duplex qPCR for the differentiation of a live attenuated Escherichia coli aroA mutant vaccine strain from field isolates in chickens.
    PLoS One. 2022;17:e0278949.
    PubMed     Abstract available


  702. ODONGO S, Okella H, Ndekezi C, Okee M, et al
    Retrospective in silico mutation profiling of SARS-CoV-2 structural proteins circulating in Uganda by July 2021: Towards refinement of COVID-19 disease vaccines, diagnostics, and therapeutics.
    PLoS One. 2022;17:e0279428.
    PubMed     Abstract available



  703. Retraction: The anti-vaccination infodemic on social media: A behavioral analysis.
    PLoS One. 2022;17:e0279796.
    PubMed    


  704. AWANDU SS, Ochieng Ochieng A, Onyango B, Magwanga RO, et al
    High seroprevalence of Immunoglobulin G (IgG) and IgM antibodies to SARS-CoV-2 in asymptomatic and symptomatic individuals amidst vaccination roll-out in western Kenya.
    PLoS One. 2022;17:e0272751.
    PubMed     Abstract available


  705. EISNECKER PS, Kroh M, Kuhne S
    The role of generalized trust in COVID-19 vaccine acceptance.
    PLoS One. 2022;17:e0278854.
    PubMed     Abstract available


  706. KNIPES AK, Summers A, Sklavounos AA, Lamanna J, et al
    Use of a rapid digital microfluidics-powered immunoassay for assessing measles and rubella infection and immunity in outbreak settings in the Democratic Republic of the Congo.
    PLoS One. 2022;17:e0278749.
    PubMed     Abstract available


  707. SHEVTSOV A, Aushakhmetova Z, Amirgazin A, Khegay O, et al
    Whole genome sequence analysis of Neisseria meningitidis strains circulating in Kazakhstan, 2017-2018.
    PLoS One. 2022;17:e0279536.
    PubMed     Abstract available


  708. SMITH LE, Sherman SM, Sim J, Amlot R, et al
    Parents' intention to vaccinate their child for COVID-19: A mixed-methods study (CoVAccS-wave 3).
    PLoS One. 2022;17:e0279285.
    PubMed     Abstract available


  709. KHOLINA K, Harmon SHE, Graham JE
    An equitable vaccine delivery system: Lessons from the COVID-19 vaccine rollout in Canada.
    PLoS One. 2022;17:e0279929.
    PubMed     Abstract available


  710. LIU M, Zhao R, Ngai CSB
    Vaccines, media and politics: A corpus-assisted discourse study of press representations of the safety and efficacy of COVID-19 vaccines.
    PLoS One. 2022;17:e0279500.
    PubMed     Abstract available


  711. ODANI S, Koyama S, Katsumi Y, Miyashiro I, et al
    Attitudes toward COVID-19 vaccination during the state of emergency in Osaka, Japan.
    PLoS One. 2022;17:e0279481.
    PubMed     Abstract available


  712. CARLSON SJ, Tomkinson S, Blyth CC, Attwell K, et al
    COVID-19 vaccine knowledge, attitudes, and experiences of health care workers in Perth, Western Australia: A qualitative study.
    PLoS One. 2022;17:e0279557.
    PubMed     Abstract available


    January 2021
  713. KIM MH, Son NH, Park YS, Lee JH, et al
    Effect of a hospital-wide campaign on COVID-19 vaccination uptake among healthcare workers in the context of raised concerns for life-threatening side effects.
    PLoS One. 2021;16:e0258236.
    PubMed     Abstract available


  714. ROBERTSON CT, Bentele K, Meyerson B, Wood ASA, et al
    Effects of political versus expert messaging on vaccination intentions of Trump voters.
    PLoS One. 2021;16:e0257988.
    PubMed     Abstract available


  715. BACHELET T, Bourdenx JP, Martinez C, Mucha S, et al
    Humoral response after SARS-CoV-2 mRNA vaccines in dialysis patients: Integrating anti-SARS-CoV-2 Spike-Protein-RBD antibody monitoring to manage dialysis centers in pandemic times.
    PLoS One. 2021;16:e0257646.
    PubMed     Abstract available


  716. MURAYAMA T, Shimizu N, Fujita S, Wakamiya S, et al
    Predicting regional influenza epidemics with uncertainty estimation using commuting data in Japan.
    PLoS One. 2021;16:e0250417.
    PubMed     Abstract available


  717. ABBASIFARID E, Bolhassani A, Irani S, Sotoodehnejadnematalahi F, et al
    Synergistic effects of exosomal crocin or curcumin compounds and HPV L1-E7 polypeptide vaccine construct on tumor eradication in C57BL/6 mouse model.
    PLoS One. 2021;16:e0258599.
    PubMed     Abstract available


  718. ZAKHOUR R, Tamim H, Faytrouni F, Khoury J, et al
    Knowledge, attitude and practice of influenza vaccination among Lebanese parents: A cross-sectional survey from a developing country.
    PLoS One. 2021;16:e0258258.
    PubMed     Abstract available


  719. WHELAN J, Marshall H, Sullivan TR
    Intracluster correlation coefficients in a large cluster randomized vaccine trial in schools: Transmission and impact of shared characteristics.
    PLoS One. 2021;16:e0254330.
    PubMed     Abstract available


  720. NAVASCUES M, Budroni C, Guryanova Y
    Disease control as an optimization problem.
    PLoS One. 2021;16:e0257958.
    PubMed     Abstract available


  721. BALDWIN SL, Reese VA, Larsen SE, Beebe E, et al
    Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model.
    PLoS One. 2021;16:e0247990.
    PubMed     Abstract available


  722. ROUBY SR, Safwat NM, Hussein KH, Abdel-Ra'ouf AM, et al
    Lumpy skin disease outbreaks in Egypt during 2017-2018 among sheeppox vaccinated cattle: Epidemiological, pathological, and molecular findings.
    PLoS One. 2021;16:e0258755.
    PubMed     Abstract available


  723. WIN TTZ, Campbell A, Magalhaes RJS, Oo KN, et al
    What drives small-scale farmers to vaccinate their multiple livestock species animals against common infectious diseases in Myanmar?
    PLoS One. 2021;16:e0258765.
    PubMed     Abstract available


  724. ALISHAQ M, Nafady-Hego H, Jeremijenko A, Al Ajmi JA, et al
    Risk factors for breakthrough SARS-CoV-2 infection in vaccinated healthcare workers.
    PLoS One. 2021;16:e0258820.
    PubMed     Abstract available


  725. MALAMBA SS, Muyinda H, Ogwang DM, Katamba A, et al
    Cango Lyec (Healing the Elephant): Chronic Hepatitis B Virus among post-conflict affected populations living in mid-Northern Uganda.
    PLoS One. 2021;16:e0251573.
    PubMed     Abstract available


  726. KURTZ SL, De Pascalis R, Meierovics AI, Elkins KL, et al
    Deficiency in CCR2 increases susceptibility of mice to infection with an intracellular pathogen, Francisella tularensis LVS, but does not impair development of protective immunity.
    PLoS One. 2021;16:e0249142.
    PubMed     Abstract available


  727. COHEN AA, Yang Z, Gnanapragasam PNP, Ou S, et al
    Construction, characterization, and immunization of nanoparticles that display a diverse array of influenza HA trimers.
    PLoS One. 2021;16:e0247963.
    PubMed     Abstract available


  728. BITAR AN, Zawiah M, Al-Ashwal FY, Kubas M, et al
    Misinformation, perceptions towards COVID-19 and willingness to be vaccinated: A population-based survey in Yemen.
    PLoS One. 2021;16:e0248325.
    PubMed     Abstract available


  729. ARGOTE TIRONI P, Barham E, Zuckerman Daly S, Gerez JE, et al
    Messages that increase COVID-19 vaccine acceptance: Evidence from online experiments in six Latin American countries.
    PLoS One. 2021;16:e0259059.
    PubMed     Abstract available


  730. GAO X, Wang L, Zhang H, Zhu B, et al
    Transcriptome analysis and identification of genes associated with floral transition and fruit development in rabbiteye blueberry (Vaccinium ashei).
    PLoS One. 2021;16:e0259119.
    PubMed     Abstract available


  731. ELLIOTT T, Yehia BR, Winegar AL, Raja JK, et al
    Analysis of COVID-19 vaccine non-intent by essential vs non-essential worker, demographic, and socioeconomic status among 101,048 US adults.
    PLoS One. 2021;16:e0258540.
    PubMed     Abstract available


  732. MARTIN-MARQUEZ BT, Satoh M, Hernandez-Pando R, Martinez-Garcia EA, et al
    The DNA co-vaccination using Sm antigen and IL-10 as prophylactic experimental therapy ameliorates nephritis in a model of lupus induced by pristane.
    PLoS One. 2021;16:e0259114.
    PubMed     Abstract available


  733. LEONHARDT JM, Ridinger G, Rong Y, Talaei-Khoe A, et al
    Invincibility threatens vaccination intentions during a pandemic.
    PLoS One. 2021;16:e0258432.
    PubMed     Abstract available


  734. TARIQ MH, Bhatti R, Ali NF, Ashfaq UA, et al
    Rational design of chimeric Multiepitope Based Vaccine (MEBV) against human T-cell lymphotropic virus type 1: An integrated vaccine informatics and molecular docking based approach.
    PLoS One. 2021;16:e0258443.
    PubMed     Abstract available


  735. JANG H, Ross TM
    Influence of the H1N1 influenza pandemic on the humoral immune response to seasonal flu vaccines.
    PLoS One. 2021;16:e0258453.
    PubMed     Abstract available


  736. ENRIA L, Bangura JS, Kanu HM, Kalokoh JA, et al
    Bringing the social into vaccination research: Community-led ethnography and trust-building in immunization programs in Sierra Leone.
    PLoS One. 2021;16:e0258252.
    PubMed     Abstract available


  737. SOWE A, Njie M, Sowe D, Fofana S, et al
    Epidemiology of measles cases, vaccine effectiveness, and performance towards measles elimination in The Gambia.
    PLoS One. 2021;16:e0258961.
    PubMed     Abstract available


  738. ARNHEIM-DAHLSTROM L, Zarabi N, Hagen K, Bencina G, et al
    Parental acceptance and knowledge of varicella vaccination in relation to socioeconomics in Sweden: A cross-sectional study.
    PLoS One. 2021;16:e0256642.
    PubMed     Abstract available


  739. GOMES D, Beyerlein A, Katz K, Hoelscher G, et al
    Is the BNT162b2 COVID-19 vaccine effective in elderly populations? Results from population data from Bavaria, Germany.
    PLoS One. 2021;16:e0259370.
    PubMed     Abstract available


  740. SCHNEIDER JA, Taylor BG, Hotton AL, Lamuda PA, et al
    National variability in Americans' COVID-19 protective behaviors: Implications for vaccine roll-out.
    PLoS One. 2021;16:e0259257.
    PubMed     Abstract available


  741. HYLAND P, Vallieres F, Hartman TK, McKay R, et al
    Detecting and describing stability and change in COVID-19 vaccine receptibility in the United Kingdom and Ireland.
    PLoS One. 2021;16:e0258871.
    PubMed     Abstract available


  742. FANTIN RF, Fraga VG, Lopes CA, de Azevedo IC, et al
    New highly antigenic linear B cell epitope peptides from PvAMA-1 as potential vaccine candidates.
    PLoS One. 2021;16:e0258637.
    PubMed     Abstract available


  743. DOHERTY IA, Pilkington W, Brown L, Billings V, et al
    COVID-19 vaccine hesitancy in underserved communities of North Carolina.
    PLoS One. 2021;16:e0248542.
    PubMed     Abstract available


  744. ANDRASIK MP, Broder GB, Wallace SE, Chaturvedi R, et al
    Increasing Black, Indigenous and People of Color participation in clinical trials through community engagement and recruitment goal establishment.
    PLoS One. 2021;16:e0258858.
    PubMed     Abstract available


  745. PRENTOE J, Janitzek CM, Velazquez-Moctezuma R, Goksoyr L, et al
    Antigenic and immunogenic evaluation of permutations of soluble hepatitis C virus envelope protein E2 and E1 antigens.
    PLoS One. 2021;16:e0255336.
    PubMed     Abstract available


  746. MUELLER JE, Seanehia J, Yaro S, Trotter CL, et al
    Knowledge, beliefs and practices regarding prevention of bacterial meningitis in Burkina Faso, 5 years after MenAfriVac mass campaigns.
    PLoS One. 2021;16:e0253263.
    PubMed     Abstract available


  747. BONAPARTE SC, Adams L, Bakamutumaho B, Barbosa Costa G, et al
    Rabies post-exposure healthcare-seeking behaviors and perceptions: Results from a knowledge, attitudes, and practices survey, Uganda, 2013.
    PLoS One. 2021;16:e0251702.
    PubMed     Abstract available


  748. KUMAR NP, Padmapriyadarsini C, Rajamanickam A, Bhavani PK, et al
    BCG vaccination induces enhanced frequencies of memory T cells and altered plasma levels of common gammac cytokines in elderly individuals.
    PLoS One. 2021;16:e0258743.
    PubMed     Abstract available


  749. WISMANS A, Thurik R, Baptista R, Dejardin M, et al
    Correction: Psychological characteristics and the mediating role of the 5C Model in explaining students' COVID-19 vaccination intention.
    PLoS One. 2021;16:e0259922.
    PubMed     Abstract available


  750. HEINE F, Wolters E
    Using moral foundations in government communication to reduce vaccine hesitancy.
    PLoS One. 2021;16:e0259435.
    PubMed     Abstract available


  751. GRAY AN, Martin-Blais R, Tobin NH, Wang Y, et al
    Humoral responses to SARS-CoV-2 mRNA vaccines: Role of past infection.
    PLoS One. 2021;16:e0259703.
    PubMed     Abstract available


  752. GOMES DE MACEDO BACURAU A, Sato APS, Francisco PMSB
    Reasons for nonadherence to vaccination for influenza among older people in Brazil.
    PLoS One. 2021;16:e0259640.
    PubMed     Abstract available


  753. KISAKA S, Makumbi FE, Majalija S, Kagaha A, et al
    "As long as the patient tells you it was a dog that bit him, why do you need to know more?" A qualitative study of how healthcare workers apply clinical guidelines to treat dog bite injuries in selected hospitals in Uganda.
    PLoS One. 2021;16:e0254650.
    PubMed     Abstract available


  754. MBULAWA ZZA, Somdyala NI, Mabunda SA, Williamson AL, et al
    High human papillomavirus prevalence among females attending high school in the Eastern Cape Province of South Africa.
    PLoS One. 2021;16:e0253074.
    PubMed     Abstract available


  755. STOCKELER AM, Schuster P, Zimmermann M, Hanses F, et al
    Influenza vaccination coverage among emergency department personnel is associated with perception of vaccination and side effects, vaccination availability on site and the COVID-19 pandemic.
    PLoS One. 2021;16:e0260213.
    PubMed     Abstract available


  756. KIKUTI M, Sanhueza J, Vilalta C, Paploski IAD, et al
    Porcine reproductive and respiratory syndrome virus 2 (PRRSV-2) genetic diversity and occurrence of wild type and vaccine-like strains in the United States swine industry.
    PLoS One. 2021;16:e0259531.
    PubMed     Abstract available


  757. MUFLIHAH H, Florido M, Lin LCW, Xia Y, et al
    Boosting BCG with recombinant influenza A virus tuberculosis vaccines increases pulmonary T cell responses but not protection against Mycobacterium tuberculosis infection.
    PLoS One. 2021;16:e0259829.
    PubMed     Abstract available


  758. VENKATESAN MM, Ballou C, Barnoy S, McNeal M, et al
    Antibody in Lymphocyte Supernatant (ALS) responses after oral vaccination with live Shigella sonnei vaccine candidates WRSs2 and WRSs3 and correlation with serum antibodies, ASCs, fecal IgA and shedding.
    PLoS One. 2021;16:e0259361.
    PubMed     Abstract available


  759. BAUM U, Poukka E, Palmu AA, Salo H, et al
    Effectiveness of vaccination against SARS-CoV-2 infection and Covid-19 hospitalisation among Finnish elderly and chronically ill-An interim analysis of a nationwide cohort study.
    PLoS One. 2021;16:e0258704.
    PubMed     Abstract available


  760. ISLAM MR, Oraby T, McCombs A, Chowdhury MM, et al
    Evaluation of the United States COVID-19 vaccine allocation strategy.
    PLoS One. 2021;16:e0259700.
    PubMed     Abstract available


  761. BRESLIN G, Dempster M, Berry E, Cavanagh M, et al
    COVID-19 vaccine uptake and hesitancy survey in Northern Ireland and Republic of Ireland: Applying the theory of planned behaviour.
    PLoS One. 2021;16:e0259381.
    PubMed     Abstract available


  762. GERRETSEN P, Kim J, Caravaggio F, Quilty L, et al
    Individual determinants of COVID-19 vaccine hesitancy.
    PLoS One. 2021;16:e0258462.
    PubMed     Abstract available


  763. SCHERRER JF, Salas J, Wiemken TL, Hoft DF, et al
    Impact of herpes zoster vaccination on incident dementia: A retrospective study in two patient cohorts.
    PLoS One. 2021;16:e0257405.
    PubMed     Abstract available


  764. PAPAZOGLOU DD, Baretella O, Feller M, Del Giovane C, et al
    Cross-sectional study on the prevalence of influenza and pneumococcal vaccination and its association with health conditions and risk factors among hospitalized multimorbid older patients.
    PLoS One. 2021;16:e0260112.
    PubMed     Abstract available


  765. SCHOMMER SK, Harrison N, Linville M, Samuel MS, et al
    Serologic titers to Leptospira in vaccinated pigs and interpretation for surveillance.
    PLoS One. 2021;16:e0260052.
    PubMed     Abstract available


  766. ACEVEDO-VILLANUEVA KY, Renu S, Shanmugasundaram R, Akerele GO, et al
    Salmonella chitosan nanoparticle vaccine administration is protective against Salmonella Enteritidis in broiler birds.
    PLoS One. 2021;16:e0259334.
    PubMed     Abstract available


  767. BRADFIELD Z, Wynter K, Hauck Y, Sweet L, et al
    COVID-19 vaccination perceptions and intentions of maternity care consumers and providers in Australia.
    PLoS One. 2021;16:e0260049.
    PubMed     Abstract available


  768. SINCLAIR DR, Maharani A, Stow D, Welsh CE, et al
    Can vaccination roll-out be more equitable if population risk is taken into account?
    PLoS One. 2021;16:e0259990.
    PubMed     Abstract available


  769. MUHAJARINE N, Adeyinka DA, McCutcheon J, Green KL, et al
    COVID-19 vaccine hesitancy and refusal and associated factors in an adult population in Saskatchewan, Canada: Evidence from predictive modelling.
    PLoS One. 2021;16:e0259513.
    PubMed     Abstract available


  770. COOKSON D, Jolley D, Dempsey RC, Povey R, et al
    A social norms approach intervention to address misperceptions of anti-vaccine conspiracy beliefs amongst UK parents.
    PLoS One. 2021;16:e0258985.
    PubMed     Abstract available


  771. RAO CY, Robinson T, Huster K, Laws RL, et al
    Occupational exposures and mitigation strategies among homeless shelter workers at risk of COVID-19.
    PLoS One. 2021;16:e0253108.
    PubMed     Abstract available


  772. GOMES LC, Sanson MCG, Brainin P, de Melo MDCV, et al
    Levels of hepatitis B antibody titers are affected by age and doses gap time in children from a high endemic area of the western Amazon.
    PLoS One. 2021;16:e0253752.
    PubMed     Abstract available


  773. JEREMIAH K, Lyimo E, Ritz C, PrayGod G, et al
    Prevalence of Mycobacterium tuberculosis infection as measured by the QuantiFERON-TB Gold assay and ESAT-6 free IGRA among adolescents in Mwanza, Tanzania.
    PLoS One. 2021;16:e0252808.
    PubMed     Abstract available


  774. VAN EGEREN D, Stoddard M, Novokhodko A, Rogers MS, et al
    Rapid relaxation of pandemic restrictions after vaccine rollout favors growth of SARS-CoV-2 variants: A model-based analysis.
    PLoS One. 2021;16:e0258997.
    PubMed     Abstract available


  775. CHACON-DIAZ C, Zabalza-Barangua A, San Roman B, Blasco JM, et al
    Brucella abortus S19 GFP-tagged vaccine allows the serological identification of vaccinated cattle.
    PLoS One. 2021;16:e0260288.
    PubMed     Abstract available


  776. DEVI YD, Goswami HB, Konwar S, Doley C, et al
    Immunoinformatics mapping of potential epitopes in SARS-CoV-2 structural proteins.
    PLoS One. 2021;16:e0258645.
    PubMed     Abstract available


  777. YAMAMOTO K, Suzuki M, Ujiie M, Kanagawa S, et al
    Catch-up immunization for adolescents and young adults during pre-travel consultation in Japan.
    PLoS One. 2021;16:e0258357.
    PubMed     Abstract available


  778. ZORIGT T, Furuta Y, Simbotwe M, Ochi A, et al
    Development of ELISA based on Bacillus anthracis capsule biosynthesis protein CapA for naturally acquired antibodies against anthrax.
    PLoS One. 2021;16:e0258317.
    PubMed     Abstract available


  779. PHATIHATTAKORN C, Wongsa A, Pongpan K, Anuwuthinawin S, et al
    Seroprevalence of Zika virus in pregnant women from central Thailand.
    PLoS One. 2021;16:e0257205.
    PubMed     Abstract available


  780. LUCHEN CC, Mwaba J, Ng'ombe H, Alabi PIO, et al
    Effect of HIV status and retinol on immunogenicity to oral cholera vaccine in adult population living in an endemic area of Lukanga Swamps, Zambia.
    PLoS One. 2021;16:e0260552.
    PubMed     Abstract available


  781. MENA G, Casas I, Casan C, Aunon M, et al
    Influenza vaccination coverage and factors associated with severe laboratory-confirmed influenza-related illness in patients receiving care at a tertiary hospital in Catalonia (Spain) during the 2018-2019 epidemic season.
    PLoS One. 2021;16:e0260397.
    PubMed     Abstract available


  782. CAPITINE IPU, Macicame IB, Uanela AM, Bhatt NB, et al
    Young at risk-people in Maputo City, Mozambique, present a high willingness to participate in HIV trials: Results from an HIV vaccine preparedness cohort study.
    PLoS One. 2021;16:e0260126.
    PubMed     Abstract available


  783. ANJORIN AA, Odetokun IA, Abioye AI, Elnadi H, et al
    Will Africans take COVID-19 vaccination?
    PLoS One. 2021;16:e0260575.
    PubMed     Abstract available


  784. BRAILOVSKAIA J, Schneider S, Margraf J
    To vaccinate or not to vaccinate!? Predictors of willingness to receive Covid-19 vaccination in Europe, the U.S., and China.
    PLoS One. 2021;16:e0260230.
    PubMed     Abstract available


  785. IOANNOU GN, Green P, Locke ER, Berry K, et al
    Factors associated with early receipt of COVID-19 vaccination and adherence to second dose in the Veterans Affairs healthcare system.
    PLoS One. 2021;16:e0259696.
    PubMed     Abstract available


  786. GUPTA S, Watanabe S, Laurent SM
    Psychological predictors of vaccination intentions among U.S. undergraduates and online panel workers during the 2020 COVID-19 pandemic.
    PLoS One. 2021;16:e0260380.
    PubMed     Abstract available


  787. MUSTAPHA M, Lawal BK, Sha'aban A, Jatau AI, et al
    Factors associated with acceptance of COVID-19 vaccine among University health sciences students in Northwest Nigeria.
    PLoS One. 2021;16:e0260672.
    PubMed     Abstract available


  788. ABDOU MS, Kheirallah KA, Aly MO, Ramadan A, et al
    The coronavirus disease 2019 (COVID-19) vaccination psychological antecedent assessment using the Arabic 5c validated tool: An online survey in 13 Arab countries.
    PLoS One. 2021;16:e0260321.
    PubMed     Abstract available


  789. DROPPA-ALMEIDA D, da Silva GA, Gaspar LMDAC, Pereyra BBS, et al
    Peptide vaccines designed with the aid of immunoinformatic against Caseous Lymphadenitis promotes humoral and cellular response induction in mice.
    PLoS One. 2021;16:e0256864.
    PubMed     Abstract available


  790. BARRY M, Temsah MH, Alhuzaimi A, Alamro N, et al
    COVID-19 vaccine confidence and hesitancy among health care workers: A cross-sectional survey from a MERS-CoV experienced nation.
    PLoS One. 2021;16:e0244415.
    PubMed     Abstract available


  791. POLLOCK BH, Kilpatrick AM, Eisenman DP, Elton KL, et al
    Safe reopening of college campuses during COVID-19: The University of California experience in Fall 2020.
    PLoS One. 2021;16:e0258738.
    PubMed     Abstract available


  792. GALLANT AJ, Nicholls LAB, Rasmussen S, Cogan N, et al
    Changes in attitudes to vaccination as a result of the COVID-19 pandemic: A longitudinal study of older adults in the UK.
    PLoS One. 2021;16:e0261844.
    PubMed     Abstract available


  793. QAMAR W, Qayum M, Sadiq N
    Assessing the knowledge and skill of vaccination staff at Adult Vaccination Counters for COVID-19 vaccines: Simulated client method.
    PLoS One. 2021;16:e0261286.
    PubMed     Abstract available


  794. FONTENOT HB, Mattheus DB, Lim E, Michel A, et al
    Undergraduate nursing students' COVID-19 vaccine intentions: A national survey.
    PLoS One. 2021;16:e0261669.
    PubMed     Abstract available


  795. MAYAN D, Nguyen K, Keisler B
    National attitudes of medical students towards mandating the COVID-19 vaccine and its association with knowledge of the vaccine.
    PLoS One. 2021;16:e0260898.
    PubMed     Abstract available


  796. YANG C, Yang Y, Li Y
    Assessing vaccination priorities for different ages and age-specific vaccination strategies of COVID-19 using an SEIR modelling approach.
    PLoS One. 2021;16:e0261236.
    PubMed     Abstract available


  797. KING WC, Rubinstein M, Reinhart A, Mejia R, et al
    Time trends, factors associated with, and reasons for COVID-19 vaccine hesitancy: A massive online survey of US adults from January-May 2021.
    PLoS One. 2021;16:e0260731.
    PubMed     Abstract available


  798. SUBEDI P, Yadav GK, Paudel B, Regmi A, et al
    Adverse events following the first dose of Covishield (ChAdOx1 nCoV-19) vaccination among health workers in selected districts of central and western Nepal: A cross-sectional study.
    PLoS One. 2021;16:e0260638.
    PubMed     Abstract available


  799. FIRSTOVA VV, Shakhova AS, Riabko AK, Silkina MV, et al
    Characterization of the adaptive immune response of donors receiving live anthrax vaccine.
    PLoS One. 2021;16:e0260202.
    PubMed     Abstract available


  800. ROSETTIE KL, Joffe JN, Sparks GW, Aravkin A, et al
    Cost-effectiveness of HPV vaccination in 195 countries: A meta-regression analysis.
    PLoS One. 2021;16:e0260808.
    PubMed     Abstract available


  801. MOHAMMED R, Nguse TM, Habte BM, Fentie AM, et al
    COVID-19 vaccine hesitancy among Ethiopian healthcare workers.
    PLoS One. 2021;16:e0261125.
    PubMed     Abstract available


  802. HORIUCHI S, Sakamoto H, Abe SK, Shinohara R, et al
    Factors of parental COVID-19 vaccine hesitancy: A cross sectional study in Japan.
    PLoS One. 2021;16:e0261121.
    PubMed     Abstract available


  803. THOMPSON J, Wattam S
    Estimating the impact of interventions against COVID-19: From lockdown to vaccination.
    PLoS One. 2021;16:e0261330.
    PubMed     Abstract available



  804. Retraction: Changes in Innate and Permissive Immune Responses after HBV Transgenic Mouse Vaccination and Long-Term-siRNA Treatment.
    PLoS One. 2021;16:e0261693.
    PubMed    


  805. KOESNOE S, Masjkuri N, Adisasmita A, Djauzi S, et al
    A randomized controlled trial to evaluate the effect of influenza vaccination and probiotic supplementation on immune response and incidence of influenza-like illness in an elderly population in Indonesia.
    PLoS One. 2021;16:e0250234.
    PubMed     Abstract available


  806. ZENS KD, Baroutsou V, Sinniger P, Lang P, et al
    A cross-sectional study evaluating tick-borne encephalitis vaccine uptake and timeliness among adults in Switzerland.
    PLoS One. 2021;16:e0247216.
    PubMed     Abstract available


  807. ISSA T, Babi A, Issanov A, Akilzhanova A, et al
    Knowledge and awareness of human papillomavirus infection and human papillomavirus vaccine among Kazakhstani women attending gynecological clinics.
    PLoS One. 2021;16:e0261203.
    PubMed     Abstract available


  808. CASAS-DEZA D, Bernal-Monterde V, Aranda-Alonso AN, Montil-Miguel E, et al
    Age-related mortality in 61,993 confirmed COVID-19 cases over three epidemic waves in Aragon, Spain. Implications for vaccination programmes.
    PLoS One. 2021;16:e0261061.
    PubMed     Abstract available


  809. HOSSAIN MB, Alam MZ, Islam MS, Sultan S, et al
    COVID-19 vaccine hesitancy among the adult population in Bangladesh: A nationwide cross-sectional survey.
    PLoS One. 2021;16:e0260821.
    PubMed     Abstract available


  810. FERWANA I, Varshney LR
    Social capital dimensions are differentially associated with COVID-19 vaccinations, masks, and physical distancing.
    PLoS One. 2021;16:e0260818.
    PubMed     Abstract available


  811. HARGREAVES HEAP SP, Koop C, Matakos K, Unan A, et al
    Good news reduces trust in government and its efficacy: The case of the Pfizer/BioNTech vaccine announcement.
    PLoS One. 2021;16:e0260216.
    PubMed     Abstract available


  812. KADELKA C, McCombs A
    Effect of homophily and correlation of beliefs on COVID-19 and general infectious disease outbreaks.
    PLoS One. 2021;16:e0260973.
    PubMed     Abstract available


  813. GLAZIK R, Moore H, Kennedy D, Bower H, et al
    A snapshot of the practicality and barriers to COVID-19 interventions: Public health and healthcare workers' perceptions in high and low- and middle-income countries.
    PLoS One. 2021;16:e0260041.
    PubMed     Abstract available


  814. MUSTAFA SS, Jamshed S, Vadamalai K, Ramsey A, et al
    Subcutaneous immunoglobulin replacement for treatment of humoral immune dysfunction in patients with chronic lymphocytic leukemia.
    PLoS One. 2021;16:e0258529.
    PubMed     Abstract available


  815. OYO-ITA AE, Hanlon P, Nwankwo O, Bosch-Capblanch X, et al
    Cost-effectiveness analysis of an intervention project engaging Traditional and Religious Leaders to improve uptake of childhood immunization in southern Nigeria.
    PLoS One. 2021;16:e0257277.
    PubMed     Abstract available


  816. AHSAN A, Dar S, Hassan F, Ghafoor F, et al
    Characterization of linear epitope specificity of antibodies potentially contributing to spontaneous clearance of hepatitis C virus.
    PLoS One. 2021;16:e0256816.
    PubMed     Abstract available


  817. MACIUSZEK J, Polak M, Stasiuk K, Dolinski D, et al
    Active pro-vaccine and anti-vaccine groups: Their group identities and attitudes toward science.
    PLoS One. 2021;16:e0261648.
    PubMed     Abstract available


  818. JENSEN EA, Wagoner B, Pfleger A, Herbig L, et al
    Making sense of unfamiliar COVID-19 vaccines: How national origin affects vaccination willingness.
    PLoS One. 2021;16:e0261273.
    PubMed     Abstract available


  819. MIRON VD, Banica L, Sandulescu O, Paraschiv S, et al
    Clinical and molecular epidemiology of influenza viruses from Romanian patients hospitalized during the 2019/20 season.
    PLoS One. 2021;16:e0258798.
    PubMed     Abstract available


  820. LEE MF, Chiang CH, Lin SJ, Wu CS, et al
    Effectiveness and safety of oral lactococci-based vaccine encoding triple common allergens to prevent airway allergy in mice.
    PLoS One. 2021;16:e0261333.
    PubMed     Abstract available


  821. BERENDAM SJ, Morgan-Asiedu PK, Mangan RJ, Li SH, et al
    Different adjuvanted pediatric HIV envelope vaccines induced distinct plasma antibody responses despite similar B cell receptor repertoires in infant rhesus macaques.
    PLoS One. 2021;16:e0256885.
    PubMed     Abstract available


  822. PEREZ CHACON G, Fathima P, Jones M, Barnes R, et al
    Pertussis immunisation in infancy and atopic outcomes: A protocol for a population-based cohort study using linked administrative data.
    PLoS One. 2021;16:e0260388.
    PubMed     Abstract available


  823. VEALS AM, Koprowski JL, Bergman DL, VerCauteren KC, et al
    Occurrence of mesocarnivores in montane sky islands: How spatial and temporal overlap informs rabies management in a regional hotspot.
    PLoS One. 2021;16:e0259260.
    PubMed     Abstract available


  824. GUAN TH, Htut HN, Davison CM, Sebastian S, et al
    Implementation of a neonatal hepatitis B immunization program in rural Karenni State, Myanmar: A mixed-methods study.
    PLoS One. 2021;16:e0261470.
    PubMed     Abstract available


  825. EZAJ MMA, Haque MS, Syed SB, Khan MSA, et al
    Comparative proteomic analysis to annotate the structural and functional association of the hypothetical proteins of S. maltophilia k279a and predict potential T and B cell targets for vaccination.
    PLoS One. 2021;16:e0252295.
    PubMed     Abstract available


  826. ZEIGLER DF, Gage E, Clegg CH
    Epitope-targeting platform for broadly protective influenza vaccines.
    PLoS One. 2021;16:e0252170.
    PubMed     Abstract available


  827. CHISENGA CC, Bosomprah S, Simuyandi M, Mwila-Kazimbaya K, et al
    Shigella-specific antibodies in the first year of life among Zambian infants: A longitudinal cohort study.
    PLoS One. 2021;16:e0252222.
    PubMed     Abstract available


  828. GENTILE A, Giglio N, Lucion MF, Martinez AC, et al
    Impact of varicella vaccine on nosocomial outbreaks and management of post exposure prophylaxis following in a paediatric hospital.
    PLoS One. 2021;16:e0251496.
    PubMed     Abstract available


  829. WOLFF E, Widgren K, Scalia Tomba G, Roth A, et al
    Cost-effectiveness of varicella and herpes zoster vaccination in Sweden: An economic evaluation using a dynamic transmission model.
    PLoS One. 2021;16:e0251644.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.